Exercise and cardiovascular risk reduction by Wijnen, J.A.G.
  
 
Exercise and cardiovascular risk reduction
Citation for published version (APA):
Wijnen, J. A. G. (1994). Exercise and cardiovascular risk reduction. Maastricht: Datawyse / Universitaire
Pers Maastricht.
Document status and date:
Published: 01/01/1994
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
EXERCISE AND CARDIOVASCULAR
RISK REDUCTION
CIP-DATA KONINKLIJKE BIBLIOTHEEK, DEN HAAG
Wijnen, Joseph Anna Guillaume
Exercise and cardiovascular risk reduction / Joseph Anna
Guillaume Wijnen. - Maastricht: Universitaire Pers
Maastricht. - 111.
Thesis Maastricht. - With ref. - With summary in Dutch.
ISBN 90-5278-165-6
Subject headings: exercise and cardiovascular diseases /
exercise and hypertension / antihypertensives
This thesis was supported, in part, by Funds from the Dutch Ministry of Welfare, Health and
Cultural Affairs and SmithKline Beecham BV
Publicatie van dit proefschrift werd mogelijk gemaakt dankzij een opleidingsgrant van
AOV/ABP
EXERCISE AND CARDIOVASCULAR
RISK REDUCTION
PROEFSCHRIFT
ter verkrijging van de graad van doctor
aan de Rijksuniversiteit Limburg te Maastricht,
op gezag van de Rector Magnificus, Prof. dr. H. Philipsen,
volgens het besluit van het college van Dekanen,
in het openbaar te verdedigen
op woensdag 21 december 1994 om 14.00 uur
door
Joseph Anna Guillaume Wijnen
geboren te Maastricht in 1958
UPM
UNIVERSITAIRE PERS MAASTRICHT
Promotor
Prof. dr. H.A.J. Struijker Boudier
Co-promotores
Dr. M.A. van Baak
Dr. L.M.A.B. Van Bortel
Beoordelingscommissie
Prof. dr. H. Kuipers (voorzitter)
Prof. dr. R.H. Fagard, Katholieke Universiteit Leuven
Prof. dr. J.W. van Ree
Prof. dr. W.H.M. Saris
Dr. J.L.R.M. Smeets
Contents
Chapter 1
General introduction 9
1.1 Is physical inactivity a risk factor for cardiovascular disease? 9
1.1.1 Direct effect 9
1.1.2 Indirect effect(s) 11
1.2 The effect of chronic exercise on blood pressure 13
1.2.1 The effect of endurance training on blood pressure at rest 13
1.2.2 The effect of endurance training on ambulatory blood pressure 16
1.2.3 The effect of endurance training on blood pressure during
exercise 16
1.3 Possible mechanisms for the hypotensive effect of exercise
training 20
1.3.1 Mechanisms for a reduction in cardiac output 21
1.3.2 Mechanisms for an exercise-related reduction in peripheral
resistance 22
1.4 Effect of chronic exercise on the heart and vessels 25
1.4.1 Heart 25
1.4.2 Vessels *u«m!fib 26
1.5 Exercise stress testing in blood pressure evaluation 29
1.5.1 Excessive blood pressure response during exercise as a !«> i.;*#
predictor of future hypertension 30
1.5.2 Exercise testing in assessment of hypertension -,-•..... . .(.. 3]
1.6 Antihypertensive medication and exercise 32
1.6.1 Which antihypertensive drug to choose in the physically active
patient? 33
1.6.2 Exercise and beta-blockers with vasodilating activity: a
comparison with classical beta-blocker therapy 35
1.7 Aims of this thesis 40
1.8 References 41
Chapter 2
Effect of exercise training on ambulatory blood pressure 55
Chapter 3
Vessel wall properties of large arteries in trained and sedentary subjects 69
Chapter 4
Vessel wall properties of large arteries and endurance training 79
Chapter 5.1
Variations in exercise systolic blood pressure in physically active
middle-aged men with normal and elevated blood pressure 89
Chapter 5.2
Exercise systolic blood pressure in middle-aged women with normal
and elevated blood pressure 101
Chapter 6
Beta-blockade and lipolysis during endurance exercise 111
Chapter 7
Effect of antihypertensive treatment with carvedilol on submaximal
endurance performance in patients with essential hypertension 123
Chapter 8
General discussion 137
Samenvatting 147
List of abbreviations 151
Dankwoord 153
Curriculum vitae 155
Publications 156
poor
ouders

CHAPTER 1
General introduction
1. GENERAL INTRODUCTION
Large epidemiologic investigations (1, 2, 3) have established three major and
independent factors that predict the mortality risk of cardiovascular disease,
especially of coronary heart disease (CHD). Blood pressure (BP), serum total
cholesterol and cigarette smoking have a continuous positive association with
major cardiovascular events (4) and a distinct escalation of risk is noted for
combinations of these risk factors (2). Other factors have been frequently
associated with the pathogenesis of CHD, such as obesity (body mass index),
high alcohol consumption, hyperglycemia, hyperinsulinemia, elevated serum
levels of uric acid, triglycerides, low-density lipoproteins (LDL) and low
serum levels of high-density (HDL) lipoproteins, although their independent
predictive ability after allowance for the standard risk factors is doubted by
some (5). Nevertheless, there is an increasing body of data to support the
independence of a direct relationship of LDL-cholesterol and the inverse
relationship of HDL-cholesterol to the risk of developing CHD (6, 7).
2.2 is p/zys/ca/ inactivity a risfc/actor /or card/oyascu/flr disease?
Several lines of evidence from epidemiological studies, cross-sectional obser-
vations and intervention studies implicate physical inactivity as an important
risk factor to develop cardiovascular disease, in different ways.
1.2.2 Direct e/fecf
Powell et al (8), reviewing the literature on the role of habitual physical
activity in the primary prevention of CHD, concluded that the relative risk for
CHD of physical inactivity appears to be similar in magnitude to that of
hypertension, hypercholesterolemia and smoking. In a more positive way, it
might be anticipated that regular exercise protects against cardiovascular
disease. However, one should bear in mind that evidence for this relationship
is derived from observational and prospective epidemiological studies. To
establish a true cause effect relationship, a large clinical trial is required in
which healthy individuals are randomly assigned to different activity pat-
terns ranging from low to high activity levels of different durations, and with
and without sufficient intensity to improve cardiovascular fitness (a training
status). Those trials have not been performed yet and their feasibility can be
questioned, because of high costs, logistic and ethical problems and they
would be accompanied by a high attrition rate associated with exercise.
Studies relating physical activity on the job with the incidence of CHD
found that workers in physically demanding jobs have a decreased risk of
CHD in comparison to their sedentary counterparts (9-13). Paffenbarger and
colleagues (14,15) followed longshoremen for 22 years and showed that after
adjustments for all major risk factors and post-morbid job transfers men in the
highest work activity category had a fatal heart attack rate of only half that of
men in the lowest work activity category. In the Framingham study (16),
overall mortality and mortality due to cardiovascular and ischemic heart
disease were inversely related to the level of physical activity for men but not
for women. In a later study of the Framingham cohort (17), improved overall,
cardiovascular and coronary mortality was found with increasing levels of
24-hour physical activity in men over a period of 24 years. These mortality
benefits applied to both individuals with as well as individuals without
intervening overt cardiovascular disease, and was not significantly related to
physical demand on the job.
More recent studies have addressed the role of leisure time activity in the
prevention of cardiovascular disease. Harvard alumni were followed after
graduation (18) and a strong inverse relation was found between habitual
exercise and total cardiovascular disease. Sedentary alumni, exercising less
than 500 kcal/week, were at 49% greater adjusted risk for a heart attack
compared to the most active men (> 2000 kcal/week). Other studies (19, 20)
suggest that especially vigorous aerobic exercise that has to be habitual, and
not high totals of physical activity per se, is protective against non-fatal and
fatal CHD. Supportive for this suggestion is a study (21) that showed that
habitual high intensity leisure time activity (> 60% VC>2max) reduced the risk
of primary cardiac arrest by 40% compared to low and moderate intensity
activity. Furthermore, it has been shown that although the risk of cardiac
arrest is transiently increased during vigorous exercise, it is much more
increased in sedentary individuals (22).
Physical fitness and regular physical activity are related (23, 24) although
they cannot be regarded as synonymous (23, 25). Fitness level depends on
genetic endowment, characteristics of the individual and kind, frequency and
duration of the activities performed. Initial physical fitness, measured either
by maximal treadmill test or maximal cycle ergometry has been found to be
predictive for future development of manifestations of cardiovascular disease
10
Table 1. Possible direct mechanisms for preventing CHD and CVD by regular physical ac-
tivity based on ref 8,24,29
- Decreased myocardial work and oxygen demand
- Enhanced myocardial function
- Improved myocardial oxygen delivery or utilization
- Enhanced myocardial electrical stability
- Modification in structure of the coronary arteries
- Retardation or regression of atherosclerosis
- Reduction of (coronary) vasospasm
- Increased fibrinolytic activity
- Reduction in aggregability of platelets
(26-28). A lower level of physical fitness is associated with a higher risk of
death from CHD and cardiovascular disease in healthy men, independent of
conventional coronary risk factors, HDL and LDL-cholesterol (24).
A strong and graded association between physical fitness and mortality due
to all causes, cardiovascular disease and cancer for both men and women has
been found (24, 28).
Table 1 summarizes direct mechanisms by which regular physical activity
could prevent CHD and cardiovascular disease (CVD), as suggested by the
literature (8, 24, 29).
1.3.2
Cross-sectional studies found a direct inverse relationship between levels of
fitness, levels of physical activity and risk factors for cardiovascular disease.
In men (30), a consistent, inverse relationship between physical fitness
categories and resting heart rate, body mass, percentage body fat, serum
levels of cholesterol and triglycerides, glucose and systolic blood pressure
(SBP) was observed. In women (31), physical fitness was independently as-
sociated with low serum triglycerides, high HDL-cholesterol, low total
cholesterol/HDL-ratio, and low blood pressure. Several studies in young,
middle-aged and older men reported cross-sectional associations between
levels of physical activity and CHD risk factors (32-36). For example, in older
Dutch men generally favorable associations were found between total weekly
physical activity and specific activities, such as gardening and walking, and
serum cholesterol and SBP (36). Even in a physically active, middle-aged
population, subjects who were physically more fit and physically more active
had better cardiovascular risk profiles based on body fat, blood pressure and
smoking habits, than subjects who were less active and less fit (37).
Physical activity is associated with decreases in adiposity among younger
and middle-aged populations, independent of caloric intake (38). Regular
11
physical activity may prevent the development of non-insulin-dependent
diabetes mellitus (39, 40).
Further support for the hypothesis that physical activity can favorably alter
risk factors can be obtained from numerous training studies. Most studies
have demonstrated that chronic exercise is associated with lower resting BP
(41). Individuals who participated in training studies have shown increased
HDL cholesterol levels (42-45), decreased LDL-cholesterol levels (42) and
increases in HDL-cholesterol/total cholesterol ratio (43). Physical exercise has
been shown to improve glucose tolerance and insulin sensitivity (46, 47).
/s p/jj/si'cfl/ inacfiuify a n'sfc /acfor /or yp
Blood pressure is consistently and quantitatively related to the risk of
developing all three major manifestations of cardiovascular disease: coronary
heart disease, stroke and transient ischemic attacks, and congestive heart
failure (48). In the general population, risks are lowest for adults with an
average SBP less than 120 mmHg and an average DBP less than 80 mmHg.
The higher the SBP, the higher the risk of premature cardiovascular death. The
same holds for DBP although SBP is a better predictor (48). Although by
convention the term hypertension is used to denote SBP and DBP in adults
that exceed 140 and 90 mmHg, high normal BP (SBP 130-139 mmHg, DBP
85-89 mmHg) requires frequent monitoring and lifestyle measures because of
the increased risk of developing definite hypertension and non-fatal and fatal
cardiovascular events (49).
There are certain risk factors that increase the probability of developing
hypertension. About one fourth of normotensive subjects and approximately
one half of the hypertensive population can be characterized as sodium-sen-
sitive, meaning that excess sodium in their diets increases their blood pres-
sures (50). Obese persons have a higher likelihood of becoming hypertensive
than the non-obese do (51). Excess alcohol ingestion increases blood pressure
(52). There is a growing body of evidence that associates a sedentary lifestyle
with high blood pressure.
Paffenbarger et al (53) followed nearly 15,000 Harvard male alumni for 6-10
years. Alumni who did not engage in vigorous sports play were at 35% greater
risk of hypertension than those who did, at all ages. Blair and colleagues (54)
found that risk of developing hypertension was substantially increased with
increasing baseline BP after a follow-up of 1-12 years. After adjusting for sex,
age, baseline BP, and body mass index, persons with low levels of physical
fitness had a relative risk of 1.52 for the development of hypertension when
compared to highly fit persons.
Fifteen endurance exercising adult males and 15 matched non-exercising
males were followed for 20 years in a study by Kasch et al (55). Resting BP was
found to be considerably higher on follow-up in the non-exercising group.
Whereas two men in the exercise group and three in the control group were
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initially hypertensive, after 20 years six of the non-exercisers became hyper-
tensive and none in the exercise group.
A graded, inverse association was shown between total weekly physical
activity and mean BP in a large random sample of a Finnish male population
(56). Total weekly physical activity and specific activities as gardening and
walking were favorably associated with SBP in a representative sample of
older Dutch men (36). In the Minnesota Heart Survey (34), greater heavy
intensity activity during leisure time was reported to be associated with lower
SBP in women, but not in men.
Several studies have shown that the level of physical fitness is inde-
pendently and inversely related to SBP after adjustments for possible con-
founders such as age, body mass and body fat (30-32, 57). This relationship
was found in middle-aged and older populations, for both men and women
(30, 31) and in children (32, 57). Even in a fit and active middle-aged popula-
tion this association was found (37). In general, DBP is not related to physical
fitness (30, 31, 57).
Most of the exercise intervention studies show a reduction in resting BP in
both normotensive and hypertensive subjects. This will be discussed in more
detail, in the next section.
In summary, studies have demonstrated that physical fitness and physical
activity, be it occupational or recreational, is associated with decreased risks
of coronary heart disease and hypertension.
2.2 The e/fecf o/ c/zronic exerc/se cm b/ood pressure
The achievement of long-term blood pressure control in persons prone to
hypertension or with mild hypertension is of central strategic concern in the
prevention of cardiovascular morbidity and mortality. Chronic aerobic exer-
cise has been suggested as an effective and physiologically desirable non-
pharmacological approach that can be used (a) in the strategy of prevention
of hypertension, (b) as a definite intervention, and (c) as an adjunct to phar-
macological therapy (58). A reduction in BP with regular participation in
aerobic exercise could be due to the accumulative effects of single exercise
bouts rather than actual long-term adaptations to exercise training. Post-exer-
cise hypotension ranging from 10-25 mmHg for SBP and 5-10 mmHg for DBP
has been observed 1-4 hours after cessation of aerobic exercise (59-61). In a
recent study (62), BP was significantly lowered even up to 13 hours in a group
of hypertensive men after a single bout of dynamic exercise. Although this is
a much noted observation which needs additional research, most attention
has been focussed on the effects of endurance exercise training.
1.2.2 Tfte e^ fecf o/ endurance framing on Wood pressure af resf
A definite conclusion on the effect of dynamic isotonic training on BP at rest
has been seriously hampered by the lack of well designed, controlled and
13
randomized studies (41, 63). Extensive variability in design has further com-
plicated the matter. Designs differ with regard to number of subjects studied
(range 4-66 subjects), length of training (range 4-52 wk), mode of training
(walking, cycling, jogging, combinations), session duration (20-60 min), fre-
quency of training (2 days/week to daily), and intensity (low to high)(41).
Various conditions for BP recording have been used and some studies in
hypertensives failed to ascertain that subjects had persistent elevations in BP
before enrollment (64). Most studies have been limited to male subjects (41,
65). In recent years, more well controlled studies with fewer design deficien-
cies have been performed (65).
On average, endurance exercise training has been found to lower BP at rest
in normotensives by 3-4 mmHg for both SBP and DBP (66, 67). In a meta-
analysis of 25 studies examining the BP lowering effects of endurance exercise
training on individuals with essential hypertension, the average reduction in
SBP by training, weighted for sample size, was 10.8 mmHg for SBP and 8.2
mmHg for DBP (65). In a more recent meta-analysis by Fagard (67) only
studies with a control group or period were included. The weighted average
training-induced change in BP was -6.2/-6.8 mmHg in borderline hyperten-
sives, and -9.9/-7.6 mmHg in hypertensives. Furthermore, it was noted that
controlled studies which followed most rigorous scientific criteria showed the
smallest decrease in BP (Table 2).
The intensity of exercise, the weekly frequency, the time per session and the
length of the training program did not contribute significantly to the inter-
Table 2. Training-induced changes in BP in controlled studies according to study design
Study design
Random allocation to control
or exercise group zt'it/i regular
contact of subjects during
control period
Random allocation to control
or exercise group u'l'J/iouf
regular contact of subjects
during control period
No random allocation to
control or exercise group
N
H
N
H
N
H
Change in BP at
SBP
-2 (-6 to +3)
-7 (-13 to -2)
-4 (-10 to +2)
-9 (-18 to 0)
-4 (-7 to -0.5)
-10 (-15 to -5)
rest
DBP
-2 (-5 to +0.6)
-5 (-9 to -1)
-3 (-5 to -0.6)
-10 (-11 to-9)
-5 (-8 to -1)
-9 (-14 to -3)
/Wapfed /rom Fagard ^Z). Granges in BP (mmHg) am/ 95% confidence /imifs. Cnanges a/ter
ad/usfmenf/or cont ro/ observations and weig/ifed/or number o/participants. N, normofensivegroups;
H, Hypertensive groups.
14
study variance of the BP response in normotensives or hypertensives (67).
Some studies (68-70) seem to indicate that low-intensity (50-55% VC>2max)
endurance training has the same BP lowering effect as training at a moderate
intensity level (70-75% VO2max)-1* is not clear how long it takes for endurance
training to elicit lower blood pressures, but most studies suggest that BP
lowering will likely occur after 3 weeks and before 12 weeks of training have
been completed (41). Jennings and colleagues found that exercising for 4
weeks, three times a week for 40 min at 60-70% W^^/ lowered resting BP by
10/7 mmHg in sedentary subjects (71) and 11/9 mmHg in hypertensive
subjects (72). In a later study (73), applying the same protocol in healthy
sedentary subjects, they even stated that BP fell 10/6 mmHg after the third
training bout at the beginning of the second training week and no further
reduction occurred beyond the fourth bout of exercise. Urata et al (74) found
resting BP to be reduced after 3 weeks of low-intensity training in mildly
hypertensive patients and no further reduction in BP was seen after 7 weeks
of training.
Less fit and less active subjects may probably show the largest increase in
exercise capacity and the largest reduction in BP following training. This is
partially suggested by the meta-analysis of training studies by Fagard (67)
who found the response of DBP to be significantly related to the increase in
exercise capacity. In addition, in a study amongst Antarctic expeditioners (75),
3 weeks of moderate exercise training significantly lowered BP in the winter,
when physical activity was limited to indoor activities because of climatic
conditions. In the summer, however, climatic conditions are improved and
subjects were more active during work and leisure time. BP at rest in the
summer was similar to the post-training levels during the winter and addi-
tional moderate training for 3 weeks did not further reduce BP.
At present it is not known whether hypertensive subjects are able to main-
tain lower blood pressure levels with continuation of training for years. In a
study by Jennings et al (76) the supine resting BP of 13 untreated hypertensive
patients fell 11/9 mmHg below sedentary levels after one month of moderate
endurance exercise three times a week. After one year of exercise three times
a week, these lower levels were maintained in all subjects. However, in the
second year several patients had a BP returning towards hypertensive levels,
despite good compliance to regular exercise.
Finally, many studies have considered weight reduction and change in diet
as possible confounding factors. These factors are unlikely to bias the ob-
served hypotensive effect by training (65,67). Studies that show a statistically
significant lowering of BP by training may be more likely to be published than
those that do not. To which extent this obscures a definite conclusion on the
effect of training on BP, especially in normotensives where the effect is small,
is not known.
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On cessation of endurance training, BP at rest will return to sedentary levels,
usually in several weeks or a few months, depending on training duration
(41).
2.2.2 77ie effect 0/endurance training on amfru/aton/ b/ood pressure
The majority of training studies suggests that blood pressure at rest is lowered
by aerobic exercise in hypertensives and to a lesser extent in normotensives.
Most of the evidence is derived from single or repeated indirect measurement
of casual BP, or more or less basal BP, in a relatively short span of time. Apart
from potential errors and inconsistencies in technique, random variation of
BP is large and fluctuations of 40% in BP can occur during the day (77). To
detect an anticipated fall by training of 8-10 mmHg (7-10%) in resting BP in a
hypertensive population or 3 mmHg (2-3%) in resting BP in a normotensive
population (67) could present a difficult problem against this background.
Ambulatory monitoring of BP can play an important role in improving the
precision of a trial and minimizing the number of subjects required by reduc-
ing within-subject variability of BP, by the greater number of observations
(77). Furthermore, levels of BP measured under resting conditions in a
laboratory often overestimate levels measured throughout the entire day
under free-living conditions (78). Ambulatory pressure measurements are
fairly reproducible (79), correlate usually better with left ventricular mass
(index) than casual pressure (80), and are free of confounding factors, such as
the alerting response (77). In longitudinal studies, casually determined pres-
sures can decrease over time without corresponding changes in levels
measured by ambulatory monitoring (81). Moreover, it is of interest to study
the effect of training on the circadian pattern of BP during the day, whereby
BP reaches its highest level at mid-morning, to fall thereafter throughout the
day to its nadir during sleep with a rise again before or at wakening (82).
The technique of ambulatory BP measurement has only recently been intro-
duced in training studies (Table 3a and 3b). Together, the results of these
investigations indicate that low- to moderate-intensity aerobic exercise train-
ing has, if any, only a small effect on 24-hour levels of arterial BP in normoten-
sive or mildly hypertensive subjects. All, but one (88), found no effect of
training on night-time BP. Some studies (86, 88) found ambulatory BP
lowered by training without a concomitant decrease in BP at rest.
3.2.3 77ie e/fecf 0/endurance framing on b/ood pressure during exercise
Relatively few controlled training studies have presented interpretable BP
data during steady-state submaximal exercise (65,67). The majority of studies
compared exercise BP at the same absolute submaximal workload, whereas
four studies (68,71,83,89) compared exercise BP at similar relative workloads
before and after training and one study (72) compared exercise SBP at a
percentage of predetermined baseline W^ax before and after training. A
reduction in BP at the same absolute workload following training could be the
16
Table 3a. Effects of training on resting and ambulatory blood pressure. Longitudinal controlled studies. Sfwdy design
Investigator
Van Hoof (1989)
Gilders (1989)
Somers(1991)
Seals and Realing
(1991)
Blumenthal(1991)
Marceau (1993)
Ref.
83
84
85
86
87
88
Group
N
N
BH/H
BH
H
H
H
H
H
n
26
10
7
13
11C13E
8Q10E
23C,35S,
41E
9
9
Age
39 ±10
41+9(SE)
46 ± 2 (SE)
35 ±9
61±2(SE)
62 ± 3 (SE)
45 + 8
43 ± 2 (SE)
43 ± 2 (SE)
Sex
M
M,F
M,F
M,F
M,F
M,F
M,F
M,F
M,F
Duration
of training
(weeks)
16
16
16
24
28
58
24
10
10
Mode of
training
Combin.
bicycle
bicycle
jogging
walking
walking
walking/
jogging
bicycle
bicycle
Frequency
(per week)
3
CO
 CO
daily
3-4
3-4
3
CO
 CO
Session
duration
(min)
60
30
30
10-30
30-50
30-60
35
30-45
30-45
Intensity
?
70% VO2max
70% VChmax
?
40-50% heart rate reserve
40-50% heart rate reserve
>70%VO2max
50% VChmax
70% VO2max
TaWe organized according fo dafe o/ pwW/cafion.
fra/ned; S, sfrength/ZZexibi/ify trained; M, nw/e; F,
Abbrepiafi'ons: N, nonnotensife; BH, border/ine /lyperfensipe; H, /lyperfensiw; C, confro/; E, exercise
/ema/e; VO2max, maxiTna/ oxygen consumption; ?, not awai/aWe; S£, standard error
00 Table 3b. Effects of training on resting and ambulatory blood pressure. Longitudinal controlled studies. Resu/fs
Investigator
Van Hoof (1989)
Gilders (1989)
Ref.
83
84
BP at rest (mmHg)
ASBP
-4
n.c.
n.c.
ADBP
-5*
n.c.
rtc.
Ambulatory BP (mmHg)
ASBP
day night 24 h
-2 +2
-1 0
-3 -9
-1
-5
ADBP
i day night
-5* -1
+2 +4
+1 -2
24 h
+3
-2
AVO2max
(%)
+14*
+10
+14*
Abody mass
(%)
n.c.
Comment
Measurements between 6 and
8 AM, and 8 and 12 PM not
used in analysis.
Training period of 16 wks
compared to control and 12
Somers(1991) 85 -10* -6» -5» +6 ? -8» +2 ?
wks deconditioning period.
Hypertensive subjects had
DBP > 85 and < 104 mmHg.
n.c. ABP measured intra-arterially
in 10 patients. Sleeping values
(n=6). Six subjects studied
after training and detraining
for 4 months.
Seals and Realing 86 -1 -1
(1991) -2 -2
-2 -1 -2 0 +1 +1 +6* n.c.
-6* -6 -6* -2 -2 -1 +10* -2*
Study with non-exercising
controls. Eight subjects conti-
nued exercising after 6 months
at higher intensity. Control
and trained subjects showed
equal decreases in casual BP.
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result of starting from an already lower BP at rest or may be a function of
exercising at a lower relative exercise intensity.
The blood pressure of normotensive subjects was found unchanged or
decreased after training, when measured at the same absolute submaximal
workload, but was usually not affected at the same relative workload (67). In
hypertensive patients, most but not all studies found a significant decrease in
BP at absolute workloads (67). So far, one training study in hypertensive
subjects (68) has reported a significant decrease (17/12 mmHg) in exercise BP
when measured at a similar relative workload.
In summary, endurance training lowers BP at rest and during exercise in
hypertensive subjects, whereas in normotensive subjects the blood pressure
lowering effect is rather small. Studies on the effect of endurance training on
24-hour BP are inconclusive. However, the majority of these studies seem to
indicate that night-time BP is not lowered.
2.3 Poss/We mechanisms /or Me wypofensi'ue e/fecf o/ exercise framing -
Hemodynam/c e/jfecfs
It is obvious that if a reduction in BP at rest takes place in response to training,
there has to be a concomitant decrease in cardiac output (CO) and/or total
peripheral resistance (TPR). Thus far, exercise studies have not provided an
unanimous picture of which factors are changed by training, and it is not
inconceivable that different results are accounted for by differences in meas-
urement techniques (direct vs. indirect measurement of CO) or differences in
study populations: normotensives, hypertensives of various age groups with
different hemodynamic profiles (borderline hypertensives vs. established hy-
pertensives).
In studies with normotensives that reported a decrease in resting BP, not
only an increase in CO with a decrease in TPR has been found (71,73,90), but
also a drop in CO with an increase in TPR (91) or an unchanged CO with a
decrease in TPR (92).
To date, seven studies in hypertensive humans have been published (69,72,
74, 86, 93-95) that all found a reduction in resting BP and presented data on
CO and TPR. In hypertensive adolescents (93), no consistent hemodynamic
changes were found with training to account for the reductions in BP, except
in subjects who initially had an elevated cardiac output. They showed a
significant decrease in CO as a result of significant decreases in both heart rate
and stroke volume. In middle-aged subjects with mild hypertension (95), low
or moderate intensity training lowered SBP and DBP significantly, but chan-
ges in CO or TPR were not statistically significant. Urata et al (74) found that
10 weeks of low intensity training reduced mean BP significantly in middle-
aged mild hypertensive subjects, but only a tendency for a reduction in CO
was found while TPR was unaltered. However, whole blood volume and
plasma volume were significantly lower. Kinoshita et al (94), applying the
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same protocol in patients with mild hypertension, found a reduction in BP
with a significant decrease in cardiac index as well as in plasma volume,
whereas TPR index was unchanged. Nelson and co-workers (72) found a
reduction in mean BP accompanied by an increase in CO in trained middle-
aged hypertensive subjects, so the entire reduction in BP was due to a
decreased TPR.
In older subjects with mild diastolic hypertension (86), 6 months of low
intensity training lowered mean resting BP and a small but significant reduc-
tion in HR and CO was found, while stroke volume and TPR were unaltered.
It was concluded that this reduction in BP was merely mediated by bradycar-
dia-evoked reductions in CO.
Nine months of low or moderate intensity training lowered mean BP sig-
nificantly in older hypertensives (69). Training resulted in a somewhat lower
CO at rest and an unchanged TPR in the low intensity group, whereas TPR
decreased slightly and CO was unaltered in the moderate intensity group.
1.3.2 Mecnam'sms /or a redwcfI'OM in cardiac
Endurance training is marked by resting bradycardia and increased stroke
volume at rest in normal subjects (96). Training increases parasympathetic
activity to the heart with a concomitant reduction in resting sympathetic
activity (96). In borderline hypertensives, a large proportion of the subjects
have high CO values, due to both a larger SV and a higher HR (97). This
usually is associated with an increased cardiac sympathetic drive and a
decreased parasympathetic tone (97). Possibly this can be opposed by training
since in hypertensive adolescents with high CO at rest, exercise reduces CO
by a decrease in HR and SV (93). Furthermore, the low baroreflex sensitivity
in borderline hypertensives can increase with endurance training (85). Some
authors (85, 88) suggest that this mechanism could, at least partially, explain
the antihypertensive action of training during daily activities. In older men
and women with mild diastolic hypertension (69, 86), low-intensity aerobic
training lowered BP solely by bradycardia-evoked reductions in cardiac out-
put. However, other investigators (74, 94) did not find a heart rate reduction
by low-intensity training in middle-aged hypertensives, despite a significant
decrease in BP. In these studies the reduction in cardiac output was associated
with a decrease in plasma volume, probably because the subjects were
volume-dependent hypertensives, i.e. characterized by high cardiac indices,
high serum sodium potassium ratios and low total peripheral resistances. In
contrast, Nelson and co-workers, studying the effect of endurance training in
middle-aged hypertensives (72), found an increase in CO accompanied by an
increase in SV and reduction in HR. They suggested this could be due to an
increase in preload to the heart, caused by plasma volume expansion, usually
seen following endurance training in normotensive sedentary subjects (98).
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1.3.2 Mechanisms /or aw exercise-re/afefl" redwcfion in per/p/iera/ resistance
Most training studies in normal and hypertensive subjects have focussed on
a reduced peripheral resistance to explain the hypotensive effect of exercise
because CO at rest is usually normal and increased vascular resistance is the
hemodynamic characteristic of established hypertension (99).
One of the possible mechanisms underlying the fall in TPR is an increase in
cross-sectional area of the vasculature in trained muscles, secondary to an
increase in local muscle mass. Increased capillary density (100), capillary to
muscle fiber ratio (101) and an increase in maximal muscle blood flow (102)
with training have been reported. Physical training increases the capacity for
vasodilation in active limbs, probably due to adaptive changes at the
arteriolar level (103,104). The extent to which these changes relate to changes
in the resistance vasculature and affect resting TPR is at present unknown.
The diameter of the arterioles can change due to vasoconstrictor and dilator
influences on vascular tone. The two main mediators of vasoconstriction are
the sympathetic nervous system (SNS) and the renin-angiotensin-aldosterone
system (RAAS), but other vasoactive hormones may also be involved.
[1] In training studies, plasma catecholamine concentrations have been
used by most investigators as an index of SNS activity and a common finding
is a decrease in plasma norepinephrine (NE) after training (71-74, 94, 95,105,
106). In both normotensives and hypertensives, plasma NE fell after training
(71-73), although in older hypertensives (69) and adolescents with hyperten-
sion (93), it did not. It was reported that the higher the baseline plasma NE,
the greater the fall in BP at rest (105). A good correlation was found between
changes in plasma NE and mean blood pressure following training (74).
However, in borderline hypertensives, where the higher BP levels are usually
associated with an increased sympathetic activity, changes in plasma NE were
small and inconsistent (89). Platelet NE was decreased after training which
may reflect a decreased long-term activity of SNS (107).
Total resting NE spill-over rate to the plasma provides a measure of whole
body average sympathetic neural activity (108). This parameter was found
greatly reduced in normal subjects after training (71). The majority (66%) of
the reduction in spill-over of NE to the plasma was accounted for by a fall in
renal NE spill-over whereas no change in cardiac spill-over was found (90).
Because one third of the reduction in total NE spill-over occurred outside
the kidney, other regional sympathetic outflows must be involved. Studies in
borderline hypertensives (109) have shown that an acute post-exercise hypo-
tension is probably caused by sympatho-inhibition of the muscle nerves as
can be measured by microneurographic techniques (109). Furthermore, using
the same technique, training markedly reduced sympathetic peroneal nerve
activity in normal subjects (110). Although the reduction in NE spill-over is
largely seen in the kidneys, the increase in total peripheral conductance seen
after training was for only 18% explained by an increase in renal vascular
conductance (90). Probably the fall in TPR can be mediated by modification of
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other regulatory functions of the sympathetic renal nerve through renin
release and/or sodium reabsorption. Although studies suggest that a reduc-
tion in SNS activity with training is related to a BP reduction, the time course
of the effect on BP appears to be more rapid than the changes in plasma NE
(73).
Detraining of subjects showed a gradual increase in BP that was parallelled
by a gradual increase in plasma NE, which suggests that the reduction in SNS
activity may help to maintain BP at relatively low levels for some time after
training (73).
Whether training can alter the sensitivity of the adrenergic system is still a
matter of debate and studies are inconclusive both in humans (111) and
animals (112,113). Pressor response to NE infusions was found to be blunted
after training (114). In healthy subjects, a variation of responses to endurance
training with respect to beta-adrenergic receptor density has been observed.
Beta-receptor density has been shown to decrease (115) or not to change (116)
in lymphocytes, to increase in leukocytes (117), and to be unchanged in
skeletal muscle (118). Probably beta-adrenergic responses to endurance trai-
ning are tissue-specific (119). Training studies on the possibility of receptor
down-regulation in hypertensive subjects have not been reported.
[2] Changes in the renin-angiotensin-aldosterone system could be an im-
portant underlying mechanism through their effect on blood volume and
through the potent directly acting vasoconstrictor angiotensin II which also
potentiates NE release. In young healthy subjects, an inverse relationship was
reported between VC>2max aid plasma renin activity (PRA) at rest (120).
Compared to non-trained subjects lower PRA levels were found in well-trai-
ned subjects (121). In normotensive subjects, resting supine PRA was unalte-
red after 4 weeks of training (71) or found to be significantly reduced after 5
months of training (122). Resting plasma angiotensin II was unchanged (123)
or increased (124) with training whereas plasma or urinary aldosterone was
lower (125), unchanged (122) or higher (124).
In trained subjects, PRA (122, 123) and plasma angiotensin II (123) were
lower during graded exercise. At a similar relative workload, PRA was un-
changed after training (126). In hypertensive subjects, training did not change
resting PRA, angiotensin II and plasma aldosterone in a series of studies by
the same group (127). Some studies (69,106) seem to indicate that hypertensi-
ve subjects with low PRA exhibited a larger reduction in BP than hypertensive
subjects with high or normal PRA.
[3] Other hormones have been postulated to explain the BP lowering effect
of regular exercise, either through a direct effect or by inhibiting NE release
from nerve terminals. Atrial natriuretic peptides (ANP) are released from
cardiac atria, predominantly by atrial stretch. ANP has a role in cardiovascu-
lar homeostasis by its diuretic, natriuretic and vasodilating effects. ANP has
an inhibitory effect on NE stimulated vasoconstriction (128), depresses the
release of renin (129) and counteracts the vasoconstrictor activity of angioten-
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sin II (130). It promotes diuresis and natriuresis, possibly by inhibition of
aldosterone or vasopressin (131).
Endurance training is thought to result in expansion of blood and plasma
volumes (132) and it is possible that this will result in a higher density of ANP
atrial granules and higher plasma ANP levels. To date only few published
data are available on the effect of exercise training on ANP in humans. Similar
resting ANP values were found when moderately trained young runners
were compared to untrained (133) and a training break of 3 weeks in enduran-
ce runners did not alter resting ANP (134). During exercise, central blood
volume rises and higher ANP levels were found, related to the absolute
workload (133). In the normotensive rat model, an increase in resting ANP
was observed with training, whereas atrial tissue ANP was not altered (135).
However BP was not changed. In mild hypertensive subjects, slightly elevated
(136) or unchanged (137) resting ANP levels were found compared to normo-
tensive subjects. Low intensity training in middle-aged hypertensives did not
change plasma ANP at rest (138).
Prostaglandin E, originating from the kidney or the skeletal muscle (139),
could increase sodium secretion from the kidney and thus reduce plasma
volume. Prostaglandin E concentrations at rest were found to be two to three
times higher after training in hypertensive subjects (106). This could explain
the volume depleting effects of physical training observed by some investiga-
tors (74) without alteration in the RAAS. In addition, prostaglandin E may
cause local vasodilation in the skeletal muscle (139) or inhibit nerve NE
release (140).
An important role for insulin in BP control has been postulated. Hyperinsu-
linemia could elevate BP by its direct effect on renal sodium retention (141) or
by releasing NE, the latter resulting in arterial smooth muscle contraction and
renal sodium retention (142). Endurance trained subjects have lower plasma
levels of insulin and an increased sensitivity to the peripheral actions of
insulin (62, 143). Insulin sensitivity rose with endurance training in normal
subjects independent of body mass changes (71). Higher levels of insulin have
usually been found in sedentary obese hypertensive individuals (144) and
Bjorntorp (145) observed a fall in BP in association with a reduction in plasma
insulin in obese patients after training. Whether endurance exercise can lower
BP in association with lower insulin levels in non-obese hypertensives inde-
pendent of a body mass reduction, warrants further research.
Several other humoral factors may play a role either by inhibiting the release
of NE at sympathetic nerve endings or promoting NE uptake (see for review
127).
Finally, endothelium-derived relaxing factor is an endogenous vasodilator
released by the vascular endothelium. Recent animal studies (146, 147) sug-
gest that chronic exercise enhances endothelium-mediated vasodilation.
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In summary, the mechanisms underlying the hypotensive action of regular
exercise are still poorly understood. Studies on hemodynamics are controver-
sial. The antihypertensive mechanism of exercise may be multifactorial and
most probably involves suppression of sympathetic activity.
2.4 E/jfecf 0/ dzrcmic exercise on tfze foarf and uesse/s
The majority of ill effects of hypertension and atherosclerosis become
manifest in the heart and large vessels. Hypertension is often accompanied
with or preceded by changes in cardiac function or structure (148), which
considerably increase the risk of morbidity. Furthermore, both components of
vascular impedance, i.e. increased resistance and decreased compliance, are
affected. So, the potentials of endurance exercise to oppose these changes,
beside its effects on blood pressure and other risk factors, are of interest.
1.4.2 Hearf
Physical conditioning results in a decrease in heart rate at rest and during
submaximal workloads, while stroke volume is increased. VC>2max and max-
imal CO are increased, while peripheral changes result in enhanced maximal
arterio-venous oxygen differences (96, 149). As a result training reduces
cardiac work in proportion to total body work.
When athletes engaged in endurance type of exercise are compared to
non-trained subjects, increased left ventricular mass (LVM) is found (150).
Athletes have a larger end-diastolic left ventricular internal diameter (150,
151) and increased posterior and septal wall thickness (150,151). The ratio of
wall thickness to internal radius of the left ventricular cavity is not different
from that in untrained persons (152,153) or slightly increased (150). The ratio
of septal to posterior wall thickness is not different in athletes and non-ath-
letes (150,151).
Training studies showed a significant increase in LVM and posterior and
septal wall thickness after 4-16 weeks without a change in cavity size, when
moderate exercise was performed (154,155). In response to vigorous training,
the end-diastolic internal diameter of the LV was already increased after one
week, whereas changes in wall thickness occurred more gradually (156). Some
authors (157) have reported increased end-diastolic dimensions without a
change in LVM or wall thickness. Systolic and diastolic function of the left
ventricle has usually been found to be in the normal range for athletes (158)
or was unchanged after endurance training in sedentary subjects (155-157).
Changes in cardiac structure with endurance training are often referred to
as eccentric LVH, because LV internal diameter increases with a proportional
increase in wall thickness; this in contrast to the LVH seen in hypertension
which is more concentric and marked by excessive wall thickness. In un-
selected groups of patients with essential hypertension, LVH is found in
approximately 12% of the borderlines (159) and 15-20% of the mild to
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moderate hypertensives (160). Hypertensives with increased LVM have near-
ly 3 times as many morbid cardiovascular events than those without (161).
The correlation between LVM and casual or clinical BP is rather poor (162)
and is usually only slightly better for ambulatory measurements (163). Al-
though not commonly observed (80), some investigators suggest that night
time SBP correlates the best with LVM (160); this is of particular interest since
endurance training does not appear to lower BP at night (84, 86, 87). The
expected reduction in BP after endurance training in hypertensives (41) could
be counteracted by an increase in LVM, due to chronic intermittent overload
of the heart by this type of training. A change away from concentric LVH and
towards eccentric hypertrophy was found after one year of physical training
in hypertensive humans (75). In this study, mean BP was significantly
reduced at rest, LV cavity diameter increased significantly, whereas average
wall thickness was reduced and LVM was unchanged.
Sixteen months of training in mild hypertensives on a low sodium diet (164)
decreased both BP at rest and at maximal exercise, with only a tendency for
LVM reduction. When LVM, however, was indexed for body mass (LVMI), no
change was seen. No significant correlations between BP changes and changes
in LVM or LVMI were found. On the contrary, in hypertensives, a decrease in
LVMI was found after 4 months of training, without a decrease in BP at rest
or during exercise, nor in 24-hour BP (165). This suggests that a reduction in
LVM by training can occur independently of changes in BP, possibly via the
involvement of the adrenergic system (166). In hypertension, the diastolic
function is often abnormal and usually seen before LVH is obvious (167). It
reflects reduced left ventricular compliance (168) or relaxation abnormalities
(169). Changes or an improvement of cardiac function in hypertensive
humans have not been reported, following endurance training (75, 164). In
hypertensive rats, training did not change diastolic cardiac function (170) or
improved it (171).
In human studies, direct evidence for an increase in the coronary collateral
circulation by training is lacking (172). Possibly a decreased propensity
towards arrhythmias may be a product of long-term training since an in-
creased threshold for ventricular fibrillation in the isolated trained rat heart
was found (173).
1.4.2 Vesse/s
Established hypertension is nearly always characterized by an elevated mean
arterial BP and elevated total peripheral vascular resistance. Arterioles and in
certain tissues (skeletal muscle, intestines), also muscular arteries contribute
to the elevated vascular resistance (174). Proposed mechanisms underlying
the overall increased vascular resistance in hypertension are (a) a decrease in
the number of arterioles and capillaries, (b) decreased internal diameter of
arterioles and small arteries, and (c) increase in arterial and arteriolar wall
mass (174). Changes in vascular smooth muscle itself like increased sensitivity
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to vasoconstrictor stimuli and a diminished relaxation process contribute to
increased resistance (175).
As discussed above, most training studies have been focussed on factors
that influence resistance on a functional basis, i.e. studying predominantly the
remote control systems (autonomic nervous system, circulating hormones) in
relation to functional vascular diameter regulation. Few studies have ad-
dressed the ability of endurance training to remodel the vascular tree.
Remodeling could be achieved by chronic change in number of parallel
vessels, vascular diameter or wall thickness.
In humans, endurance training can induce capillary growth in active skele-
tal muscles, if performed for a sufficiently long time (minimum 8 wks) (100-
102). This growth is predominantly seen in the vicinity of slow oxidative
fibers. As suggested by Hudlicka (176), capillary growth in skeletal muscles
is probably initiated by increased blood flow. Increased shear stress in capil-
laries in skeletal muscle can initiate capillary growth by producing a distur-
bance of the luminal side of the endothelium. The involvement of growth
factors has recently been suggested in endurance-trained rats (177). Whether
endurance training induces growth of arterioles in human skeletal muscle is
not clear. In rat models, an increase in number of small arterioles in skeletal
muscle has been demonstrated, following endurance training (178). Further-
more, an increase in passive diameter of large arteries was shown. In humans,
minimal vascular resistance is usually assessed by indirect measurement of
limb flow (calf, forearm) by plethysmography at maximal vasodilation. In
hypertensive subjects (179), borderline hypertensives (180), and even in nor-
motensive young men with a parental history of hypertension (181), minimal
vascular resistance has found to be increased during maximal vasodilation
compared to age-matched normotensives. These physiological observations
provide indirect evidence for the existence of the afore-mentioned structural
abnormalities in hypertension. Physical training increases the capacity for
maximal vasodilation in active limbs (104, 182) in normal subjects. Whether
endurance training can induce regression of structural changes in hyperten-
sive humans in various vascular beds has not been studied. It is known from
antihypertensive treatment with different pharmacological agents that struc-
tural changes can be reversed in animal models of hypertension and it is
evident from these studies that control of BP is not enough to achieve regres-
sion (183) and that trophic factors (catecholamines, angiotensin II, insulin)
must be favorably altered (184). Reversibility of structural changes depends
on the duration of hypertension (183). In man, only prolonged treatment with
pindolol, captopril and nitrendipine for at least 6 months has convincingly
shown to reduce minimal vascular resistance in the forearm vascular bed (185,
186).
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Large vesse/s
Visco-elastic properties of the arterial wall enable large arteries to store to the
volume of blood ejected from the heart during cardiac contraction, and to
drain this volume during diastole (187). While an increase in vascular resis-
tance causes a proportional elevation of mean BP (and thus SBP and DBP), a
reduction in the visco-elastic properties of the arterial wall causes an increase
in pulse pressure resulting in an increase in SBP in combination with a
decrease in DBP, without a change in mean BP (188).
Several investigations have suggested that increased pulse pressure may be
an important risk factor in subjects with hypertension and relates well to
increased LVM in hypertensives with similar mean BP (189, 190). Further-
more, since cardiovascular morbidity and mortality of hypertensives is main-
ly related to disease of the large arteries, evaluation of cardiovascular risk
could be more suitably done by indexes of arterial disease (191). An adequate
quantification of the visco-elastic properties of the large arteries can be made
by evaluating compliance and distensibility in a given artery. Arterial com-
pliance is defined as the product of arterial volume by distensibility of the
artery. Distensibility is evaluated either from the measurement of pulse wave
velocity over a given arterial traject (187) or can be measured locally by the
related displacement of the arterial walls per unit of pressure (192). Pulse
wave velocity correlates strongly and positively with SBP measured by am-
bulatory monitoring (191).
Several studies have shown that arterial compliance and distensibility of the
large arteries are significantly reduced with age (193) and (borderline) hyper-
tension (194,195). The changes may be due to structural changes, to particular
responses of arterial smooth muscle tone or to a combination of both (196,
197).
It has been recognized that different antihypertensive drugs have different
effects on large artery compliance, despite of equal reductions in mean BP
(198). Calcium antagonists, ACE-inhibitors and some beta-1 selective beta-
blockers improve large artery compliance, while some diuretics and non-
selective beta-blockers do not (198). Because these conclusions are based on
acute or short-term chronic studies, it is likely that this reflects functional
changes rather than structural changes. Whether structural changes resulting
in a decrease in compliance can be reversed is not known at present (198).
It has been suggested that an increased distensibility of large arteries will
decrease the load on the vessel wall and thus may prevent accelerated aging
of the vessels and maybe also atherosclerotic disease (199). Increased com-
pliance might result in a smaller afterload for the heart, and as a consequence,
help to prevent cardiac hypertrophy (199).
It would be of particular interest to know whether endurance training can
improve compliance and distensibility of large arteries in normotensive and
hypertensive subjects and thus reduce pulsatile stress on heart and vessels.
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In a recent study (200), regional aortic compliance was measured by magnetic
resonance imaging and endurance athletes were compared to age-matched
healthy volunteers. Aortic compliance was found to be negatively related to
age and was significantly higher in athletes. A strong negative relation was
found between physical working capacity and pulse wave velocity over the
carotid-femoral traject in young men (201), which suggests a positive relation-
ship between physical fitness and arterial distensibility. An increased com-
pliance and diameter was found in the radial artery of the dominant arm of
hammer throwers compared to sedentary controls (202). The effect of 4 weeks
of endurance exercise on regional arterial (aortic) compliance was studied in
7 sedentary males (203). A significant increase in arterial compliance was
noticed with a significant fall in SBP. It was suggested that pressure-inde-
pendent factors could contribute to the improvement (203).
The morphology of systemic arteries following endurance training has been
studied in animal models. In trained rats, medial wall thickness was sig-
nificantly greater in large arteries, whereas number of smooth muscle cells
and lumen diameter were unchanged (204). It was suggested that this would
lead to a decrease in tangential wall stress at rest. Training in hypertensive rats
(205) resulted in a reduction of wall-to-lumen ratio in several large arteries
(descending aorta, iliac artery, femoral artery). The trained rats had similar
wall thickness values as non-trained hypertensive animals, but larger lumen
diameter.
In overview, more studies are needed to establish the remodeling effects of
regular exercise on the vascular tree in normotensive and hypertensive
populations.
1.5 Exercise s/ress tesfmg in b/ood pressure eya/uahow
In clinical practice, routine measurements of BP during exercise are mainly
performed to detect an inadequate BP rise as can be due to aortic valve disease
or left ventricular impairment. A decrease of SBP during exercise below the
usual resting SBP or a limited (10 mmHg) increase in SBP in patients with
suspected or clinically severe cardiovascular disease is a reason to terminate
stress testing because of a high likelihood of post-exertional ventricular fibril-
lation (206).
A limited increase in SBP in normal healthy persons may not be serious in
the early stages of stress testing because it may reflect anxiety-induced hyper-
tension (207). Although an excessive rise in SBP (well over 200 mmHg) is a
reason to stop exercise in some centers, complications related to high exercise
SBP have never been seen (207).
The so-called double product, or SBP multiplied by heart rate, is often used in
clinical and /or pharmacological studies because it provides an excellent
index of myocardial oxygen consumption (208). Several investigators (see for
review 209) have addressed the question whether exercise (systolic) BP is a
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better predictor of target organ damage or cardiovascular morbidity or mor-
tality than resting BP. Most studies found no significant and independent
contribution of exercise BP to the variance of left ventricular mass when
adjustments were made for potential confoundens such as resting BP, age,
height, weight and aerobic power. The exercise-induced change in SBP from
baseline to a work load of 164 W was found an independent predictor of
cardiovascular mortality in a study of healthy male subjects (210). In contrast
in hypertensive subjects, Fagard and colleagues (211) found exercise BP not to
be an independent predictor of mortality or incidence of cardiovascular
events.
2.5.3 Excess/we b/ood pressure response during exercise as a predictor o//Mfwre
Numerous studies have tried to identify markers for the development of
hypertension. In Western society, age, body mass, resting HR and BP have
been found to be predictors (212). Laboratory predictors, such as cationic
transporters and hormones, especially insulin, have been suggested (212).
In recent years, an excessive rise in BP during exercise has been proposed as
a predictor of future hypertension (213-217). Wilson and Meyer (213)
retrospectively analyzed the blood pressure profiles of 3395 men and 425
women who attended their clinic two times or more. After an average follow-
up time of 32 months, subjects with a normal resting BP (< 140/90 mmHg) but
with an exaggerated BP response during exercise (> 225/90 mmHg) at first
visit were compared to subjects with a normal resting and exercise BP. The
incidence of subsequent hypertension was for the subjects with exaggerated
exercise response 2.38 (relative risk) times greater. Dlin et al (215) examined
two matched groups of normotensive young adults. The only differentiating
variable was the high BP during exercise (< or > 200/100 mmHg). After 5.8
years of follow-up, the group with the higher BP response had a l l .6% higher
incidence of hypertension. In general, the prevalence of hypertension on
follow-up among normotensive subjects with an exaggerated response to
exercise testing is 2.1 to 3.4 times higher than among subjects with a normal
response (216). Sensitivity of an exaggerated response to exercise for future
hypertension varied for studies between 16 and 60% and specificity between
53 and 95%. However, the predictive value is limited since 38 to 89% of those
with an exaggerated response to exercise did not have hypertension on fol-
low-up (0.5-15 yr) and a normal response only marginally reduced the risk of
hypertension. A common point of critic on most of these studies is the absence
of standardization of the employed exercise protocols and different defini-
tions of an exaggerated BP response. Further research should define a cut-off
point separating normal from abnormal response according to age, sex and
physical fitness (216), and must not only consider the absolute value of BP
response but also the magnitude of BP change at each workload and establish
norms that include race, sex, body mass and fitness levels. For testing pur-
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poses, the use of bicycle ergometry should be favored and more studies are
needed on the acute BP response to exercise in women (41).
The mechanisms behind an exaggerated BP response to exercise are poorly
understood. Both an impaired capacity for exercise-induced vasodilation and
an increased CO have been suggested. Alternatively, one could speculate that
it is related to a low baroreflex sensitivity or a decreased arterial compliance.
Wilson et al (218) compared normotensive young men with normal BP
responses to exercise with normotensive men with exaggerated BP responses
(> 230/110 mmHg) and a positive parental history of hypertension. A third
group of normotensive normal responders with a positive parental history
was formed. All three groups had equivalent cardiovascular parameters at
rest and CO increased similarly during exercise. The group of exaggerated
responders with a positive parental history showed a blunting in peripheral
resistance decline during exercise. Iskandrian and Heo (219) studied nor-
motensive subjects, with and without an exaggerated SBP response to exercise
(> 200 mmHg) and patients with uncomplicated essential hypertension. Com-
pared to the normal subjects exaggerated responders differed only with
regard to a higher cardiac index and SBP during exercise. Compared to the
hypertensives, exaggerated responders had a higher exercise HR, SBP, cardiac
index, and left ventricular ejection fraction and lower total vascular resistance
and end-systolic volume during exercise. Gottdiener and colleagues (220)
compared cardiac findings in groups of sedentary normotensive men who did
or did not have exaggerated elevation of SBP during treadmill exercise (< or
> 210 mmHg). Men with exaggerated SBP during exercise had significantly
elevated left ventricular mass.
L5.2 Exercise testing in assessment o/ hypertension
Some studies strongly suggest that the assessment of BP during ergometric
testing is quite useful in distinguishing between "true" normotensive, border-
line hypertensive and hypertensive subjects (221,222). Hypertensive patients
were characterized by a rise in diastolic BP during submaximal exercise,
whereas diastolic BP remained unchanged or showed only a slight increase in
normotensive subjects (221, 222). This different hemodynamic pattern can be
explained by the inability of hypertensive patients to reduce peripheral resis-
tance to the same extent as normotensive subjects (223). Franz (221) studied a
group of male subjects with borderline hypertension at rest (SBP: 140-160
mmHg; DBP: 90-95 mmHg). Subjects with BP of more than 200/100 mmHg at
100 watt and BP of more than 140/90 mmHg after 5 min of recovery were
classified as positive responders, i.e. showing a hypertensive response. These
subjects did not differ in BP response to exercise from age-matched patients
with established hypertension. Subjects with a negative response had the
same DBP at 100 watt as normotensive subjects. In a follow-up study of the
same investigator (224), 97% of the borderline hypertensives showing a hy-
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pertensive response during and after exercise testing developed established
hypertension under resting conditions within 4 years.
In contrast, other investigators judged that the BP response during exercise
was not particularly useful as a modality for diagnosing hypertension, in
young females with borderline hypertension (225), and in children with high
resting BP (226). Children with a resting BP above the 95th percentile showed
a similar rise in exercise SBP as the normal group (226). Although the exercise
BP was significantly higher in young females with borderline hypertension,
the mean change between resting and exercise SBP and DBP was not sig-
nificantly different from the normal group (225). In general, it is believed that
in hypertensives changes in BP during exercise resemble the normal response
found in normotensive subjects; this is, hypertensives do not have a greater
change in SBP from rest to exercise (225,227,228). Others have pointed to the
fact that an excessive rise is mainly seen in hypertensives with advanced
stages of disease (229).
More large sample studies are needed to test whether exercise BP is a useful
modality for diagnosing hypertension and adjustments should be made for
potential confounders as age, sex, weight, body fat, resting BP and physical
fitness. Furthermore, both clinical and epidemiological studies (230, 231)
found substantial variation in the magnitude of BP response to exercise
among healthy men and women and limited data are available at present to
explain this variation. Age is independently and positively associated with
SBP response to exercise (231, 232), whereas obesity (Quetelet index) is posi-
tively associated with the SBP response during treadmill testing (230). In
smokers SBP during exercise is higher although only for men (232). Whether
gender differences exist is not clear at the moment.
3.6 /4nr iTjypertensiue medication and exercise
Lifestyle modifications are frequently advised by physicians as the start of
antihypertensive treatment in mildly hypertensive subjects or as an adjunc-
tive therapy to pharmacologic treatment. Lifestyle modification includes
weight reduction, moderation of dietary sodium or alcohol intake, and in-
creased physical activity.
Dynamic physical exercise is considered beneficial for many patients with
hypertension because its potential benefits include a reduction in BP and
favorable effect on other cardiovascular risk factors, increased work capacity
and a general sense of well-being (233). However, in many hypertensive
patients regular exercise does not lower BP to normotensive levels (65) and
pharmacological treatment is necessary.
In the selection of initial drug therapy many factors should be considered and
basically two approaches have been suggested (49, 234). The first approach
(49) emphasizes the fact that although all major classes of antihypertensive
drugs are equally effective in lowering BP at rest, only diuretics and beta-
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blockers have been shown to reduce cardiovascular morbidity and mortality
in long-term controlled trials. Consequently, they are recommended as first
choice agents, unless they are contra-indicated or unacceptable. In the second
approach (234), the selection is based on the hemodynamic profile of the drug,
i.e. it should reverse the hemodynamic abnormalities of hypertension by
lowering the systemic vascular resistance and preserving cardiac output and
perfusion. Furthermore, concomitant diseases should be taken into account,
good quality of life maintained and the drugs should have no, or favorable,
effects on other CHD risk factors. Consequently in this latter approach, cal-
cium-antagonists, angiotensin-converting enzyme inhibitors and alpha-1
receptor blockers are advocated as first choice drugs.
3.6.2 Wni'di anf/Hypertensive drwg to dioose m f«e p/iys/ca/Zi/ acf iwe paflenf ?
In addition to the afore-mentioned considerations, the ideal antihypertensive
agent for patients who wish to engage in physical exercise should (a) effec-
tively lower BP during exercise, (b) reduce BP by lowering systemic vascular
resistance and preserving cardiac output and organ (active muscle) perfusion
during exercise, (c) not impair left ventricular function, (d) have no arrhyth-
mogenic potential, and (e) not impair endurance performance and train-
ability.
Exercise b/ood pressure. Table 4 compares the antihypertensive effect of
several classes of drugs at rest and during exercise. Although all antihyper-
tensive agents effectively lower BP during exercise, beta-blockers reduce
exercise SBP more than other classes of antihypertensive agents. This could be
an advantage in those patients with very high SBP during exercise. A much
more pronounced reduction in exercise HR (20-25%) is seen with beta-block-
ade than with other antihypertensive drugs (235). As a consequence, the
so-called double product (HRxSBP), and thus myocardial oxygen consump-
tion, is considerably lowered by beta-blockade, which could be an advantage
in the treatment of patients with concomitant limited coronary blood supply
during exercise.
Exercise /jemodj/Ham/cs. Beta-blockers lower exercise BP by reducing cardiac
output (5-20%), while systemic vascular resistance (SVR) is normal or slightly
increased (236). Diuretics lower exercise BP by SVR reduction with preserva-
tion of cardiac output (234). Calcium-antagonists and ACE-inhibitors reduce
SVR and, during long-term treatment, cardiac output during exercise is usual-
ly unaffected (234).
Le/f uenfr/cu/ar /wncf/on during exercise. All classes of beta-blockers and the
calcium-antagonist verapamil impair left ventricular function, while cardiac
contractility is better preserved with nifedipine and diltiazem. Other
antihypertensive agents have absent or negligible effects on myocardial con-
tractility (237).
/Irr/zyfnmias during exercise. Beta-blockers and non-selective calcium-an-
tagonists like verapamil and diltiazem have mild anti-arrhythmic properties.
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Table 4. Change in resting and exercise blood pressure during chronic treatment (> 4 weeks) with antihypertensive agents in patients with
essential hypertension
Non-selective beta-blockers
Beta-1 selective blockers
ACE-inhibitors
Calcium-antagonists
Diuretics
(n=17)
(n=16)
(n=12)
(n=24)
(n=10)
Rest
SBP
-11% (-7 to-21)
-10% (-5 to -20)
-13% (-6 to -19)
-12% (-1 to -26)
-14% (-8 to -24)
DBP
-12% (-5 to -20)
-12% (-4 to -20)
-11% (-2 to-19)
-13% (-1 to -29)
-12% (-6 to -19)
Exercise
SBP
-13% (-5 to -20)
-15% (-7 to-24)
-8% (-5 to-12)
-8% (+4 to -12)
-8% (-5 to -14)
DBP
-7% (+4 to -19)
0% (+1 to -19)
-8% (-3 to-13)
-11% (-4 to-20)
-5% (-4 to -14)
/Idapfed /rom Van Baait (235.). SBP, sysfo/ic Wood pressure; DBP, diasfo/ic Wood pressure; n, number o/ sfudi'es. Mean percentage changes and range o/
studies are snown.
Table 5. Change in maximal oxygen consumption and endurance performance after admi-
nistration of antihypertensive agents
VO2max Endurance time
Non-selective beta-blockers (n=19) -10% (-1 to-19) (n=10) -41% (-25 to -55)
Beta-1 selective blockers (n=21) -6% (-2 to-17) (n=10) -24% (-11 to-39)
ACE-inhibitors (n=3) 0% (+2 to-2) (n=3) - 8 % (-3 and-12)
Calcium-antagonists (n=13) -2% (+7 to-8) (n=2) -11% (-7 and-16)
Diuretics (n=7) -7% (-1 to-17) (n=l) -29%
/4dapted/rom Van BaaJt (235). VCkmw, maxima/ oxygen consumption; Endurance f/me, h'me unti/
ex/iausfion af« constant SMbmaxima/ worit/oad; n, number o/sfudies; totn sf udies in /jyperfensiue and
normofewsiue sub/'ecfs inc/uded. Duration o/studies wifn diuretics ranged/ro/n sing/e dose to 7 days.
Va/ues are percentage cnanges /irom confro/. Mean and range o/studies are s/jown.
Diuretics could induce hypokalemia and thus increase the frequency of
premature ventricular contractions at rest and during exercise (238).
Exerdse performance. Table 5 summarizes the effects of several classes of
antihypertensive drugs on exercise performance. Beta-blockers have a more
pronounced negative effect on both maximal aerobic exercise capacity and
endurance performance than most other agents. However, in almost all
studies a lower endurance exercise capacity with antihypertensive treatment
has been reported (235).
TVa/HflW/ify. Very little is known about the influence of antihypertensive
medication on trainability. Some studies have shown an attenuated condition-
ing response with beta-blocker therapy (i.e. a negative influence on the in-
crease of VO2max) (239-241), although this is not supported by others (242,
243). Part of this inconsistency is possibly due to the fact that a training effect
may become only apparent when the drug is withdrawn (244). A blockade of
peripheral adaptations with training during beta-blockade has been reported
(239). Beta-1 selective blockade may impair trainability to a lesser degree
(245). Trainability is not impaired by calcium-antagonists like nifedipine (246)
and diltiazem (247).
2.6.2 Exercise and beta-b/ocfcers wM uosodi'/flf ing activity; fl compansorj
c/flssi'oj/ beta-b/ocA:er f/jerapy
Recently, beta-blockers with vasodilating activity have been developed
(labetalol, dilevalol, carvedilol, nebivolol). Labetalol is a non-selective beta-
blocker with additional (weak) alpha-1 adrenoceptor antagonist activity
(248). Dilevalol, which is the RR-isomer of labetalol, combines non-selective
beta-blockade with beta-2 adrenoceptor stimulation (248). Carvedilol can be
characterized as a non-selective beta-blocker with an additional vasodilator
component, possibly caused by alpha-1 adrenoceptor antagonist activity
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Table 6. Hemodynamic effects of chronic treatment with labetalol, dilevalol and carvedilol
in hypertensive patients
Labetalol Dilevalol Carvedilol
BP
HR
CO
SV
TPR
Exercise
BP
HR
CO
SV
TPR
-17%
-16%
^3%
+16%
-14%
-20%
-18%
-10%
+10%
- 1 1 %
-15%
-12%
-13%
+1%
-10%
-10%
-25%
-11%
+8%
+5%
-14%
-10%
-12%
- 3 %
- 3 %
-16%
-18%
-9%
+6%
-5%
sfud/es 249-254. BP, mean arfena/ Wood pressure; HR, nearf rafe; SV, sfrofce w/ume, CO,
cardiac owfpuf; TPR, fofa/ penp/iera/ resistance. Mean percentage c/ianges are s/iown.
(248). Nebivolol is a selective beta-1 antagonist, which has an ancillary
vasodilating property of unknown nature (199).
If beta-blockade and vasodilation are properly balanced, these multiple-ac-
tion drugs could prove to be attractive in the treatment of physically active
patients by achieving a similar BP reduction at rest and during exercise as
classical beta-blockers, but in a more physiological way. This is by reducing
total peripheral resistance with no or only a minor reduction in cardiac
output. Possibly this would lead to no or a lesser impairment of exercise
tolerance.
Hemodyttamics. Table 6 summarizes studies on the hemodynamic effects of
labetalol, dilevalol and carvedilol. A marked reduction in BP at rest is found
with all agents, caused by a reduction in both cardiac output and total
peripheral resistance. Resting heart rate is reduced to a lesser extent than
usually seen during chronic treatment with selective and non-selective beta-
blockers without ISA (approximately 20-25%)(249). Compared to a reduction
in cardiac output of 15-20% during conventional beta-blocker therapy,
vasodilating beta-blockers reduce cardiac output less, especially labetalol. All
agents reduce total peripheral resistance in contrast to the classical beta-block-
ers which are found to increase total peripheral resistance by 15-20% during
long-term treatment (234).
During exercise, the beta-1 blocking activity of the multiple-action drugs seem
to become more pronounced, i.e. the reduction in heart rate. Exercise heart
rate reduction during conventional beta-blockade is in the order of 20-25%
(236). Exercise stroke volume is increased with labetalol, dilevalol and car-
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vedilol, as usually seen with classical beta-blocker therapy (236). Cardiac
output reduction with the vasodilating beta-blockers (-9 to -11%) is in the
range found with classical beta-blockers (-5 to -15%)(236). During exercise
total peripheral resistance is decreased during labetalol treatment, whereas
changes during dilevalol and carvedilol treatment are minor. Most studies
found total peripheral resistance unchanged during selective or non-selective
beta-blockade (246).
At present, no data are available on regional hemodynamics during exercise
with vasodilating beta-blockers. When beta-blocker administration also leads
to systemic effects, i.e. a reduction of exercise cardiac output, a reduction of
skeletal muscle blood flow at submaximal workloads (50-70% VC>2max) has
been found (255). Although a reduced skeletal muscle blood flow has been
suggested to explain the marked impairment of endurance performance
during beta-blockade (Table 5), it is probably not the sole mechanism. Oxygen
uptake is on the average normal in the exercising muscles during beta-block-
ade because of an increased oxygen extraction (255).
Metabo/i'sm c/un«^ exercise. Skeletal muscle metabolism during exercise relies
on liver and muscle glycogenolysis for provision of energy substrates. Beta-
oxidation of free fatty acids (FFA) provides an alternative energy source,
especially during prolonged submaximal exercise.
Although animal studies have shown that beta-2 receptors located in the
skeletal muscle are involved in the regulation of muscle glycogenolysis
during prolonged exercise (256), human studies in general show that the rate
of muscle glycogen utilization is unaffected by non-selective as well as beta-1
selective blockade (257, 258). Beta-2 adrenergic stimulation may increase
glucose output from the liver (259) and after beta-2 selective blockade lower
blood glucose levels were found at the end of a progressive maximal exercise
test (260). Blockade of liver nerve activity, however, had no effect on hepatic
glucose output during exercise (261). Whether liver glycogenolysis or
gluconeogenesis is impaired by beta-blockers is at the present not known and
doubted by some investigators (262). In general, plasma glucose levels during
exercise are unaffected by beta-blockade (236).
Lipolysis, i.e. the breakdown of triacylglycerols into glycerol and FFA, in
adipose tissue in vivo, is regulated by adrenergic mechanisms at rest and
during exercise. Alpha-adrenergic inhibitory effects modulate lipolysis at
rest, whereas beta-adrenergic stimulatory effects modulate lipolysis during
exercise (263). During exercise, reductions in plasma glycerol and FFA were
found ranging from 0-50% after beta-blockade (236). During recovery from
exhaustive exercise, however, levels were consistently found to be lower (264,
265). This decrease tends to be more pronounced after non-selective than after
beta-1 selective blockade (236). Because the uptake of FFA by the active
skeletal muscles depends on the plasma concentration, it could be seriously
diminished under beta-blockade (255). When lipolysis is attenuated, the
reduced availability of FFA during prolonged exercise might cause a shift
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from fat to carbohydrate combustion, leading to a more rapid depletion of the
limited carbohydrate stores in the body. This shift is suggested by studies
showing a higher respiratory exchange ratio during exercise after beta-block-
ade (266, 267).
On average, a slight reduction of plasma lactate with beta-blockade is found
during submaximal and maximal exercise (236). Consistently, increased plas-
ma potassium levels have been found during exercise with beta-1 selective
and non-selective beta-blockade (236), probably due to a reduced reuptake of
potassium by inactive skeletal muscles (268).
At present, limited data on the effect of beta-blockers with vasodilating
properties on metabolism during exercise are available. During prolonged
treatment with labetalol (251), a significant reduction in arterial blood lactate
during steady-state submaximal exercise was found. The metabolic effects of
treatment with nebivolol, atenolol and placebo have been compared during
and after endurance exercise in healthy volunteers (269). During recovery of
endurance exercise, plasma FFA and glycerol concentrations were reduced
during atenolol and nebivolol treatment as compared to placebo, although
these reductions tended to be more pronounced during atenolol than during
nebivolol treatment. Lactate and glucose concentrations during exercise did
not differ between the three conditions. Plasma potassium concentrations
during endurance exercise were significantly higher during atenolol treat-
ment than during nebivolol and placebo treatment.
Exercise per/ormance. One of the most noted side-effects during classical
beta-blocker therapy, especially in physically active patients, is exercise-re-
lated fatigue. These complaints have been objectivated as a reduced aerobic
exercise performance capacity (236). Usually a reduction in maximal aerobic
power output and maximal oxygen consumption between 5 and 10% is found
(235) (Table 5). Probably, the hemodynamic effects of beta-blockers play a
major role in this reduction since maximal heart rate and maximal cardiac
output are reduced and thus oxygen transport capacity. A positive correlation
between the reduction of exercise heart rate (and thus dose of the beta-block-
er) and the reduction of maximal oxygen consumption has been noted (235).
Furthermore, it has been suggested that a maximal heart rate reduction below
15-20% does not significantly reduce maximal exercise capacity (270). Few
studies have investigated maximal work capacity during treatment with
vasodilating beta-blockers. VO2max was significantly reduced (-6%) during
labetalol treatment for 2 weeks (250) with a concomitant decrease in maximal
heart rate of 21% and maximal cardiac output of 9%. Labetalol did not
significantly affect (-6%) the time to exhaustion on a progressive maximal
cycle ergometer test, but VO2max was not measured (271). Treatment with
dilevalol significantly reduced VO2max (-8%)(252), while maximal heart rate
(-28%) and maximal cardiac output (-19%) were also reduced. Nebivolol had
no effect on VO2max (-1%)/ whereas maximal heart rate decreased by 14%
(269). In an uncontrolled study in healthy volunteers (272) the effect of a
2-week treatment with carvedilol was investigated. Maximal oxygen con-
sumption was unchanged and maximal heart rate declined by 11%.
In a number of studies, the influence of beta-blockade on submaximal
endurance performance has been investigated. Endurance exercise is the
performance of work at a constant submaximal intensity until exhaustion. It
reflects more closely normal daily sporting activity and can thus be of greater
importance in clinical practice than maximal work capacity.
Endurance exercise time was found to be greatly reduced in all studies
under beta-blockade, ranging from -11 to -55% (Table 5) (235). These negative
effects on endurance performance tend to be more pronounced during non-
selective than during beta-1 selective blockade. The reduction in submaximal
endurance performance is not related to the reduction in exercise heart rate
(235). In contrast to classical beta-adrenoceptor drugs, nebivolol did not
decrease endurance time significantly (-6%) (269). Studies on the effect of
other vasodilating beta-blockers on endurance performance have not been
reported.
How beta-blockade impairs endurance performance is not clear. Although
active skeletal muscle blood flow is probably reduced during submaximal
steady-state exercise, oxygen delivery to the muscles is preserved by in-
creased oxygen extraction from the blood (255). During beta-blockade a
reduced extramuscular lipolysis is found (236) combined with a blockade of
muscle lipolysis (257). Although the significant increase in respiratory ex-
change ratio in some studies is in line with the expectation that there is a shift
from fat to carbohydrate combustion during endurance exercise, muscle
glycogenolysis occurs at a comparable rate (257). Some investigators suggest
that this apparent inability to increase the rate of glycogenolysis in the muscle
is the cause of the reduced exercise capacity (257). Furthermore, a drop in
plasma glucose under beta-blockade is not a consistent finding (236). Since
plasma lactate is found to be slightly reduced (236), lactate accumulation in
the working muscle has to be considered. In hypertensive subjects, slightly
higher muscle lactate concentrations have been found after treatment with a
non-selective beta-blocker, alprenolol (273). These concentrations are, how-
ever, far below those seen after maximal exercise and in healthy subjects
muscle lactate accumulation was not seen up to nearly maximal exercise (262).
Changes in potassium homeostasis as seen under beta-blockade could poten-
tially decrease endurance performance by a reduction of muscle membrane
potential, resulting in impaired excitability and thus contractibility (274).
Interestingly, nebivolol, which did not impair endurance performance,
showed similar metabolic effects as the classical beta-blockers, except for
potassium concentrations which were unchanged (269).
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3.7 /4/ms 0/ f/ris Mesis
Physical inactivity and poor fitness can be regarded as important risk factors
of hypertension and cardiovascular disease (section 1.1). Sedentary subjects,
either normotensive or hypertensive, may benefit from regular exercise by the
favorable influence on various risk factors for cardiovascular diseases, such
as a lowering of blood pressure (section 1.1 and 1.2). It is recognized that the
reduction in resting blood pressure with endurance training is rather small,
especially in normotensive subjects. Ambulatory blood pressure monitoring
may provide a better estimate of the real pressure load on the heart. To date,
few studies have investigated the effect of endurance training on blood
pressure during daily activity and at night. In chapter 2, the effect of a
moderate endurance training program on basal, exercise and ambulatory
blood pressure was studied in a sedentary male population with normal or
slightly elevated resting blood pressure.
It is known that mortality and morbidity from hypertension are better
correlated with systolic than with diastolic blood pressure, indicating an
important role of pulsatile stress. Because vessel wall properties (compliance
and distensibility) of large arteries are important determinants of pulsatile
stress it is of interest to know whether regular exercise can improve these
determinants. To answer this question, the vessel wall properties of three
large arteries (the common carotid, brachial and common femoral artery) of
well-trained subjects and sedentary controls were compared, using an
original ultrasound echo-tracking system based on Doppler shift (chapter 3).
The vessel wall properties of these same three arteries were studied after
sedentary subjects were trained for 6 weeks. Because we speculated that a
potential improvement of the vessel wall properties is probably rather a
reflection of functional intrinsic modification than structural change, some
neurohumoral parameters were studied as well (chapter 4).
On the one hand, the blood pressure response during acute exercise testing
is more frequently used as a diagnostic tool in the detection of true hyperten-
sion and in normotensives an exaggerated response is regarded as a predictor
of future hypertension (section 1.5). On the other hand, it is noted by some
investigators that hypertensives and normotensives show similar blood pres-
sure responses to exercise, that there is considerable interindividual variation
in response and that reference values of exercise blood pressure are remarkab-
ly scarce, especially in women. Therefore, factors that could explain the
variation in blood pressure response to exercise were studied in a large
population sample with normal, borderline elevated, and elevated resting
casual blood pressure. In chapter 5.1, this was done for men, and in chapter
5.2 for women. Furthermore, reference values were established.
Many patients with hypertension are physically active and need phar-
macological treatment to control blood pressure. In the selection of drug
therapy, several factors should be considered. It is preferable to choose a
medication that does not interfere with exercise performance. Especially beta-
blockers have been shown to considerably reduce endurance capacity, possib-
ly by a reduction of skeletal muscle flow during exercise and/or by an
impairment of lipolysis (section 1.6). During endurance exercise, reductions
in plasma glycerol and free fatty acids may or may not be seen. During
recovery, reduced levels are a more consistent finding. Because these lower
levels could be the consequence of an impaired performance rather than the
cause, we tried to differentiate this in chapter 6.
Beta-blockers with vasodilating properties are currently increasingly avail-
able and could provide an attractive alternative in the treatment of physically
active patients with hypertension because skeletal muscle blood flow during
exercise could be unaltered or even enhanced, or because lipolysis is not or
less impaired. At present, data on the effect of these drugs on endurance
performance are scarce. In chapter 7, carvedilol a new non-selective beta-
blocker with vasodilating properties was studied during exercise in hyperten-
sive subjects. Special interest was given to the effects on endurance
performance, metabolic parameters, and neurohumoral factors during exer-
cise.
This thesis contains seven papers which have been originally written as
separate manuscripts and are presented in chapter 2 to 7.
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ABSTRACT
/4 poss/b/e /lypofens/w acfiow 0/ regu/ar ewdwraMce exercise m normotensipe seden-
tary sub/ects sti// remains a matter 0/debate. Tnis is part/y caused by ffte/acf f«af f/ie
anficipafed /a// in resting b/ood pressure is rafner sma// a«d /7wcfuafions in b/ood
pressure dwnng f«e day can be /arge. 7ne bene/ifs 0/ ambu/atory b/ood pressure
monitoring CABP) originate /or a great dea/ /rom fne /act tnaf fne repeatabi/ify on
di/ferent occasions 0/ fne ambu/atory b/ood pressure average is improved by fne
greater number 0/ readings, /n tnis contexf we eua/uafed fne e/fecf 0/ moderate
exercise training in 19 sedentary ma/e sub/ecfs, aged 22 to 44 years, witfi norma/ or
s/ignf/y e/euafed b/ood pressure. 7ney entered a randomized cross-ouer study. Meas-
urements were performed be/ore fne study, a/ter 6 u>eefcs 0/sedentary /i/e sty/e (S) and
a^er 6 weefcs 0/ training fT) on a cyc/e ergometer 3 times a wee/c/or 45 mi'n at 75%
V02max. /4BP was measured wif« a Space/abs 90207 monitor and cardiac output at
rest witn ec/10-Dopp/er. Training increased V^O2max/^ "w 3.13 ± 0.09 to 3.40 ± 0.08
//min Cp < 0.02 X Resting neart rate decreased /rom 60 ± 2 to 57 ± 2 bpm at rest (p <
0.05). Resting b/ood pressure was unchanged a/ter training. Resting strode uo/ume
increased/ro?n 82 ± 3 to 89 ± 3 m/ (p < 0.02). Systemic yascu/ar resistance index was
signi/icant/y decreased due to conditioning (p < 0.05). Tne 24-h means o/systo/ic BP
fS: 325 ± 4; T: 225 ± 4 mmHg), diasfo/ic BP fS: 79 ± 3; 7: 78 ± 3 mmHg) and HR (S:
73 ±3; 7: 72 ±4 bpm) did not di//er between tne two cross-oyer periods, /n con-
c/usion, moderate pnysica/ training /or six weefcs does not /ower ambu/atory b/ood
pressure, b/ood pressure at rest and during exercise in normotensiue sedentary ma/e
swb/ects; tnis despite c/ear cardiac adaptations and a reduction in systemic yascu/ar
resistance.
INTRODUCTION
There is strong evidence from well controlled intervention studies, that
regular isotonic exercise can reduce resting casual blood pressure in sedentary
untreated hypertensive subjects (10). Reductions in blood pressure are
reported with an average of 11 mmHg for systolic blood pressure and 6
mmHg for diastolic blood pressure (7). Jennings et al demonstrated that a
regular exercise program can lower blood pressure to normotensive levels in
untreated patients with hypertension, in 4 weeks (21) and over 1 year (13).
However, in normotensive sedentary subjects, a possible hypotensive action
of regular endurance exercise still remains matter of debate. In a recent
consensus statement by the World Hypertension League (8) a small average
decline of 4 mmHg for systolic as well for diastolic blood pressure is assumed.
But recent controlled studies did not find any blood pressure lowering effect
(14,17,26). It is suggested that in the basal state the effect of physical training
on blood pressure in normotensives is small, but becomes more important
during conditions of stress (26).
The benefits of ambulatory blood pressure monitoring in the assessment of
the efficacy of antihypertensive drug treatment are now well established (22).
Ambulatory blood pressure measurements make it possible to achieve a 24
hour profile of blood pressure during normal daily stress and may
demonstrate a blood pressure lowering effect where conventional measure-
ments fail to detect it mainly by reducing within subject variability due to the
greater number of observations available (22). Therefore, the purpose of our
present study was to evaluate the effect of moderate exercise training on basal
blood pressure and on blood pressure during normal daily activities in seden-
tary men with normal and borderline-elevated blood pressure.
SUBJECTS AND METHODS
Twenty men aged 22 to 44 years were recruited from the general population
by advertising in a local newspaper. Based on 3 consecutive casual blood
pressure measurements in the morning on 2 different days 13 subjects had on
average blood pressure values lower than 140/90 mmHg, 6 subjects between
140/90 mmHg and 160/95 mmHg, and one subject had a blood pressure of
160/100 mmHg. All were free of overt cardiovascular disease or other medical
problems as judged by questionnaire, physical examination, routine
laboratory examination, resting electrocardiogram and stress testing. They
were non-smokers and took no medication. Their life style and jobs were
sedentary; none of the subjects was engaged in regular sport activities of more
than 1 hour/week for the last two years.
Design
Each subject gave written informed consent. The protocol of the study was
approved by the Ethical Committee of the University of Limburg.
Subjects entered a randomized two-way cross-over study. One group of 10
subjects continued their sedentary lifestyle for 6 weeks, followed by 6 weeks
of exercise training. The other group of 10 subjects started with 6 weeks of
exercise training followed by normal sedentary activity. The exercise training
consisted of 45 min exercise on a cycle ergometer at 75% VO2max three times
a week. Each session was preceded by a 5 min warming-up and completed by
a 5 min cooling down. The sessions were strictly supervised and heart rate
was monitored. The work load was adjusted to maintain a constant heart rate
which was between 130-160 beats/min for each subject. Subjects took no
medication and kept factors as physical activity, diet and weight as constant
as possible during the study. Weight was measured weekly, body fat was
calculated from the sum of 4 skinfolds (6), at the start and end of each period.
Urine was collected for 24 hour at the start and end of each period, to
determine urinary sodium excretion. In the non-training period subjects were
seen in our laboratory, every week, to promote compliance with the sedentary
lifestyle.
Measurements were performed at the start of the study and at the end of each
6-week period. After the training period, evaluation took place two days after
the last exercise bout to avoid acute post-exercise effects (15). Measurements
were performed between 9 and 12 a.m. after an overnight fast and abstinence
of caffeine for at least 12 hours. Care was taken that every subject was
investigated at the same time of the day for the three measurements sessions.
Measurements
Blood pressure was measured after 5 minutes in sitting position, and after 30
minutes in a supine position using a Hawksley random-zero sphyg-
momanometer. The mean of 3 consecutive measurements in each position was
taken. All blood pressure measurements were made by the same investigator.
Cardiac output at rest was measured with the subjects in left lateral recum-
bent position by means of echocardiography and Doppler ultrasound meas-
urements of blood flow velocity over the aortic valve with a conventional
echosystem (Ultramarkt V; ATL, Bothell, Washington, USA) after 30 minutes
of supine rest.
Aortic diameter (D) was measured from a standard 2-dimensional long-axis
parasternal view at the site of the aortic root with a 2.25 Mhz transducer.
The cross-sectional area (CSA) of the aortic anulus was calculated from the
aortic diameter as CSA = 0.25 7t * D .^ Maximal blood flow velocity in the
ascending aorta was recorded from the cardiac apex with a 1.9 Mhz con-
tinuous wave transducer. The RR-interval was derived from a simultaneous
recorded ECG. Heart rate (HR) was calculated as 60/RR-interval.
Evaluation of the flow velocity-time curve for each heart cycle gives an
estimate of blood flow which is related to stroke volume. The area under the
flow velocity curve - or the flow velocity integral (FVI) - and its corresponding
RR-interval were determined off-line with built in electronic calipers. Cardiac
output was computed according to the equation: CO (1/min) = CSA (cm )^ *
FVI (cm) * HR (beats/min) * 10"3. The mean of 6 heart beats was taken. The
average stroke volume (ml) was calculated as CO/HR * 1000. In our hands,
stroke volume intra- and inter-day variability, expressed as coefficient of
variation, was less than 5%. Simultaneous arterial pressure was measured
using a semi-automated device (Dinamap, Criticon, Tampa, USA). Mean
arterial pressure (MAP) was calculated as diastolic pressure + 1/3 pulse
pressure. Systemic vascular resistance index was calculated as MAP/cardiac
index (CD.
Thereafter a progressive maximal cycle ergometer (Lode, Groningen, The
Netherlands) test was performed. This test started with a work rate of 100 W
for 5 minutes, which was increased by 30 W every 3 minutes until exhaustion.
Heart rate and systolic blood pressure (sphygmomanometer) were measured
at rest, and at the end of the 100 W and 160 W stage. A blood sample was
obtained from an antecubital vein for determination of plasma lactate con-
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centration at exhaustion. During exercise oxygen consumption and res-
piratory exchange ratio were measured with a Sensor Medics Horizon meta-
bolic measurement card. Peak oxygen uptake was defined as the mean oxygen
uptake during the last minute. Plasma lactate was measured by an enzymatic
auto-analyzer method, urine sodium levels by flame photometry. Am-
bulatory blood pressure was monitored with a non-invasive automated
device, Spacelabs system model 90207 (Spacelabs Inc, Redmond, Wash, USA).
With this system blood pressure is measured by oscillometry. All registrations
were done on a weekday and included working periods employed outside the
home. The subjects were asked to keep the same day and night rhythm
throughout the three measurement periods and perform their normal daily
routine. Blood pressure and heart rate were recorded every 15 minutes during
the day (7 a.m. to 11 p.m.) and every 30 minutes during the night (11 p.m. to
7 a.m.). Subjects were instructed to stop muscular activity and keep their arms
entirely still during BP measurements. Each reading was edited by computer
and was rejected if the diastolic blood pressure was less than 40 mmHg or
more than 140 mmHg, systolic blood pressure less than 80 mmHg or more
than 245 mmHg, pulse pressure less than 20 mmHg and heart rate less than
40 bpm or more than 150 bpm. Over a 24 hour period, for each subject 70 to
80 blood pressure values could be analyzed.
Statistical analysis was performed according to the non-parametric Koch
procedure for the two-way cross-over design using the Mann-Whitney U-test
(16). If appropriate, the method of Willan and Pater (28) was used. Compara-
tive data analysis with baseline data was made by Wilcoxon m.p.s.r. Am-
bulatory blood pressure data were compared by one-way analysis of variance
(repeated measurements) and the Bonferroni post-hoc test. A p-value < 0.05
was considered statistically significant. All data are expressed as mean ±
standard error of the mean.
RESULTS
No interactions and order effects were found, except for a slight carry-over
effect for VC^max- Analysis according to Willan and Pater (28), however,
indicated that the cross-over analysis of VO2max based on the data of the two
periods was a better estimate than a parallel group comparison based only on
the data of the first period.
Twenty subjects entered the study, but one stopped in the training period
due to lack of motivation. Due to technical failures in two subjects more than
25% of the recordings of ambulatory blood pressure after the training period
were unsuccessful. The recordings of these subjects were not used in the
analysis. As a consequence, data are presented for 19 subjects, except for
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ambulatory blood pressure (n=17). At the start of the study, the subjects were
on average 37 ± 1 years old, weighed 77 ± 2 kg, had a percentage body fat of
20 ±2% and were 179 ±1 cm tall. The weight and percentage body fat
remained unchanged throughout the study. The 24-hour urinary excretion of
sodium was 184 ±17 mmol at the start of the study and was not significantly
different after the sedentary (167 ±17 mmol) and training period (150 ±15
mmol).
Based on casual blood pressure measurements there were 12 normotensive
subjects and 7 subjects with a (borderline) elevated blood pressure. Using the
recently proposed reference values for ambulatory pressure (25), only one
subject was probably hypertensive (blood pressure over 24 hours > 139/87
mmHg) with an average blood pressure of 139/91 mmHg at the start of the
study. Data are presented for the whole group. In addition, subanalyses of
blood pressure at rest and during exercise were made in the elevated blood
pressure group (n=7).
Six weeks of training increased peak oxygen uptake (VO2max) by 9% (p <
0.01) (Table 1). Heart rate after 30 min supine rest declined from 60 ± 2 bpm
after sedentary activity to 57 ± 2 bpm after endurance training (p < 0.05) (Fig.
1). Stroke volume increased from 82 ±3 ml to 89 ±3 ml (p < 0.02) (Fig. 2).
Calculated stroke index increased from 42.2 ± 1.3 to 45.6 ±1.4 ml/m^ at rest
(p < 0.001) and calculated cardiac index at rest increased significantly (p <
0.05) during training from 2.57 ± 0.09 to 2.71 ± 0.09 l/min/m2. Calculated
systemic vascular resistance index fell from 2875 ±114 dyn.s.cnrS.m^ at the
end of the sedentary period to 2692 ± 90 dyn.s.cm~5.m2 after training (p < 0.05)
(Fig. 3).
Table 2 presents data of resting sitting and supine blood pressure measured
with the Hawksley random-zero meter. As expected, values after 5 min sitting
were slightly higher compared to the supine rest values. No significant chan-
ges in resting blood pressure were found at the end of 6 weeks of training.
When resting blood pressure was analyzed for the subgroup with casually
elevated blood pressure (n=7) no significant changes occurred either (At the
end of the sedentary period 130 ±5/84 ±4 mmHg versus at the end of the
training period, 130 ± 3/83 ± 2 mmHg). Heart rate in this group declined from
Table 1. Data on maximal aerobic exercise capacity (n=19).
At start study Sedentary period Training period
Peak heart rate (bpm) 181 ±3
Peak oxygen uptake (1 / min) 3.15 ± 0.08
Peak respiratory exchange ratio 1.15 ± 0.01
Peaklactate(mmol/1) 11.3 ±0.7
180 ±2
3.13±0.09
1.16 + 0.02
10.3 ± 0.6
178 ±3
3.40 ± 0.08 *
1.18 + 0.01
11.8 ±0.7
i4// pa/ues are expressed as mean
training pen'orf.
± standard error. * p < 0.01 /or deference between sedentary and
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at rest
win 24 hours day
Fig. 1 Hearf rafe a/ter 30 m/n o/swpme rest a«d during 24-nour ambu/afory
recording af fne sfsrf o/ f/ie study (B,), af fne end o/a sedenfary period o/ 6
weefcs CS.) and af fne end o/ f/ie (raining period fT). * p < 0.05 /or deferences
/rom sedentary values.
Cardiac index Stroke volume
Fig. 2 Cardwc index and sfrofce ro/ume at t«e start o/fne study CB), af fne enrf
o/ a sedenfary period o/ 6 weeits (S> and af fne end o/ f/ie training period (T).
* p < 0.05 /or differences /rom sedentary t>a/ues.
65 ± 2 bpm to 60 ± 3 bpm (p < 0.02). Blood pressure and heart rate measured
at rest sitting on the bicycle and during submaximal exercise are shown in
Table 3. No significant changes in blood pressure were found due to the
exercise training; this in contrast to a highly significant decline (p < 0.01) in
the submaximal exercise heart rate following training. Comparable changes
were observed in the elevated blood pressure group: sitting systolic blood
pressure was 157 ±4 mmHg after the sedentary period and 151 ±6 mmHg
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SYSTEMIC VASCULAR RESISTANCE
INDEX
Fig. 3 Systemic iwscu/ar resistance index
af t/ie sfarf 0/ Me study (B,), af f/ie end 0/
f/ie sedentary (S) and at t/ie end 0/ f/ie
training period (T). * p < 0.05 /or di/-
/erences/rom sedentary i>a/ues.
Table 2. Blood pressure after 5 minutes of sitting and 30 minutes of supine rest (n=19)
Sitting
SBP (mmHg)
DBP (mmHg)
St/pine
SBP (mmHg)
DBP (mmHg)
At start study
123 ±4
80 ±2
115±2
76 ±2
Sedentary period
117±3
78 + 2
111 ±2
73 ±2
Training period
120 ±3
79 ±2
113±3
73±3
Means are presented ± standard error. SBP, sysfo/ic Wood pressure; DBP, diasfo//c Wood pressure.
B/ood pressure measured with f/ie Hawfcs/ey random-zero meter.
after training (not significant), whereas sitting heart rate at rest was sig-
nificantly decreased from 79 ± 5 bpm to 72 ± 4 bpm after training (p < 0.05).
At a workload of 100 W, a systolic blood pressure of 192 ± 9 mmHg was found
after the sedentary period and 194 + 7 mmHg after training (n.s.); for the heart
rate, these values were 124 ± 6 and 113 ± 4 bpm (p < 0.05).
Table 4 presents data of the ambulatory blood pressure monitoring and Fig.
4 shows the 24-hour blood pressure profile. Ambulatory blood pressure is not
lowered by training, neither during 24 hours nor during the day- or night-
time. There is a small, but statistically significant decline in ambulatory
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Table 3. Systolic blood pressure and heart rate at rest and during submaximal exercise
(n=19).
SBP at rest (mmHg)
HR at rest (bpm)
SBP at 100 W (mmHg)
HR at 100 W (bpm)
HR at 130 W (bpm)
SBP at 160 W (mmHg)
HR at 160 W (bpm)
At start study
146 ±4
70±3
179 ±6
118±4
137 ±4
201 ±6
157 + 4
Sedentary period
141+4
74 ±3
181 ±5
118±3
136 ±4
194 ±6
157 ±4
Training period
141 ±4
71 ±3
177±5
111 ±3*
129 ± 4»
198 ±5
145 ± 4*
/If rest: sifting on the bicyc/e immediate/y before exercise. Means are presented ± stanrfard error.
SBP, sysfo/ic Wood pressure; HR, heart rafe. * p < 0.02 /or differences berween sedentary and framing
period.
Table 4. Ambulatory blood pressure and heart rate (n=17).
24 hr meow
SBP
DBP
HR
Dayf/me mean (7 a.m. - 23 p.m.)
SBP
DBP
HR
Night time mean (21 p.m. - 7 a.m J
SBP
DBP
HR
At start study
126 ±4
80 ±3
73 ±4
130 ±3
83 ±3
76±4
112±3
67±3
62 + 2
Sedentary period
125 ±4
79 ±3*
73 ±3
129 ±4
82 ±3+
76 ±3
110±3
65 + 3
61 ±2
Training period
12514
78 ±3+
72±4
12913
8113+
7514+*
11013
6412
6313*
Means are presented 1 standard error. SBP, sysfo/i'c Wood pressure; DBP, diasfo/i'c Wood pressure;
HR, heart rafe. +p < 0.05 /or differences /rom i>a/ues at the start o/ the study; * p < 0.05 /or differences
between sedentary and training period.
diastolic blood pressure between the first (at the start of the study) recording
and the recordings during the cross-over periods. Training lowered the heart
rate only during the daytime (p < 0.05). During nighttime heart rate was even
somewhat higher after training (p < 0.05). For the elevated casual blood pres-
sure group, only 5 subjects had complete records and the average 24-hour
blood pressure was 130 ± 3/84 ± 4 mmHg for the sedentary period, and 130 ±
5/83 ± 2 mmHg after training. Day- and night-time recordings were in line
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ambulatory
24-hour curve
40
10 12 14 16 18 20 22 24 6 hours
95% confidence levels during sedentary life style
mean values after training
Fig. 4 Circadwn r/iyf/im o/ sysfo/ic anrf d/asto/ic Wood pressure af
fhe end o/ fhe sedenfary and framing period. The ambu/atory Wood
pressure curc>e a/rer fraini/ig is compared with f/ie 95% con/idence
/imif s o/ fhe ambu/afory Wood pressure curw in fhe sedenfary period.
with the whole group and showed no effect of physical exercise training,
while conditioning lowered the heart rate during the day (p < 0.05).
DISCUSSION
The anticipated fall in resting blood pressure from exercise training in seden-
tary normotensive subjects is small (8). An average fall of 4 mmHg for systolic
as well as diastolic blood pressure must be viewed against the magnitude of
the variability in blood pressure. Fluctuations of 40% in blood pressure can
readily occur at random during the day (18). By using ambulatory recordings
and thus increased numbers of readings, the variability between repeated
blood pressure estimations is markedly reduced and smaller differences in
blood pressure fall are more easily detected (4). In addition, evidence is
growing that ambulatory blood pressure measurement is superior to tradi-
tional blood pressure measurements in providing a proper estimate of the real
pressure load to the heart (19).
In this study a Spacelabs 90207 oscillometric blood pressure monitor was
used, which has been successfully validated according to the British Hyper-
tension Society protocol (23). All but one of the subjects in this study could be
classified as normotensive based on recently proposed reference values for
ambulatory blood pressure, although 7 subjects had elevated casual blood
pressure values at the start. This points to an additional advantage of am-
bulatory monitoring, namely to better differentiate between true and pseudo-
hypertensives (24). It is conceivable that part of the inability to find a
significant decrease in systolic blood pressure by conditioning in 11 out of 33
studies in sedentary hypertensive men (10) can be explained by misdiagnosis.
Comparing the ambulatory diastolic blood pressure averages at the start with
sedentary and training (pooled) averages, there is a small but significant
decline. Thus, the absence of some first measurement effect cannot be ruled
out (5).
The most important finding of this study, however, is the lack of any
hypotensive effect, as measured with ABP, of conditioning in normotensive
sedentary subjects. This is in agreement with other studies (9, 27). Gilders et
al (9) studied 10 normotensive sedentary male and female subjects after a
16-week endurance exercise conditioning period (3 days/week, 30 min of
exercise at 80% of maximal heart rate) and after a 12-week de-conditioning
period. Although conditioning increased VC*2max in that study by 14%, which
is higher than the average 9% in the present study, blood pressure (measured
with the Del Mar Pressurometer III) did not decrease, neither over 24-hours
nor during the day or night. A shortcoming of the study by Gilders et al is the
fixed order in which conditioning and de-conditioning periods were alter-
nated, which cannot rule out an order effect. Using a randomized cross-over
design, Van Hoof et al (27) studied 26 sedentary men who trained for 4
months (3 days/week, intensity not mentioned) or continued their sedentary
lifestyle for 4 months. An increase in VO2max by 14% did not change the
ambulatory blood pressure during the day or the night (measured by a
Spacelabs 5200 device), except for the day-time diastolic blood pressure which
was lowered by 5 mmHg. Average 24-hour blood pressure values were not
given because measurements between 6 and 8 A.M. and 8 and 12 P.M. were
excluded. The findings in the present study and afore-mentioned studies (9,
27) on ambulatory blood pressure and training are in contrast with the
prevailing view that endurance training lowers blood pressure at rest in
normotensive sedentary subjects (8).
We also measured casual blood pressure at rest after 5 min sitting and in a
more basal state after 30 min of rest but did not find a reduction in blood
pressure, despite of clear adaptive effects at rest of the heart rate, stroke
volume and systemic vascular resistance to training. Jo et al (14) trained 14
untreated hypertensives and 14 normotensives for 12 weeks and observed a
significant fall in blood pressure in the hypertensive group but not in the
normotensives. Lightfoot et al (17), studying the effect of 10 weeks of aerobic
training on lower body negative pressure responses, did not find a change in
systolic and diastolic blood pressure at rest in normotensive subjects in spite
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of a 20% increase in VC>2max-1* is possible that the blood pressure response to
training was influenced by other factors. Diet, weight and body composition
were, however, not altered. It can be argued that the level of physical activity
of our subjects in normal daily life was too high to see an effect of conditioning
on blood pressure. Jennings et al (12) suggested that the antihypertensive
effect of regular exercise is a low threshold phenomenon and the major effect
occurs when sedentary subjects increase their activity level to only moderate
levels. But all our subjects had white-collar jobs and did not engage in regular
(endurance) sporting activities for the last 2 years. Vanhees et al (26) and Van
Hoof et al (27), reporting on the same normotensive subjects, described train-
ing-induced changes varying according to the measuring conditions. They
found that in the basal state (after about one hour rest in recumbent position),
the effect of physical training on blood pressure in normotensive subjects is
neglible (26), but becomes more important during conditions of stress. They
reported a decrease in submaximal exercise blood pressure. In sharp contrast
to our findings, Meredith et al (20) measured supine blood pressure after the
normotensive subjects had been lying for 25 min, and found a decrease of 8
mmHg for systolic blood pressure and 5 mmHg for diastolic blood pressure
after 4 weeks of training at a workload of 60-70% W^x- In the present study
no effect of training on exercise blood pressure measured at 100 and 160 W
was found despite a clear reduction in submaximal heart rate and this is in
accordance with De Vries et al (5), who found no effect on blood pressure
measured at 75 W in older men.
Remarkably, training induced a significant 6% increase in cardiac index.
This modest rise in the resting cardiac index is in line with previous studies
(11, 20), using the "indirect Fick" method, but conflicts with the study by
Gilders et al (8), who measuring cardiac output with echo-Doppler, found an
unaltered cardiac output at rest following conditioning. The increase in car-
diac index was caused by an increase in stroke volume, which in turn is most
likely to be the result of an increased preload and increased central blood
volume associated with training (1). Because the mean arterial pressure was
found to be unchanged by training and the cardiac index was increased,
systemic vascular resistance index was consequently decreased. Afterload
reduction is a crucial component of the integrated cardiovascular response to
training. An increase in the size of the capillary bed of the skeletal muscle is a
well-known training effect. This could in part account for the reduction, but
it is believed that regulatory effects on arteriolar level are most important (2).
A lot of research has focussed on a probable decline in sympathetic activity
due to conditioning, but results lack consistency (10).
Although we discussed the subjects as one group, being normotensive
based on their ambulatory recordings, we made analyses of the subjects with
elevated casual blood pressure. A hypotensive effect of a physical exercise
training could not be detected neither on resting, exercise or ambulatory
blood pressure. Recently, Blumenthal and colleagues (3) assessed the effects
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of a moderate physical exercise program in patients classified as mild hyper-
tensives, based on resting blood pressure. Ambulatory blood pressure
monitoring was performed using an Accutracker monitor, from 8 am until
bedtime. The study was designed as a randomized controlled trial. After 4
months of exercise training (3 times a week, aerobic exercise for 35 minutes at
70%VO2max) subjects in the aerobic exercise group did not exhibit greater
reductions in ambulatory blood pressure than subjects in the control group.
In conclusion, this study shows that in normotensive sedentary subjects six
weeks of training does not lower ambulatory blood pressure, blood pressure
at rest and during exercise, despite clear cardiac adaptations and a reduction
in systemic vascular resistance at rest.
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ABSTRACT
Vesse/ a;a// properties Crf/sfe«s/b///fi/ and comp/iance) 0/ ffte e/asf/c common carofid
artery and tne mMscw/ar /emora/ and fcracwio/ arfenes zwre sfudi'ed wi7li a dedicafed
u/frasound system in 15 trained ma/e cyc/ists and 25 nea/fhy sedentary ma/es
matcned /or «^e, neig/zt and wei^nt. Si'mw/faneoMs/y, arm Wood pressure was
measured wifn a Dinamap and neart rate and sfrofce mdex wifn bioimpedance
e/ectrocardiograpny.
Heart rate at rest was s/gnj/icanf/y /ower and strode index signi/icanf/y nigner in
fne trained subjects. B/ood pressure and pw/se pressure did not differ. Vesse/ wa//
properties and diameter 0/ tne common carotid artery snowed no differences between
t/ie groups. Diameter 0/ tne /emora/ artery was signi/icant/y /arger (p < 0.05) in
cyc/i'sfs and cross-sectiona/ comp/i'ance fended to be /11'g/ier. Distensibi'/i'ty coefficient
was not different. Diameter 0/ f/ie bracnia/ artery did not di/fer between fne two
groups. Cross-sectiona/ comp/iance o/tne brac/iia/ artery was sigm/icanf/y nigner in
fne cyc/isfs (p < 0.02), rf/s^Ms/W//fi/ coe//icienf was 22% nigner (p = 0.09).
Tnese resu/fs suggest tnaf endurance training in cyc/ists mignt cause strucfura/
adaptation 0/ tne /emora/ artery and a more genera/ decrease in smootn musc/e tone
0/ muscu/ar arteries.
INTRODUCTION
Physical conditioning, especially endurance training is accompanied by
various central and peripheral cardiovascular adaptations. Striking features
of the training response are an increase in left ventricular end-diastolic
volume of the heart, a sinus bradycardia at rest, a decreased heart rate during
submaximal exercise and an increase in the size of the capillary bed of the
skeletal muscle (1).
Furthermore physical training increases the capacity for vasodilation in
active limbs, probably by increasing the capacity of arteriolar vessels to
accommodate blood flow during exercise (2). Large arteries have a conduit
and buffering function (3). They transform the systolic flow jet from the heart
into a more continuous flow for tissue perfusion. Arterial extensibility and
compliance are vessel-wall properties that determine, respectively, the elastic
and buffering function of large arteries. Whether physical training induces
changes in these properties has not been studied yet.
Recently, ultrasound techniques have been developed (4), by which these
vessel-wall properties can be measured. In the present study we compared the
vessel-wall properties of three large arteries i.e. the common carotid artery,
the brachial artery and the common femoral artery, between endurance-
trained cyclists and sedentary subjects at rest.
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MATERIALS AND METHODS
The study was performed on 15 well-trained male cyclists and 15 healthy
sedentary male subjects matched for age ( ± 2 yr), height ( ± 2 cm) and body
mass (± 2 kg). The cyclists had been active in competition for at least two
consecutive years and measurements were taken in the second month of the
training season. The sedentary subjects did not perform endurance or com-
petitive types of sports and were mostly recruited from a student population.
All subjects were free of overt cardiovascular disease, did not smoke and used
no cardiovascular medication.
After 15 min of supine rest, 3 consecutive measurements of blood pressure
with a Hawksley random zero meter showed a blood pressure less than
140/90 mmHg in all subjects. The protocol was approved by the institutional
Ethics Committee. Informed written consent was obtained from each subject.
On the day of examination, the subjects abstained from caffeine and reported
at the laboratory at least 3 hours after they had their last meal. Furthermore,
no vigorous exercise was performed the day before. Body height and body
mass were measured and body fat was calculated from the sum of 4 skinfolds
according to Durnin and Womersley (4).
The ultrasound investigation was carried out in a quiet room (22 ± 1°C) after
15 min in the recumbent position. Arterial blood pressure was measured
every 2 min at the left arm with a semi-automated oscillometric blood pres-
sure device (Dinamap, Criticon, Tampa, USA). Systolic and diastolic pres-
sures were recorded at least 6 times during the echo investigations and the
average value was taken as the subject's reading.
Vesse/ wo// properties
A 7.5 MHz ultrasound system (Ultramark-V, ATL, Bothell, Washington, USA)
was used to locate subsequently the common carotid artery, the common
femoral artery and brachial artery, all at the right side, whereafter the system
was switched to the M-mode with M-line placed perpendicular to the axis of
the vessel. For a period of 4 to 5 seconds, the radio-frequency signals received
in M-mode were stored temporarily in a dedicated memory module (5),
synchroneous with an ECG-derived trigger for timing reference purposes.
After completion of the data collection, the signals were transferred to a
personal computer (PC), where the first M-line acquired was used to identify
the positions of the vessel walls. Off-line Doppler processing of the radio-fre-
quency signals within windows coinciding with both walls (Fig. 1A) reveals
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Fig. IB Reg/'sf ration 0/ fhe i>esse/ ZMJ// movement 0/ the common carofid orfery during 5 heart
cyc/es in a young Ziea/fny ro/nnteer. anf: anterior wa// movemenf; pos: posterior aw//
mouemenf; disf: distension, change in diameter during f/ie heart cyc/e
the displacement of the arterial walls was a function of time, while the
difference between both represents the distension waveform (Fig. IB). The
coefficient of variation in the peak-to-peak distension varied from 8-13%,
depending on the artery (6). This variation can (partly) be attributed to the
beat-to-beat changes in local pulse pressure.
From the diameter at the onset of the cardiac cycle (D), the relative change
in diameter during the cardiac cycle (distension; AD) and pulse pressure (AP,
systolic minus diastolic blood pressure), distensibility coefficient (DC), and
cross-sectional compliance (CO were calculated using the following equa-
tions:
DC = - 2(AD/D)AP
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Cardiac oufpwf measurement
Cardiac output and heart rate were continuously measured by electrical
bioimpedance (NCCOM3-R7; BoMed Medical Manufacturing LTD, Irvine,
California, USA). The monitor automatically averages stroke volume over 12
cardiac cycles. Recently, Northridge et al (7) compared this method to Dop-
pler echocardiography and the thermodilution method in patients within 24
hours after acute myocardial infarction and found close agreement in most
patients, and good reproducibility.
Exerc/se fesf
After the ultrasound investigations, maximal working capacity (W^x) was
assessed on a bicycle ergometer (Lode, Groningen, The Netherlands) with a
progressive protocol until exhaustion (start 100 W; then 50 W increase every
3 min). Peak heart rate was obtained from ECG and blood was sampled from
a cubital vein after 3 min in the recovery phase for determination of plasma
lactate. Plasma lactate was determined spectrophotometrically according to
the LDH method with a centrifugal analyzer (type Cobas Bio).
Data ana/ysis -»:;.'' K^rs^mt !?•
Results are presented as mean±SEM (n = 15 in both groups). Comparison
between the trained and sedentary subjects was made by the non-parametric
Mann-Whitney U-test. A p-value less than 0.05 was considered statistically
significant.
RESULTS
Subject characteristics are presented in Table 1. With regard to age, height and
body mass no significant differences between the two groups existed. Trained
subjects had a significantly lower percentage body fat and resting heart rate
was on average 10 beats.min^ lower (p < 0.05). Stroke index was significantly
higher. Maximal effort during the progressive maximal exercise test was
comparable between the two groups as judged by maximal heart rate and
peak plasma lactate concentration. A large significant difference was found in
absolute maximal aerobic power (W^x) arid W^ax standardized for body
mass ( W k l )
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Table 1. Subject characteristics
Sedentary Trained
Age (y)
Body height (cm)
Body mass (kg)
Body fat (%)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Pulse pressure (mmHg)
Resting heart rate (bpm)
Stroke index (ml.irr^)
Wmax (W)
Wn,ax.kg-1 (W.kg-1)
Maximal heart rate (bpm)
Plasma lactate (mmol.l~')
24.3 ±1.0
183.5 ±1.3
74.7 ± 2.5
14.3 ±1.0
120.9 ±2.9
68.5 ±1.9
52.3 ± 2.6
60.2 ±2.1
66.9 ± 2.9
289.6 ± 10.4
3.91 ±0.15
189.7 ±2.6
10.9 ± 0.6
24.4 ±1.0
182.2 ±1.9
74.9 ± 2.1
10.8 ±1.6*
117.5 ±2.4
63.5 ±1.1
54.0 ±2.0
50.0 ±2.1*
74.8 ± 3.4*
392.2 ± 12.8*
5.24 ±0.12*
186.1 ± 2.8
11.5 ±0.4
* p < 0.05. B/ood pressure measured a>«7i Dinamap in supine position.
Table 2. Arterial diameter (D), diameter change (AD), distensibility coefficient (DC) and
cross-sectional compliance (CO for the right common carotid artery, right common femo-
ral artery and right brachial artery in sedentary and trained subjects
Sedentary Trained
Carofid artery
D(mm)
AD (um)
DC (10--VkPa)
CC (mmVkPa)
Femora/ artery
D(mm)
AD (urn)
DC (10-3/kPa)
CC (mmVkPa)
Bracni'a/ arfery
D(mm)
DC (10-VkPa)
CC (mmVkPa)
•p<0.05.
6.37 ±0.13
630 ±24
29.6 ± 2.0
0.93 ± 0.05
8.81 ±0.18
690 ±43
23.4 ±1.9
1.43 ±0.12
4.36 ± 0.08
409 ±39
27.5 ± 2.6
0.40 ± 0.03
6.41 ±0.11
669 ±33
30.3 ± 2.9
0.97 ±0.08
9.89 ± 0.31*
819 ±57
25.4 ± 3.8
1.82 ±0.19
4.40 ±0.11
523 ± 35*
33.7 ±2.5
0.51 ± 0.03*
''V'Ji,
With regard to blood pressure, systolic blood pressure was not significantly
different, but diastolic blood pressure tended to be lower in the trained group
(p = 0.05). Pulse pressure did not differ.
In Table 2, vessel wall properties of the three large arteries are shown. No
significant differences for the elastic common carotid artery were found.
Diameter of the muscular common femoral artery was on average 12% larger
in the cyclists (p < 0.02). Cross-sectional compliance averaged 27% higher and
distensibility coefficient 9% higher, but the level of significance was not
reached (p = 0.09 for cross-sectional compliance). Diameter of the muscular
brachial artery showed no difference between the groups. Distensibility of the
brachial artery tended to be higher (23%; p = 0.09) in the trained group.
Cross-sectional compliance was 28% higher (p < 0.02) in the cyclists.
DISCUSSION
In this study assessment of local vessel wall properties was made by a
dedicated ultrasound technique. Using this technique, it has previously been
shown that distensibility and compliance of large arteries decrease with age
(8), that they are lower in females than in males (9), and that arterial (border-
line) hypertension is associated with a decrease in compliance and disten-
sibility (10). Recently a diurnal pattern in vessel wall properties of large
arteries has been demonstrated (11).
It has been established that in order to increase maximal cardiac output with
physical training the combined effects of an improved myocardial perfor-
mance and a reduced resistance to flow are needed (12). Physical training
increases the capacity for vasodilation in the active muscles, probably by
structural changes at the arteriolar level, and enables the trained individual to
utilize a larger fraction of maximal vascular conductance than the sedentary
subject (2). Literature data on the effect of physical training on large arteries
are scarce.This is the first study in which vessel wall properties of large
arteries were compared between endurance trained athletes and sedentary
subjects.
Physical training of competitive cyclists is characterized by many hours of
repeated bouts of high-intensity exercise, predominantly isotonic and per-
formed especially with the quadriceps muscles. In addition, some work is
done by the arms and upper body, mainly isometric in nature. The present
study observed several differences between the vessel wall properties of the
large arteries of cyclists and their sedentary counterparts, which could be the
result of physical training. However, the possibility that these differences
merely reflect genetic endowment cannot be ruled out. With regard to the
common femoral artery, the internal diameter was found to be 12% larger in
cyclists at rest. Most likely this represents a local adaptation to facilitate the
large blood flow to the quadriceps muscles during strenuous exercise. It can
be hypothesized that it is in part the resultant of [1] a chronic flow-dependent
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vasodilation (13), [2] caused by a reduced sympathetic stimulation during
exercise, [3] by other neurohumoral regulatory mechanisms or [4] simply is
the consequence of volume overload.
It is not clear whether the vasodilation seen at rest is primary functional or
rather structural in origin. Recently, it has been found (14) that the radial
artery of the dominant arm of hammer throwers has a significantly larger
diameter and increased compliance at rest, compared to the opposite arm and
the arms of sedentary controls, which probably suggests a more structural
adaptation. A flow-dependent vasodilation of the femoral artery at rest seems
unlikely, because leg blood flow at rest is not different in endurance-trained
and sedentary subjects (2). A more systemic functional component to the
dilation could be imagined, however, this is not revealed by differences in the
brachial diameter between the two groups.
Surprisingly, we found no differences in vessel wall properties (cross-sec-
tional compliance and distensibility coefficient) of the femoral artery in
cyclists. Distensibility coefficient of the femoral artery was not significantly
different, probably as a consequence of the structurally larger diameter. An
increased cross-sectional compliance could be expected since the diameter
was significantly larger with an unchanged distensibility coefficient. An ob-
vious explanation for the absence of statistical significance could be the wide
dispersion of individual data.
The most interesting finding of the present study is a better cross-sectional
compliance of the brachial artery in trained subjects compared to that of
sedentary subjects. As described in the method section, cross-sectional com-
pliance is related to diameter and distensibility coefficient. Because average
diameter was only 1% larger in the trained group and average distensibility
coefficient was 23% higher, the better cross-sectional compliance has to be
considered the resultant of a better vessel wall distensibility. The better
cross-sectional compliance was only observed in the muscular brachial artery
and not in the more elastic common carotid artery. Therefore, it is tentative to
suggest that aerobic training can induce a decrease in muscle tone of the
brachial artery and perhaps also a more general decrease in muscle tone of
other muscular arteries. This could be related to a reduction in sympathetic
activity. Whole-body spill-over rate of norepinephrine into the plasma, a
measure of average sympathetic neural activity, is significantly reduced with
training (15). Whether central, peripheral or local mechanisms are primarily
or secondarily responsible for this change remains to be established. A
preferential effect of endurance exercise training on renal sympathetic activity
has been noticed (16) and endurance training reduced sympathetic activity of
the peroneal nerve assessed by microneurography (17). Alternatively, train-
ing could decrease the response to adrenergic stimulation at the level of the
smooth muscle (18). The renin-angiotensin system could also play a role since
in trained subjects lower levels of plasma renin have been found (15, 19). In
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addition, endothelial-mediated flow-dependent changes of the arterial wall
cannot be ruled out (20).
An improvement in vessel wall properties of large arteries in cyclists is in
line with the observed higher regional compliance of the aorta of athletes
compared to age-matched controls as measured with magnetic resonance
imaging (21). A strong inverse linear relationship was found between pulse
wave velocity measured over the carotid-femoral traject and physical work-
ing capacity in young men (22). This indicates a positive relation between
aortic distensibility and physical working capacity. Arterial compliance is a
major determinant of the afterload of the heart (23). A decrease in afterload by
a decrease in vascular impedance due to an increase in arterial compliance
with training could therefore improve cardiac performance (24).
Longitudinal studies are needed to find out whether training can improve
vessel wall properties of large arteries in sedentary populations. If it does, it
might contribute to explain why physical inactivity is associated with a higher
risk of developing hypertension (25) and with a higher cardiovascular mor-
bidity and mortality (26).
REFERENCES
1. Blomqvist CG, Saltin B. Cardiovascular adaptations to physical training. Ann Rev
Physiol45:159-189,1983.
2. Snell PG, Martin WD, Buckey JC, Blomqvist CG. Maximal vascular leg conductance in
trained and untrained men. J Appl Physiol 62: 606-610,1987.
3. O'Rourke M. Arterial stiffness, systolic blood pressure, and a logical treatment of arterial
hypertension. Hypertension 15: 339-347,1990.
4. Durnin JA, Womersley }. Body fat assessed from total body density and its estimation
from skinfold thickness: measurement on 481 men and women aged from 16-72 years.
BrJNutr 32: 77-94,1974.
5. Hoeks APG, Brands PJ, Smeets FM, Reneman RS. Assessment of the distensibility of
superficial arteries. Ultrasound Med Biol 16:121-128,1990.
6. Kool MJ, Van Merode T, Reneman RS, Hoeks AP, Struijker Boudier HA, Van Bortel LM.
Non-invasive evaluation of vessel wall properties of large arteries with a vessel wall
movement detector system. Cardiovasc Res 28: 610-614,1994.
7. Northridge DB, Findlay IN, Wilson ] et al. Non-invasive determination of cardiac output
by Doppler echocardiography and electrical bioimpedance. Br Heart J 63: 93-97,1990.
8. Reneman RS, Van Merode T, Hick P, Muytjens AMM, Hoeks APG. Age-related changes
in carotid artery wall properties in men. Ultrasound Med Biol 12: 465-471,1986.
9. Van Merode T, Hick PJ], Hoeks APG, Smeets FAM, Reneman RS. Differences in carotid
artery wall properties between presumed healthy men and women. Ultrasound Med Biol
14: 571-574,1988.
10 Van Merode T, Hick PJJ, Hoeks APG, Rahn KH, Reneman RS. Carotid artery wall
properties in normotensive and borderline hypertensive subjects of various ages.
Ultrasound Med Biol 14: 563-569,1988.
11. Kool MJ, Wijnen JA, Hoeks AP et al. Diurnal pattern of vessel wall properties of large
arteries in healthy men. J Hypertens 9 (suppl 6): 108-109,1991.
12. Clausen JP. Effect of physical training on cardiovascular adjustments to exercise in man.
Phys Rev 57: 779-815,1977.
77
13. Laurent S, Lacolley P, Brunei P et al. Flow-dependent vasodilation of brachial artery in
essential hypertension. Am J Physiol 258: H1004-H1011,1990.
14. Giannattasio C, Cattaneo BM, Mangoni AA et al. Changes in arterial compliance induced
by physical training in hammer-throwers. J Hypertens 10 (suppl 6): 53-55,1992.
15. Jennings G, Nelson L, Nestel P et al. The effects of changes in physical activity on major
cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utiliza-
tion in man: a controlled study of four levels of activity. Circulation 73: 30-40,1986.
16. Meredith IT, Friberg P, Jennings GL et al. Exercise training lowers resting renal but not
cardiac sympathetic activity in humans. Hypertension 18: 575-582,1991.
17. Grassi G, Seravalle G, Calhoun D et al. Physical exercise in essential hypertension. Chest
101 (suppl): 312-314,1992.
18. Rogers PJ, Miller TD, Bauer BA et al. Exercise training and responsiveness of isolated
coronary arteries. J Appl Physiol 71: 2346-2351,1991.
19. Fagard R, Grauwels R, Groeseneken D et al. Plasma levels of renin, angiotensin II and
6-keto-prostaglandin F ^ in endurance athletes. J Appl Physiol 59: 947-952,1985.
20. Pehl U, Holtz J, Busse RF, Bassenge E. Crucial role of endothelium in the vasodilator
response to increased flow in vivo. Hypertension 8: 37-44,1986.
21. Mohiaddin RH, Underwood SR, Bogren HG et al. Regional aortic compliance studied by
magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br
Heart J 62: 90-96,1989.
22. Eugene M, Vandewalle H, Bertholon, JF, Teillac A. Arterial elasticity and physical
working capacity in young men. J Appl Physiol 61:1720-1723,1986.
23. Van Bortel LM, Hoeks AP, Kool MJ, Struijker Boudier HA. Introduction to large artery
properties as a target for risk reduction by antihypertensive therapy. J Hypertens 10
(suppl) 6:123-126,1992.
24. Yagihuma R, Wakabayashi A. Effects of aortic distensibility on the cardiac force in man.
Jpn Circ J 36: 187-193,1972.
25. Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of
hypertension in healthy normotensive men and women. JAMA 252: 487-490,1984.
26. Blair SN, Kohl HW, Paffenbarger RS et al. Physical fitness and all-cause mortality: a
prospective study of healthy men and women. JAMA 262:2395-2401,1989.
78
CHAPTER 4
Vessel wall properties of large
arteries and endurance training
JAG Wijnen, MJF Kool, JP Kooman, MA van Baak, AP Hoeks,
HAJ Struijker Boudier, and LMAB Van Bortel
Departments of Pharmacology, Human Biology, Internal Medicine, and
Biophysics, University of Limburg, Maastricht, The Netherlands
/ Hyperferzsi'o« 22 (sup/?/ 5): SS-S9, 2993
79
ABSTRACT
Cross-sectiona/ sfwd/es /ownd a pos/fiue re/«fio«
p/iysi'ca/ worJt/«g capac/fy, /j/^ /jer regions/ comp/iance 0/ fne aorta m endurance-
framed afn/efes and better uesse/ U7fl// properties o/the bracnia/ and/emora/ artery m
cyc/i'sfs compared fo sedenfary swb/ecfs.
In this sfwdy, if has been hypothesized fnaf physica/ fraining mignf induce c/wnges
in yesse/ wa// properties 0/ /urge arfen'es in sedentary men. Nineteen hea/thy men
entered a randomized fi^ o-iyay cross-ouer sfwdy, consisting o/eitner continuation 0/
their sedentary /i/esty/e/or 6 wee/cs or 6 zweefcs 0/moderate exercise training at 75%
V02nwx, 3 times a u;eeA:/or 45 minutes. Be/ore and a/ter tnese periods, yesse/ zt?a//
properties fdi'stensibi/ity and compliance) o/fne e/asti'c common carotid artery and tne
muscu/ar /emora/ and bracnia/ arteries were studied wifn a dedicated u/trasound
system, /n addition, p/asma catecno/amines, p/asma renin and p/asma atria/ na-
triwrefic pepfide concentrations were measured at rest.
Training increased VC^max/™'" -3.23 ± 0.09 to 3.40 ± 0.08 //mm Cp < 0.02). Rest-
ing neart rate dec/ined sigm/icant/y. Resting b/ood pressure was 228 ±2/74 ±2
mmHg be/ore and 2 2 7 ± 3/74 ± 2 mmHg a/fer training. Pu/se pressure was una/tered.
Diameter, disfens/bi7i7i/ coefficient and cross-sectiona/ comp/iance 0/ tne tnree /arge
arteries were not sigm/i'cant/y different between tne sedentary and training period.
No signi/icant c/ianges in neurohumora/ parameters were/o«nd/o//owing training.
7n conc/usion, a moderate exercise training program 0/6 weefcs does not change the
uesse/ wa// properties o//arge arteries in sedentary men.
INTRODUCTION
Recent training studies have provided supporting evidence for a blood
pressure lowering effect of regular moderate isotonic exercise, both in nor-
motensive (1,2) and in hypertensive populations (3,4). The underlying
hemodynamic mechanisms, however, remain unclear; both changes in car-
diac output and/or a decline in vascular resistance have been reported (5, 6).
To what extent neurohumoral changes are associated with the decrease in
blood pressure also remains a matter of debate. A reduction in sympathetic
nervous system activity has been a common finding (2, 3, 4), while a role of
the renin-angiotensin-aldosterone system is controversial (2, 5). At present,
few data are available on the effect of training on atrial natriuretic peptides
(ANP). In animals, an increase in resting ANP was observed after training (6),
but in humans cross-sectional comparison between sedentary and endurance-
trained subjects failed to show significant differences (7).
Beside a possible decline in vascular resistance, exercise training could have
an effect on another component of vascular impedance, i.e. compliance. This
has been suggested by cross-sectional studies finding a positive relationship
between arterial elasticity and physical working capacity in young men (8),
higher regional compliance of the aorta in endurance-trained athletes vs.
sedentary age-matched controls (9) and in a recent study which found cyclists
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to have improved vessel wall properties of the brachial and femoral artery
compared to sedentary controls (10).
Pulsatile stress in the vessel wall is substantially determined by arterial
distensibility and may play a role in the onset of atherosclerosis. A decrease
in compliance increases pulse pressure and left ventricular load. Distensibility
and compliance are vessel wall properties properties which can now be
measured non-invasively with ultrasound techniques (11). Distensibility and
compliance have been found decreased with age (12) and hypertension (13).
An improvement by training of vessel wall properties may offset the age-re-
lated changes and the changes seen with high blood pressure and may help
to explain why physically inactive persons have a higher risk of developing
hypertension and cardiovascular disease (14,15).
The primary hypothesis to be tested in this study was whether moderate
exercise training would result in an improvement of vessel wall properties of
large arteries in sedentary men. Furthermore, the possibility that improved
vessel wall properties might be associated with changes in neurohumoral
parameters (i.e. plasma catecholamines, ANP, and plasma renin) was inves-
tigated.
SUBJECTS AND METHODS
Swb/ecfs
Nineteen healthy male subjects entered the study. They were all non-smokers.
None of the subjects had been engaged in regular sport activities for more
than 1 h/week over the last 2 years and their life style and jobs were seden-
tary. They aged 37 years (range 22-44 y), weighed 77 kg (range 58-95 kg) and
were 179 cm tall (range 169-186 cm). Casual systolic/diastolic blood pressure
was up to 160/100 mmHg.
Sfudy desigM
Each subject gave written informed consent. The protocol was approved by
the Ethical Committee of the University of Limburg. Subjects entered a ran-
domized, two-way, cross-over study, consisting of either continuation of their
sedentary life style for 6 weeks or 6 weeks of exercise training on a cycle
ergometer at a previously determined workload of 75% VO2max 3 times per
week for 45 minutes. Physical activity, diet and weight were monitored and
kept constant during the study. Compliance to the sedentary life style was
promoted by weekly returns to the laboratory.
Subjects were investigated at the start of the study (data not used in
analysis) and after each 6-week period. Evaluation after the training period
took place 2 days after the last exercise bout. Measurements were performed
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between 9 and 12 a.m. after an overnight fast and abstinence of caffeine for 12
hours, for each subject at the same time of the day.
On arrival at the laboratory, a short catheter was inserted in the v. cubitalis
of the left arm, whereafter the subjects rested for at least 30 min.
Hemodynamic measurements were performed in the recumbent position
after another 15 min of supine rest in a quiet room (22 ± 1°C). The diameter
(D) and relative change in diameter (distension; AD) during the heart cycle of
the elastic right common carotid artery, the muscular right brachial artery and
the muscular right common femoral artery were measured over 5 s with a
vessel wall movement detector system. This system, as described by Hoeks et
al (11), consists of an radio-frequency-data acquisition system, a conventional
echo imager (Ultramark-V, ATL, Bothell, Washington, USA) and a personal
computer. Simultaneously, blood pressure was measured with a Dinamap
(Criticon, Tampa, USA). Pulse pressure (AP) was defined as systolic blood
pressure minus diastolic blood pressure. Vessel wall properties were calcu-
lated as:
K/»y «#«»<) =
. , AV7L 7 t D * A D
CC (cross-sechonfl/ compliance) = „ = — r — 5 —
- re/afii>e c/iange in cross-secfiona/ ares 0/ Me pesse/
AV/L: c/wnge in i>o/wme per unit o//engf/i
The average value of AD and D measured 3 times and the average value of
blood pressure (BP) recorded 6 times were taken as the subject's readings.
Thereafter, blood samples were obtained, with the subjects in supine position
for 30 min, for determination of plasma catecholamines, plasma renin (REN)
and plasma atrial natriuretic peptide (ANP) concentrations.
Blood samples were collected in 5 ml polystyrene tubes for ANP and REN
and in 10 ml polystyrene chilled tubes for norepinephrine (NE) and
epinephrine (E), kept on ice-water. Tubes for ANP and REN contained EDTA
(1 mg). Those for NE and E were heparinized and contained 12 mg glu-
tathione. For ANP, the peptidase inhibitor aprotinin (10,000 U/l) was added.
After collection, the samples were centrifuged immediately at 4°C during 30
min at 1,500 g for NE/E and during 15 min at 1,500 g for the other hormones.
Plasma was stored at -70°C until assayed.
NE and E levels were measured by means of HPLC with fluorescence
detection, according to Van der Hoorn et al (17). The intra-assay coefficient of
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variation was 4% for NE and 12.3% for E, the interassay coefficient of variation
6.9% for NE and 16% for E. The detection limit was 20 pg/ml for NE and 3
pg/ml for E. ANP was determined with an indirect RIA (INC-Star; Stillwater,
USA) after extraction on SepPak C18 cartridges (Water Associates, Milford,
Massachusetts, USA). The intra-assay coefficient of variation was 8.6% and
the interassay coefficient of variation 11.6% (18). REN was quantitated with
an indirect RIA as described by Derkx et al (19).
VO2max was determined in a progressive maximal exercise test, measuring
oxygen consumption with a Sensor Medics Horizon metabolic measurement
card. Data are presented as means ± S.E.M. and statistical analysis was per-
formed according to the non-parametric Koch procedure for a two-way cross-
over design using the Mann-Whitney U-test. P < 0.05 was considered
statistically significant.
RESULTS
Endurance training increased VC>2max from 3.13 ± 0.09 to 3.40 ± 0.08 1/min (p
< 0.01). Resting heart rate declined from 60 ± 2 to 57 ± 2 bpm (p < 0.05). Rest-
ing BP, measured with the Dinamap, was 118 ± 2/74 ± 2 mmHg before and
117 ±3/74 ±2 mmHg after training. AP was unaltered (sedentary: 44 ±2
mmHg; trained: 43 + 2 mmHg). Differences in D, DC and CC of the three large
arteries between the 2 periods were not statistically significant. Data are
presented in Table 1. Training induced no significant changes in the various
hormones measured at supine rest. Data are presented in Table 2.
Table 1. Diameter (D), distensibility coefficient (DC) and cross-sectional compliance (CC)
of the right common carotid artery (CCA), right brachial artery (BA) and right common fe-
moral artery (FA).
Sedentary Trained
DCCA (mm)
DBA(mm)
DFA(mm)
DCCCA (10-VkPa)
DCBA (10-VkPa)
DCFA (10-VkPa)
CCCCA (mmVkPa)
CCBA (mmVkPa)
CCFA (mmVkPa)
6.39 ± 0.10
4.13 ± 0.08
8.34 ±0.17
27.311.7
24.7 ±2.7
18.7±1.6
0.8810.06
0.32 ± 0.03
1.04 ±0.09
6.5010.11
4.1710.09
8.4510.18
27.512.0
22.912.1
19.411.5
0.9110.06
0.3110.03
1.10 + 0.09
Mean Dfl/ues 1 S.E.M.; no signi/iconf (/inferences between sedentary anrf frain/ng per/ods.
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Table 2. Plasma catecholamine concentration, plasma ANP and plasma renin at supine
rest, during sedentary lifestyle and after training.
Sedentary Trained
Norepinephrine
Epinephrine
ANP
Renin
(pg/ml)
(pg/ml)
(pg/ml)
(uU/ml)
229 ±26
24 ±7
49 ±11
8.0 ±0.7
224 + 11
20 ±4
55 ±12
7.6 ± 0.9
Mean ra/ues ± S£M; no signi/icanf rf/^erences between sedentary and training periods.
DISCUSSION
The present study provides no evidence for the hypothesis that 6 weeks of
moderate exercise training can improve vessel wall properties in previously
sedentary men, despite a clear increase in maximal exercise capacity of 9%
and a significant decrease in resting heart rate following training. Changes in
vessel wall properties could occur due to changes in transmural pressure,
changes in the contractile state of the vascular smooth muscle, or due to
structural changes of the vessel wall. Basal systemic arterial pressure was,
however, unaltered.
This failure of training to lower blood pressure(BP) seems to contradict with
most studies, finding a decrease in resting blood pressure (BP) in normoten-
sive and hypertensive populations (20). As previously reported (16), 24-h
blood pressure monitoring at the start of the study showed that 18 subjects
could be classified as normotensive, based on recently proposed criteria
(average 24-h BP: 126 ± 4/80 ± 3 mmHg). One subject was probably hyperten-
sive (mean 24-h BP: 139/91 mmHg).
A BP lowering effect following training, if any, is expected to be small; on
the average a decline of 4 mmHg in both systolic and diastolic BP is found
(20). On the other hand, our findings agree with some recent studies which
have neither found a hypotensive effect on basal BP (21, 22) or on 24-hr BP
(22). Furthermore, even in labile hypertensive subjects (23) or in established
hypertensives (24), a failure of exercise training to lower BP has been reported
(see for a detailed discussion chapter 2).
One could argue that the duration (6 weeks) or intensity (75% VO2max) of
the training program was inappropriate. However, even 4 weeks of moderate
(60-70% Wmax) exercise has shown to reduce BP significantly in sedentary
normotensive subjects. With regard to the training intensity, however, there
is growing support to favor mild to moderate exercise (50-60% VO2max) (25).
Our subjects could have been physically too active, a possibility we cannot
rule out in Western Europe where it is more common to habitually walk or
cycle. Nevertheless, all our subjects had a sedentary lifestyle, their jobs were
physically not demanding, and none of the subjects had been engaged in
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regular sport activities for more than 1 h/week over the last 2 years. In
addition, the sedentary leg of our experiment was closely supervised.
The absence of a change in vessel wall properties of large arteries in our
study could be solely due to a failure to reduce blood pressure with training.
This is supported by the findings of Gilders et al (26) who did not observe a
reduction in blood pressure with conditioning and a change in pulse wave
velocity both in normotensives and in hypertensives. In contrast, Cameron et
al (27) reported an increased arterial compliance and a fall in systolic blood
pressure in sedentary subjects after 4 weeks of training. In the latter study, it
was stated that further modeling of the changes in arterial compliance sug-
gested a contribution from alteration in pressure-independent factors in addi-
tion to a passive, pressure-dependent mechanism, although this was not
substantiated by the limited data presented.
Intrinsic modification of vessel wall properties by training was also sug-
gested by cross-sectional studies comparing trained athletes and sedentary
individuals (9, 10) and a strong inverse linear relationship that was found
between pulse wave velocity and physical working capacity in young men (8).
In a recent study (10), we observed a higher cross-sectional compliance of the
brachial artery and a tendency for a better compliance of the common femoral
artery in cyclists when compared to sedentary controls, without significant
differences in pulse pressure between the two groups. The better compliance
of the brachial artery was due to a better arterial distensibility, probably by a
decrease in muscle tone. A decrease in muscle tone could be the resultant of a
decline in resting sympathetic nervous activity by endurance training or be
mediated via changes in circulating hormones, e.g., the renin-angiotensin
system or ANP. Alternatively, animal studies (28, 29) have provided some
evidence for the fact that training is associated with a decrease in response to
adrenergic stimulation at the level of the smooth muscle.
In the present study, however, no changes in resting plasma catechol-
amines, plasma renin or plasma ANP were detected following training. The
absence of a reduction in supine basal norepinephrine levels is contradictory
to most training studies, although no significant changes in resting nor-
epinephrine concentrations have been noted by other authors in both nor-
motensives (30) and patients with labile (23) or established hypertension (30,
31), following training. No reduction in plasma renin activity was found after
4 weeks of training in sedentary normotensive subjects (2) and in hyperten-
sives (32), which is in agreement with the present study. In accordance with a
cross-sectional study, which did not find a difference in resting plasma ANP
between controls and distance runners (7), no change in plasma ANP at rest
was found.
At present, the effect of training on vessel wall properties of large arteries
has not been studied in hypertensives who are likely to have a reduced arterial
compliance and distensibility and are possibly more likely to show an im-
provement after training. Oppliger and colleagues (33) trained hypertensive
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rats and found lower vessel wall/lumen ratios of several large arteries in the
trained compared to the untrained, resulting from similar wall thickness
values but significantly larger lumen diameters.
In conclusion, a moderate exercise training program of 6 weeks does not
lead to an improvement in vessel wall properties in previously sedentary
subjects, despite a clear training effect on VO2max and a decrease in resting
heart rate.
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ABSTRACT
Considerab/e mferindi'yidMa/ variation in fne response 0/ Wood pressure fo exercise
/ias been /bund, /n fnis sfwdy fne response 0/ sysfo/ic Wood pressure during a
progressive maxima/ bicyde ergometer test was investigated in 747 pnysica//y active
ma/e sub/ects over age 0/ 40 years witn norma/, border/ine e/evated, and e/evated
resting Wood pressure. Tne in/Zuence 0/ severa/ sub/'ect characteristics on tnis
response was studied: 53% 0/ variation in exercise systo/ic Wood pressure feSBPJ
cou/d be exp/ained by worfc /oad, pre-eSBP, and maxima/ wording capacity (W^,-,).
No difference in tne s/ope o/eSBP during tne exercise test was seen between tne tnree
groups. Sub/ects wifn nigner W^^ nad /ower systo/ic Wood pressure at tne same worfc
/oad compared witn sub/ects wit/i a /ower W^^. Subjects in tne e/evated b/ood
pressure group nad signi/icant/y /ower W ^ i , a/f/iougn maxima/ neart rate and
/actate were simi/ar. Ofner variab/es were not signi/icant/y associated witn eSBP.
INTRODUCTION
Exercise stress testing usually includes measurements of blood pressure
before, during, and for several minutes after exercise. Routine measurements
during exercise are mainly performed to detect an inadequate blood pressure
rise as can be due to aortic valve disease or left ventricular impairment.
However, in the last decade it has also been indicated that the blood pressure
response during exercise may be of diagnostic and prognostic value in various
study populations. In subjects with coronary heart disease, maximal systolic
blood pressure showed to be significantly related to the severity of coronary
artery disease (12). Also, ratios of early recovery systolic pressure to peak
systolic blood pressure have been found to be a sensitive tool for identification
of patients with severe coronary artery disease (1). The blood pressure
response during exercise testing has been used in the assessment of hyperten-
sion (8, 18, 21) or to detect persons at risk for future hypertension (5,13, 26).
A common finding in most of these studies is a considerable amount of
intersubject variation in the response of blood pressure to exercise (8,12, 23,
27). Factors independently contributing to this variation are insufficiently
evaluated. In men, higher age, obesity index, and cigarette smoking have been
shown to be associated with a more pronounced systolic blood pressure
response to treadmill exercise. Regular exercise (judged by questionnaire)
was not associated independently (4). On the other hand, cross-sectional
studies actually measuring physical working capacity suggest that physical
fitness is independently and inversely related to resting blood pressure (10).
The risk of developing hypertension was found to be substantially increased
with low levels of physical fitness (3). Recently, training studies have shown
that regular exercise significantly lowered resting systolic and diastolic blood
pressure and exercise systolic blood pressure in normotensive and untreated
hypertensive sedentary subjects (14,15, 22). It is not clear whether the reduc-
tion of exercise systolic blood pressure is merely related to a decrease in
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resting blood pressure or is independently associated with an increase in
physical fitness.
In this study the response of systolic blood pressure during a progressive
maximal bicycle ergometer test was investigated in three different resting
blood pressure groups to further evaluate the influence of several subject
characteristics on this response, i.e., age, body height, body weight, body fat,
supine resting DBP, supine resting SBP, supine resting heart rate, pre-exercise
DBP, pre-exercise SBP, pre-exercise heart rate, smoking, alcohol consumption,
exercise heart rate, and maximal working capacity.
METHODS
At three different centers for community health in the south of The Nether-
lands, 1840 male subjects over the age of 40 years and actively participating in
sports at least 1 h/week volunteered to participate in an experimental sports-
medical examination. At the three centers the same protocol and equipment
were used by three especially trained physicians throughout the study. A
detailed medical and family history was taken. Subjects were asked about
their age, alcohol use, smoking habits, and about medication they were
taking. Alcohol consumption was converted into g ethanol/week, the number
of cigarettes was recorded. Anthropometric measurements taken included
body height, body weight, and body fat (%), estimated from the sum of four
skinfolds (6). Supine blood pressure was measured from the right upper arm
by standard sphygmomanometry; if it was elevated, it was remeasured after
at least another 5 min supine rest. The lowest value was taken. Fifth-phase
diastolic pressures were used. Based on these casual blood pressure measure-
ments, the participants were classified into a group with normal supine blood
pressure (diastolic < 90 mmHg and systolic < 140 mmHg), borderline-ele-
vated supine blood pressure (90 < diastolic < 95 mmHg and/or 140 < systolic
< 160 mmHg), or elevated supine blood pressure (diastolic > 95 mmHg and/
or systolic > 160 mmHg), according to WHO criteria, excluding 65 subjects
using cardiovascular drugs. Prior to the exercise test, a thorough physical
examination was performed to judge whether the subjects could safely per-
form the test, supine heart rate was measured, and a 12-lead ECG in supine
position made. Ten subjects were excluded (three for signs of recent infarc-
tion, four because of severe hypertension (diastolic > 120 mmHg), two were
poorly regulated diabetics, one had a left bundle-branch block with heart
murmur).
Exercise fesf
The subjects were seated upright on a Lode bicycle ergometer with the 3-lead
(II, VI, V5) ECG electrodes in place. The test was performed with a pedal
frequency between 60 and 80 rpm, starting 5 min at a work load of 100 W.
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Thereafter, the work load was increased by 50 W every 2.5 min until a heart
rate between 140 and 150 b/min was reached. Then the increment was 25 W
every 2.5 min until exhaustion. Maximal work load (W^ax) was the highest
work load that could be maintained for 2.5 min. If the final work load was not
completed, W ^ * was calculated out of the completed time. Between the 3rd
and 5th min of recovery, a blood sample was drawn form a cubital vein for
measurement of plasma lactate concentration (LA 640 Roche)(9). This exercise
test design was chosen because it allowed to evaluate the maximal working
capacity (W^ax) in a relatively short time (approximately 15 min) and yet to
make reliable blood pressure measurements. It has been shown that at higher
work loads, a plateau in blood pressure is reached after 2 min (21). Systolic
and diastolic blood pressures were recorded with standard sphyg-
momanometry at rest just before testing, sitting on the bicycle (pre-exercise
blood pressure), and during the last 30 s of each work load. The point of
muffling of Korotkoff sounds (phase IV) was taken as exercise diastolic blood
pressure. During measurements, the arm was extended over the handle bars
of the bicycle ergometer and supported by the physician. Heart rate was
determined from the ECG at the end of each work load.
Start's? ica/ ana/ysts
Data records of 1765 male subjects not using cardiovascular medication and
having performed the exercise test were available. The measurement of exer-
cise systolic blood pressure (esBP) at the final work load was judged to be
unreliable and not included. To compare between the three blood pressure
groups with respect to the means of baseline characteristics, analysis of
variance (ANOVA) and two sample t-tests were performed. Differences be-
tween frequencies were evaluated by the chi square test. Significance tests
were performed at the 0.05 and 0.01 levels. Inspection of individual data on
eSBP at different work loads suggested that a linear relationship between
eSBP and work load would be appropriate. At higher work loads the observed
lines leveled off. Hence, a multiple regression analysis was performed with
eSBP as the dependent variable and work load (WL) as the independent
variable and 14 prognostic factors to control for intersubject variation: age,
body height, body weight, body fat, supine DBP, supine SBP, supine heart
rate, pre-exercise DBP, pre-exercise SBP, pre-exercise heart rate, smoking,
alcohol consumption, exercise heart rate, and W^ax- Only subjects with at
least two values of eSBP (i.e., exercise test with two or more submaximal work
loads) were included because no linear relation can be assumed with only one
measurement. As a consequence, subjects included in the analysis had a W^ax
of 150 W or more (n = 1726). Moreover, only subjects who fulfilled strict
criteria for a maximal exercise performance (i.e., maximal heart rate > (220-
age) and plasma lactate after exercise > 8 mmol/1) were included so that with
greatest possible certainty true W^ax was reached. This limited analyses to
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747 subjects. To test whether the relationships between eSBP and WL were
different for the three blood pressure groups, two dummy variables were
introduced in the multiple regression analysis. The first dummy variable
BORD (value 0 or 1) identified the borderline-elevated blood pressure group,
the second dummy variable ELEV (value 0 or 1) identified the elevated blood
pressure group. The decision on how many prognostic factors to retain in the
final form of the regression model was made by using the all-possible subset
method. That subset with the largest number of prognostic factors plus WL
and the two dummy variables with regression coefficients significantly dif-
ferent from zero was selected and considered to be the best-fitted model. The
assessment of significance was done by comparing the estimated regression
coefficients relative to their standard errors with the usual 0.975 percentile of
the ^-distribution. As a by-product, the coefficient of determination R2 was
assessed. R2 represents the proportion of total variability of the dependent
variable that is accounted for by the regression model. In the multiple regres-
sion analysis, the dependence of eSBP between successive work loads within
individuals was ignored. This resulted in an overestimation of the standard
errors of the regression coefficient estimators. For this reason the best-fitted
model according to the all-subset method might be only suboptimal. How-
ever, only the relation between WL and eSBP for the three blood pressure
groups was of particular interest. The other variables were considered in the
analysis only to adjust for these factors. As a consequence, the regression
coefficient for WL of the best-fitted model was compared with that of the
regression model containing all possible prognostic factors at hand. If the two
coefficients were not substantially different than for reasons of parsimony the
condensed model was considered to be a more convenient summary of data.
RESULTS ^ "
Subject characteristics for the three blood pressure groups are presented in
Table 1. The subjects in the highest blood pressure group were slightly older
than in the other groups. Body weight did not differ across the blood pressure
groups, but the subjects with borderline elevated or elevated blood pressure
had a significantly higher % body fat than the normal blood pressure group.
Compared with the other groups the borderline-elevated group was slightly
taller. Smoking habits and alcohol consumption did not significantly differ
between the groups. Supine heart rate was lower in the normal blood pressure
group. Wmax was significantly lower in the highest blood pressure group
despite the fact that maximal heart rate and plasma lactate were similar in all
three groups. Average eSBP for the three groups at 100, 150, 200 and 250 W
are presented in Table 2. Results from the multiple regression analysis on
eSBP are shown in Table 3. The variable explaining most of the variance was
work load (WL) (R2 = 0.386). An additional 14.2% could be explained by
pre-exercise SBP (pre-eSBP)(R2 = 0.099) and W^ax (R* = 0.043); 6.6% of
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Table 1. Comparison between normal, borderline-elevated, and elevated blood pressure
groups.
Variables (means ± SD)
Age (y)
Body height (cm)
Body weight (kg)
Body fat (%)
Smokers (%)
Alcohol consumers (%)
Alcohol consumption (g/w)
Supine SBP (miriHg)
Supine DBP (mmHg)
Supine HR (bpm)
Pre-exercise SBP (mmHg)
Pre-exercise DBP (mmHg)
Pre-exercise HR (bpm)
Wmax (W)
HRmax (bpm)
Plasma lactate (mmol/1)
blood pressure
Normal
(n=322)
46.4 ± 4.8
175.2 1 6.2
77.1 1 8.0
22.5 ± 5.0 "
24.8
89.1
1391112
126.017.5"
80.814.4 "
62.6 ± 7.8 "
127.5110.4 "
84.6± 6.1 "
68.0110.6"
258.5143.9
181.917.7
12.012.5
Borderline-elevated
(n=278)
47.216.4
175.5 + 6.1*
78.118.2
23.814.7
21.7
90.1
1361114
138.917.5 "
88.013.4 "
64.618.6 "
134.3 110.9 "
89.315.2 ••
69.7110.7"
258.6145.6 "
181.8 + 10.1
11.9 + 2.6
Elevated
(n=147)
48.4 16.4 "
174.216.3
78.117.8
24.714.9 "
27.2
85.7
1541132
149.2112.0 "
96.814.5 "
68.0 ± 9.5 ••
144.8112.5 "
96.3 ± 5.6 "
73.5111.1"
243.2146.2 "
181.217.9
11.712.2
* p < 0.05; " p < 0.01 (/or fwo-samp/e f-fesf, based on befween-group significance /n J 4 N O W \ test).
ZlsferisAs a/ter the f/i/rd co/umn re/er fo differences between the /irst and third co/umns. Asterisks
between co/umns re/er to differences befzt;een ad/acenf co/umns. SBP, sysfo/ic Wood pressure; DBP,
d/asfo/ic Wood pressure; HR, Zieart rate.
Table 2. Exercise systolic blood pressure (mean 1 SD, mmHg) at different work loads for
the normal, borderline-elevated, and elevated blood pressure groups.
blood pressure
Work load (W) Normal
163 ±15
322
179117
322
192116
291
201117
166
Borderline-elevated
169116
278
185116
277
198117
249
203116
129
Elevated
180117
147
197119
146
208 ± 18
115
216114
48
100
n
150
n
200
n
250
n
n = number o/subjects
94
Table 3. Summary of multiple regression results on exercise systolic blood pressure.
Variable
Constant
Pre-exercise SBP
Work load
cWork load*
cWmax
cWmax*
BORD
ELEV
Regression coefficient
103
0.64
0.274
-0.00059
-0.115
0.00034
1.4
4.8
Standard deviation
3
0.02
0.005
0.00007
0.007
0.00009
0.6
0.8
t-ratio«
32.27
25.65
55.25
-8.07
-17.48
3.68
2.30
5.7
R* = .594; s = 14.34; R* = proportion zwrwnce ejrp/awed by f/ie mode/; s = standard dewafion o/ fte
error; a = a// (-ratios are signi/icanf af 0.05 /we/; cVVorJt /oad = awfc /oad - mean uwfc /oad (172.59);
CWMI = Wmax - mean IVin (264.33); BORD = dummy i>anaWe C0-2> o/ border/i'ne-e/et>afed Wood
pressure group; ELEV = dummy pariaWe (0-1) o/e/euafed Wood pressure group. Regression equation
is eSBP = 92.3 + .64 pre-exercise SBP + .474 worit /oad - 59 X 10~5 zwrJt /oad* - .295 W n + 34 x
10-5 w ^ 2 + 2.42 BORD + 4.S3 ELEV
M
E
B 3 2 0 -
>> 180-
workload (watt)
Fig. 1 Regression /ines wit/i 95% con/i'dence bands
/or f/ie re/a(ion between eSBP and twrfc /oad/or f/ie
norma/ Ca), border/ine-e/euated (W, and e/ewted (c)
Wood pressure group.
variation was accounted for by the division of supine blood pressure in the
three blood pressure groups. In addition, other prognostic variables did not
independently contribute to the variation of eSBP. Fig. 1 shows regression
lines with 95% confidence bands of eSBP and WL for the three blood pressure
groups. Note that at high work loads the increase in eSBP becomes less.
Analysis reveals it is not caused by a selection of subjects at higher work loads
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100 129 150 179 200 225 290 279
workload (watt I
Fig. 2 Regression /ines o/eSBP in re/af ion to tt>orJt /oad/or
f/iree di^ ferenf /ei>e/s o/pre-exercise sysfo/ic Wood pressure
(220, 240, and 260 mmHg) when ad/usfmenfs are made
K
B 230-
cd
:
140-
aoowatt watt ^ K » watt
129 190 175 200 229
workload (watt)
290 279 300
Fig. 3 Regression /ines 0/ eSBP in re/afion to worfc /oad /or
(nree di/ferenf /eve/s 0/ W™x (200, 250, and 300 W) wnen
ad/'usf menfs are made/or pre-exercise sysfo/ic Wood pressure.
with a high W^x and low pre-eSBP. Mean increase above pre-eSBP at a work
load of 100 W was 35 mmHg in the normal, borderline-elevated, and elevated
blood pressure group. Figures 2 and 3 show regression lines of eSBP in
relation to work load when adjustments are made for W ^ ^ or pre-eSBP,
respectively. When W^ax is controlled initial differences in pre-eSBP are
maintained during exercise. Analysis (by introducing interaction between the
dummy and other variables) showed no difference in pressure rise for dif-
ferent levels in pre-eSBP. In case pre-eSBP is controlled differences in physical
working capacity are reflected. For example, a subject with a pre-eSBP of 125
mmHg and a W^x of 200 W has an eSBP of 168 mmHg at 100 W compared
with 161 mmHg for a subject with the same pre-eSBP but a W^ax of 250 W.
DISCUSSION
The study shows that 53% of variation in eSBP during cycle ergometry could
be explained by work load, pre-eSBP and W^ax- No differences in the slope
of eSBP between groups of subjects with normal, borderline-elevated, and
elevated supine blood pressure were seen although absolute values were
clearly different. In accordance with other studies using either treadmill
testing or bicycle ergometry (4,8,12, 27), our study showed a wide variability
of eSBP. This is reflected by the fact that work load alone explains only 39%
of total variance in eSBP. Our values of eSBP during submaximal exercise are
comparable with those found in a physically active population of the same
age by Heck et al (11), but somewhat lower than in a study on sedentary
subjects by Nordenfeldt et al (23), which could be explained by the fact that
our subjects were all actively participating in sports. The main rinding in our
study was the negative association between eSBP and Wmax- Subjects with
higher Wmax had lower systolic blood pressures at the same work load
compared to subjects with a lower W^x- Classification of physical fitness
based on a questionnaire has failed to show a relationship with eSBP (4),
possibly because no reliable estimate of physical fitness was obtained. Com-
parison between athletes and non-athletes showed no differences in eSBP
between the two groups (11), but it was not clear whether differences in
resting blood pressure were considered. Training studies, on the other hand,
have shown that regular moderate exercise can lower systolic blood pressure
at rest and during exercise in normotensive and untreated hypertensive
sedentary subjects (14, 24). Pre-training blood pressure and the magnitude of
the increase in W^^ are important determinants for the blood pressure
response to training (7). Although there were differences between the three
blood pressure groups with regard to age, % body fat, body height, and
resting heart rate, we could not find an independent association with eSBP for
these variables. Subjects in the elevated blood pressure group had significant-
ly lower Wmax than those in the two other groups, although maximal heart
rates were similar, suggesting differences in stroke volume between the
groups (2, 19). No differences in eSBP were found between the three blood
pressure groups. This confirms studies by other authors (4,12,16, 20, 21). On
the other hand, one study showed an exaggerated systolic blood pressure
response during exercise in a subgroup of borderline hypertensives (8).
Others have pointed to the fact that an excessive rise in SBP during exercise is
mainly seen in hypertensives with advanced stages of disease (25). Subjects
with severe hypertension and those using antihypertensive medication were
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excluded from our study (see Methods section). Although some studies show
positive associations between age and eSBP (4,17,19), we could not confirm
an independent relationship. A possible explanation is the relatively small age
range (40-63 y) in our study compared to other studies. In another study with
a comparable range in age, no relationship was found between changes in
eSBP and age either (12). Weight and estimated % body fat were not sig-
nificantly correlated with eSBP. In treadmill testing, a strong positive associa-
tion was found between Quetelet index and eSBP, with the regression
coefficient growing larger with increasing duration of the test (4). It is conceiv-
able that an independent relationship between eSBP and body weight is only
found during treadmill exercise, where the intensity at a certain speed
depends on body weight. Smoking (yes/no) was not associated with eSBP.
For treadmill testing only positive associations with eSBP at higher work
loads were found (4). Association of smoking with eSBP could be masked by
a selection of our population (physically active) or a small number of smokers.
There was no association between eSBP and alcohol consumption (yes/no)
which is in agreement with data in male subjects (4). Pre-exercise heart rate,
supine heart rate, and exercise heart rate were not independently associated
with eSBP. There was a higher supine heart rate in higher blood pressure
groups. There was a mean increase of 5 b/min in resting heart rate from
supine to sitting position, possibly also due to some anticipation to the
beginning of exercise.
The variables determined in our study explained 59% of variation in eSBP.
It is reasonable to assume there are some variables we did not include in our
study which influence eSBP additionally (for instance, biochemical or hor-
monal factors). The variability of the indirect method for blood pressure
measurement itself undoubtedly also contributes to the total variation of
eSBP.
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ABSTRACT
uanaffon i« (ne response 0/ b/ood pressure to exercise
nas bee«/o«nd. Factors independenf/y confr/bwfi'n^ fo f/11's yanafion are insw/jfi'rienf-
/y eya/wafed. 7/JIS espec/fl//y frwe /or women and o/der a^e groups. Re/erence ua/ues
ofpo&rasiye maximfl/ exercise fesfin^ in midd/e-aged, ach'ye sub/ecfs, especia//y in
women, are scarce. In fni's study, fne response 0/ sysfo/ic arferia/ b/ood pressure
during a pro^ress/ue maxima/ cyc/e ergometer fesf was inuesfi'gated in 872 pnysica//y
acfi'ye /ema/e sub/ecfs aged 40 years or o/der wi'fn norma/, border/ine e/ei>afed and
e/evafed b/ood pressure. TTie in/Zuence 0/14 di/ferenf sub/ecf cnaracferisfi'cs on this
response was studied: 63% 0/ uar/afion in exercise sysfo/ic b/ood pressure CeSBP)
cou/d be exp/ai'ned by worJt /oad, pre-eSBP, age and exercise wearf rafe. No difference
in eSBP wifn increasing wor/c /oad was/ound between f«e fnree groups. Sub/ecte wrtfc
nigner exercise nearf rafes nad ni'gner sysfo/ic b/ood pressures af fne same worfc /oad
compared fo sub/ecfs a;jfrt /ower exercise nearf rafes. Maxima/ wording capacity
(W^,fl^ was signi/icanf/y /ower in f/ie e/euafed b/ood pressure group a/f«ougn maxi-
ma/ nearf rafe and /acfafe were simi/ar. W^flx ^""s age-dependenf. Ofner sub/ecf
yariab/es were nof sigm/icanf/y associated wifn eSBP. Ka/ues o/eSBP/or reference
purposes are presented.
INTRODUCTION
Nowadays, the blood pressure response during exercise testing is often used
for diagnostic and prognostic purposes. In patients with coronary heart dis-
ease, maximal systolic blood pressure was shown to be significantly related to
the severity of coronary artery disease (10). The blood pressure response to
exercise has been used in the assessment of hypertension (7, 14) or to detect
persons at risk for future hypertension (4, 21). Considerable amount of varia-
tion in blood pressure has been reported (2).
Factors independently contributing to this variation are insufficiently
evaluated. This is especially true for women and older age groups. In women,
systolic blood pressure (SBP) increased more during bicycle exercise in sub-
jects aged 50 years or older than in younger subjects (15). During submaximal
treadmill exercise, a positive association was found between SBP response
and age in 20 to 49 year old women but not in women of 50 years or older (3).
In 20 to 49 year old women, Quetelet index and alcohol consumption were all
positively associated with the SBP response to treadmill exercise, but smoking
and regular exercise were not (3).
In this study the response of SBP during a progressive maximal cycle
ergometer test was investigated in a large, middle-aged female population.
The influence of several subject characteristics (i.e. age, body weight, body
height, body fat, supine resting diastolic blood pressure (DBP), supine resting
SBP, supine resting heart rate (HR), pre-exercise DBP, pre-exercise SBP, pre-
exercise HR, smoking, alcohol consumption, exercise heart rate and maximal
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work capacity) on SBP response to maximal exercise was studied in women
with normal, borderline elevated and elevated resting blood pressure.
SUBJECTS AND METHODS
At three different centers for community health in the south of the Nether-
lands, 1257 female subjects over the age of 40 years and actively participating
in sports at least 1 h/week volunteered to participate in an experimental
sports-medical examination. Most popular types of sport were calisthenics
(37%), tennis (35%), jogging (22%), and swimming (20%). On the average, the
study population participated 3.5 ± 2.8 h/week in sport activities in the year
preceding this examination. At the three centers the same protocol and equip-
ment were used by three specially trained physicians throughout the study.
A detailed medical and family history was taken. Subjects were asked about
their age, alcohol use, smoking habits, and about any medication they were
taking. Alcohol consumption was converted into g ethanol/week, the number
of cigarettes per day was recorded. Anthropometric measurements taken
included body weight, body height, and body fat (%), estimated from the sum
of four skinfolds (6). Casual supine blood pressure was measured after 10 min
rest from the right upperarm by standard mercury sphygmomanometry; if it
was elevated (> 140/90 mmHg), it was remeasured after at least another 5 min
supine rest. The lowest values were taken. Fifth phase diastolic pressures
were used. Based on these casual blood pressure measurements, the par-
ticipants were classified into a group with normal supine arterial blood
pressure (diastolic < 90 mmHg and systolic < 140 mmHg), borderline elevated
supine arterial blood pressure (90 < diastolic < 95 mmHg and/or 140 < sys-
tolic < 160 mmHg), or elevated supine arterial blood pressure (diastolic > 95
mmHg and /or systolic > 160 mmHg), excluding 85 subjects using cardiovas-
cular drugs. Prior to the exercise test, a thorough examination was performed
to judge if the subjects could safely perform the test, supine heart rate
measured, and a 12-lead ECG in supine position made. Sixteen subjects were
excluded (five severe anemia, six severe hypertension (diastolic pressure >
120 mmHg), one orthopedic disability, one instable angina, three poorly
regulated diabetes mellitus).
Exercise fesf
The subjects were seated upright on a Lode cycle ergometer with the 3-lead
(II, VI, V5) ECG electrodes in place. The test was performed with a pedal
frequency between 60 and 80 rpm, starting 5 min at a work load of 50 W.
Thereafter, with the pedal rate fixed, the work load was increased by 50 W
every 2.5 min until a heart rate between 140 and 150 beats/min was reached.
Then the increment was 25 W every 2.5 min until exhaustion. Maximal work
load (Wmax) was the highest work load that could be maintained for 2.5 min.
If the final increment of power output could not be maintained for 2.5 min,
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was calculated with a correction for the completed time of that incre-
ment (5 W per 30 s). Between the 3rd and 5th min of recovery, a blood sample
was drawn from a cubital vein for measurement of plasma lactate concentra-
tion (LA640 Roche) (8). This exercise test design was chosen because it made
it possible to evaluate the maximal working capacity in a relatively short time
(approx. 15 min) and yet to make reliable blood pressure measurements. It has
been shown that at higher work loads a plateau in blood pressure is reached
after 2 min (16). Systolic and diastolic blood pressures were recorded with
standard mercury sphygmomanometry at rest just before testing, sitting on
the cycle ergometer (pre-exercise blood pressure) and during the last 30 s of
each work load. The point of muffling of Korotkoff sounds (phase IV) was
taken as exercise diastolic blood pressure. During measurements, the arm was
extended over the handle bars of the bicycle ergometer and supported by the
physician. Heart rate was determined from the ECG before exercise and at the
end of each work load.
Stof /sf lea/ anfl/ysis
Data records of 1156 female subjects not using cardiovascular medication and
having performed the test were available. To compare between the three
blood pressure groups with respect to baseline characteristics, analyses of
variance (ANOVA) and two sample t-tests were performed. Differences be-
tween frequencies were evaluated by chi square test. Significance tests were
performed at the 0.05 and 0.01 levels. Inspection of individual data on exercise
systolic blood pressure (eSBP) at different work loads suggested that a linear
relationship between eSBP and work load was appropriate. Hence, a multiple
regression analysis was performed with eSBP at the dependent variable and
work load (WL) as the independent variable and with 14 prognostic factors to
control for intersubject variation: age, body height, body weight, body fat,
supine DBP, supine SBP, supine heart rate, pre-exercise DBP, pre-exercise
SBP, pre-exercise heart rate, smoking, alcohol consumption, exercise heart
rate, and W^ax- Only subjects with at least two values of eSBP (i.e. exercise
test with two or more submaximal work loads) were included because no
linear relation can be assumed with only one measurement. As a consequence,
subjects included in the analysis had a W^x of 100 W or more (n = 1149).
Moreover, only subjects who fulfilled strict criteria for a maximal exercise
performance (i.e. maximal heart rate (> (200-age) and/or plasma lactate after
exercise > 6 mmol/1) were included, so that with greatest possible certainty
true Wmax was reached. This limited analysis to 817 subjects. To test whether
the relationships between eSBP and WL were different for the three blood
pressure groups, two dummy variables were introduced in the multiple
regression analysis. The first variable BORD (value 0 or 1) identified the
borderline elevated blood pressure group, the second dummy variable ELEV
(value 0 or 1) identified the elevated blood pressure group. The decision on
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how many prognostic factors to retain in the final form of the regression
model was made by using the all-possible subset method. That subset with
the largest number of prognostic factors plus WL and the two dummy vari-
ables with the regression coefficients significantly different from zero was
selected and considered to be the best-fitted model. The assessment of signifi-
cance was done by comparing the estimated regression coefficients relative to
their standard errors with the usual 0.975 percentile of the f-distribution. As
a by-product the coefficient of determination R2 was assessed. R2 represents
the proportion of total variability of the dependent variable that is accounted
for by the regression model. In the multiple regression analysis, the depend-
ence of eSBP between successive work loads within individuals was ignored.
This resulted in an overestimation of the standard errors of the regression
coefficient estimators. For this reason the best-fitted model according to the
all-subset method might be only suboptimal. However, only the relation
between WL and eSBP for the three blood pressure groups was of particular
interest. The other variables were considered in the analysis only to adjust for
these factors. As a consequence, the regression coefficient for WL of the best
fitted model was compared with that of the regression model containing all
possible prognostic factors at hand. If the two coefficients were not substan-
tially different than for reasons of parsimony the condensed model was
considered to be a more convenient summary of data.
RESULTS
In Table 1, subject characteristics for the three blood pressure groups are
shown. Subjects with borderline elevated and elevated blood pressure were
significantly older, had a higher total body weight, and % body fat than
subjects in the normal blood pressure group (all; p < 0.01). Compared with the
other groups, the elevated blood pressure group had a lesser height (p < 0.01).
Smoking habits and alcohol consumption did not differ across the groups.
Supine heart rate was lower in the normal blood pressure group (p < 0.01).
Only slight differences in maximal heart rate and similar plasma lactate in all
three groups were found. W^ax was significantly higher in the normal blood
pressure group (p < 0.05). Analysis of covariance with W^x as dependent
and age as independent variable showed W^x to be age-related. Average
eSBP for the three groups at 50 W, 100 W, 150 W, and 175 W are given in Table
2. Results from the multiple regression analysis on eSBP are presented in
Table 3. Most of the variance was explained by the variable work load (WL)
(R2 = 0.414). Pre-exercise systolic blood pressure explained 9.8% of the varia-
tion. Age (R2 = 0.019) and exercise heart rate (eHR) (R2 = 0.032) had a
relatively small, although significant influence; 6.7% of variation was ac-
counted for by the division of supine blood pressure in the three blood
pressure groups. None of the other prognostic variables did additionally
contribute to the variation of eSBP.
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Table 1. Comparison between normal, borderline-elevated, and elevated blood pressure
groups
Variables (means ± SD)
Age (y)
Body height (cm)
Body weight (kg)
Body fat (%)
Smokers (%)
Alcohol consumers (%)
Alcohol consumption (g/w)
Supine SBP (mmHg)
Supine DBP (mmHg)
Supine HR (b/min)
Pre-exercise SBP (mmHg)
Pre-exercise DBP (mmHg)
Pre-exercise HR (b/min)
Wmax (W)
HRmax (b/min)
Plasma lactate (mmol/1)
blood pressure
Normal
(n=497)
45.8 ± 5.4 "
164.1 ±5.8
62.3 ± 7.0 ••
32.0 ± 5.1 "
20.3
71.7
78 ±75
123.3 ± 8.4 "
79.1 ± 5 . 4 "
65.3 ± 8.0 "
122.8 ± 10.2 "
80.7 ± 6 . 7 "
72.2 ± 10.7 "
166.2 ± 27.1 *
173.2 ± 10.9 *
8.412.3
Borderline elevated
(n=212)
48.5 ± 7.0 *
163.7 + 6.3
64.4 ± 7.8
33.8 ± 3.9 •
17.0
75.5
86 ±81
141.2 ± 7 . 9 "
86.6 ± 4.7 "
69.1 ±9.9
135.9 ± 1 1 . 2 "
87.3 ± 7.7 "
76.0 ± 12.5
161.3 ±27.5
171.2±11.2
8.6 ±2.7
Elevated
(n=108)
50.317.3 "
162.3 ± 5.8 "
65.2 ± 8.2 "
34.9 ± 5.3 "
17.8
70.1
81 ±80
153.2 ± 1 3 . 1 "
95.8 ± 6.0 "
69.3 ± 10.8 "
146.9 ± 16.0 "
93.7 ± 8.2 "
74.1 ±11.6
157.6 ± 25.7 "
172.1 ± 10.6
8.9 ± 2.6
* = P < 0.05; " = P < 0.01 (/or too samp/e f-fesf, based on betoeen-growp signi/icance in A/VOV./4
fesO. /Isfen'sfcs a/fer f/ie f/ii'rd co/umn re/er fo di/jferences betoeen f/ie //rsf and fhird co/umns.
Asterisks betoeen co/umns refer fo rf/^ferCTices betoeen ad/acenf co/wmns. SBP = sysfo/ic Wood
pressure; DBP = diasfo//'c Wood pressure; HR = Ziearf rafe.
Table 2. Exercise systolic blood pressure (mean ± SD, mmHg) at different work loads for
the normal, borderline-elevated, and elevated blood pressure groups
Work load (W)
50W
n
100 W
n
150 W
n
175 W
n
n = number o/sub/ecfs
blood pressure
Normal
145 ± 14
497
163 ±16
497
175115
322
183116
39
Borderline elevated
159 + 15
212
177115
212
189118
126
192 + 16
12
Elevated
171121
108
187116
108
200117
60
202122
9
106
Table 3. Summary of multiple regression results on exercise systolic blood pressure
Variable Regression coefficient Standard deviation
3.94
0.02
0.01
0.02
0.05
0.73
1.03
t-ratii
4.37
21.99
15.61
14.81
11.04
7.30
8.69
Constant
Pre-exercise SBP
Work load
Exercise heart rate
Age
BORD
ELEV
17.20
0.53
0.17
0.28
0.53
5.32
8.93
R* = 0.630; s ± 2334; R* = proportion o/variance earp/a/nerf by fne mode/; s = standard deviation o/
f/ie error; a = a// t-rafios ore signi/iconf at 0.001 /ewe/; BORD = dummy nariaWe C0-2> o/border/ine
e/euafed Wood pressure group. ELEV = dummy i>ariab/e (0-2,) o/ e/ei>afed Wood pressure group.
Regression equation is eSBP = 27.2 + 0.53 pre-exercise SBP + 0.27 awrJt /oad + 0.2S exercise nearf
rate + 0.53 age + 5.32 BORD + 8.93 ELEV.
O» , 0 0 - iso mm Hg
140 mm Hg
no mm Hg
too
' — I — '
2OO
•—I
290
workload iwatt)
Fig. 1 Regression /ines o/ eSBP in re/af ion to work /oad
/or fwree different /ei>e/s o/ pre-exercise systo/ic Wood
pressure (220,240, and 260 mmHg) wflen adjustments
are made/or age and exercise neart rate.
Figures 1 and 2 show regression lines of eSBP in relation to work load when
adjustments are made for age and eHR or pre-eSBP and eHR, respectively.
When age and eHR are controlled initial differences in pre-eSBP are main-
tained during exercise. Analysis (by introducing interaction between dummy
and other variables) revealed no difference in pressure rise for different levels
in pre-eSBP. In case pre-eSBP and eHR are controlled differences in age are
reflected. For example, a subject, 40 years of age, with a pre-eSBP of 125
mmHg has an eSBP of 155 mmHg at 100 W when eHR is 120 beats/min. A
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workload iwatt)
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Fig. 2 Regress/on /ines o/eSBP in re/afi'on fo worfc Zoad/or
40,50, and 60 years o/d /ema/es ui/ien ad/usfmenfs are made
/or pre-exerrise sysf o/ic Wood pressure and exercise Ziearf raf e.
female subject ten years older has an eSBP of 160 mmHg with the same
pre-eSBP and eHR at 100 W.
DISCUSSION
We found that 63% of variation in eSBP during cycle ergometry could be
explained by work load, pre-eSBP, age and exercise heart rate. The wide
variability in eSBP found by others, either during treadmill exercise (3,10) or
testing on a cycle ergometer (7) was confirmed by the fact that work load itself
could account for only 41.4% of the variation. Our values of eSBP at different
work loads are comparable with those found by others in studies with much
smaller groups (9,17). However, in applying our reference values it should be
stressed that all our female subjects were regularly physically active. No
differences in eSBP behavior were found between the three blood pressure
groups. Mean increase above pre-eSBP at 100 W was 40 mmHg in all groups.
In a recent study (5) no differences in eSBP-rise between normotensive and
borderline hypertensive young women were found, either. Some authors
point to the fact than an excessive rise in SBP during exercise is mainly seen
in hypertensives with advances stages of disease (19). These subjects were,
however, excluded from our study. Age was positively and significantly
related to eSBP in middle-aged women, so that an increase of 10 years of age
was associated with an 5 mmHg eSBP increase for the same resting systolic
blood pressure. A significant correlation between age and maximal systolic
blood pressure during cycle ergometry was recently observed by Michelsen
et al (15), too. It was not clear however if differences in resting SBP were
considered. It has been reported that the age-related increase in SBP can be
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possibly attributed to a decrease in distensibility of large arteries with age
(18). We found a clear and positive association of exercise heart rate with
eSBP. For every 10 beats/min difference in eHR between individuals with
same age and pre-eSBP a difference of 2-3 mmHg in eSBP was found. Dif-
ferences between individuals in eHR at the same work load may reflect
differences in physical fitness-level (1). In middle-aged men a significant
negative association between W^ax arid eSBP was found (22), but no associa-
tion with eHR. The fact that in our study W^x was not associated with eSBP,
may be because only a relative small range in W^ax was found for women in
this study (100-263 W) compared to men (150-400 W) (22) or W^x was mainly
a reflection of genetic endowment than of physical fitness. Alternatively, one
could argue that maximal oxygen consumption (VC>2max) is a better estimate
of physical fitness than W^^. In our experience, however, the feasibility of
the direct measurement of VC>2max is poor in large scale studies because of
unfamiliarity of the subjects with the proceedings. Furthermore, in cycle
ergometry VC>2max and W^x are closely related (20) and the intra-individual
variation of W^x is lower than the intra-individual variation of VC»2max (13).
Classification of physical fitness based on a questionnaire has failed to show
a relationship with eSBP (3) possibly because no reliable estimate of physical
fitness was obtained. Training studies, on the other hand, have shown that
regular exercise can lower systolic blood pressure at rest and during exercise
in normotensive and untreated hypertensive subjects (11, 12). Body weight,
body height and % body fat were not significantly correlated with eSBP. In
treadmill testing, a strong positive association was found between Quetelet
index and eSBP (3). It is conceivable than an independent relationship be-
tween eSBP and body weight is only found during treadmill exercise, where
the physiological load at a certain speed depends on body weight. Smoking
was not associated with eSBP in women, which is in keeping with results from
treadmill testing (3). There was no association between eSBP and alcohol
consumption. Supine heart rate and pre-exercise heart rate were higher in the
elevated blood pressure groups. There was a mean increase of 5-7 beats/min
in resting heart rate from supine to sitting position in women, possibly also
due to some anticipation to the beginning of exercise. We were not able to
explain the remaining 37% of variation in eSBP in this study. Some authors
show that education and use of gonadal hormones (especially post-
menopausal estrogens) can contribute to total variation in eSBP (3). We
believe that the variability of the indirect method for blood pressure measure-
ment and biological variability in eSBP itself also explains at least part of the
remaining variation.
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CHAPTER 6
Beta-blockade and lipolysis during
endurance exercise
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ABSTRACT
0/adipose i/ssue /ipo/ysis may be i«yo/yed m f/je impairment 0/endurance
capacity a/ter administration 0/ a (3-Woc/cer. During endurance exercise, wo sig-
nificant decrease in p/asma g/ycero/ and/ree/atfy acid (NEF^4) concentrations a/fer
P-b/ocfcade is /bund. However, f«e /eve/s during recovery /rom exhaustion are /ower
a/ter p-b/ocfa?de. This study was designed to investigate whether t/iese /ower /eve/s
a/ter exercise are due to P-b/odrade or to t/ie snorter time to exhaustion a/ter p-b/ocfcer
administration, /n a sing/e-b/ind study, 22 we//-trained ma/e sub/ects Cage 23 ±0.9
yr) performed a cyc/e ergomefer test at 70% W^* unti/ exhaustion, 2 «r a/ter intafce
o/#0 mg proprano/o/. One wee/c /ater, t«e test was repeated a/ter inta/ce o/p/acebo and
was stopped at the time 0/exhaustion 0/ the previous test. i4verage exercise time was
24 ± 2 min. During exercise p/asma g/ucose was /ower, whereas p/asma /acfate and
respiratory exchange ratio were higher on proprano/o/ fa// p < 0.05). G/ycero/ and
NEFA concentrations during exercise were not sigm/icant/y different comparing
both conditions. Despite an identica/ exercise time, during recovery g/ycero/ and
NEF/4 concentrations were /ower a/ter proprano/ treatment (p < 0.05). /n conc/usion,
/ipo/ysis is inhibited during exercise a/ter proprano/o/, probab/y causing a shift /rom
/at to carbohydrate combustion.
INTRODUCTION
Beta-adrenoceptor antagonists are commonly used in various cardiovascular
disorders such as hypertension, coronary artery disease and cardiac arrhyth-
mias. For many patients with these disorders dynamic physical exercise is
considered to be beneficial (18). Since a large number of the physically active
patients are treated with P-blocking drugs, the side-effects of blockade of Pi-
and P2-adrenoceptors during exercise has become the scope of numerous
studies. It has been shown that P-blockade interferes with hemodynamics,
energy metabolism, thermoregulation and potassium homeostasis during
exercise (4, 21). Maximal aerobic exercise capacity is significantly reduced in
most studies in normotensive and hypertensive subjects (21). More important
from a therapeutic point of view, however, is the effect of P-blockade during
endurance exercise. Endurance exercise is the performance of work at a
constant submaximal intensity. Both in normotensive and hypertensive sub-
jects, reductions in exercise time ranging from 16 to 50% were found, com-
pared to placebo (21). The negative effect is more pronounced during
non-selective blockade than during Pi-selective blockade. The exact mecha-
nism behind this reduced endurance performance is not yet clear. It has been
suggested that a reduced exercise cardiac output is responsible or possibly a
reduced rate of lipolysis or changes in potassium homeostasis (21). With
regard to an inhibition of adipose tissue lipolysis, plasma glycerol and non-
esterified fatty acid (NEFA) reductions ranging from 0 to 50% were found
(21). In one study NEFA levels at the end of a one hour run were even higher
when subjects were given P-blockers than when given placebo (13). However,
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the levels during recovery from exhaustive endurance exercise are consistent-
ly found to be lower during (3-blockade (14, 15). This study was designed to
differentiate whether these lower NEFA levels after exercise are due to P-
blockade or to a shorter time to exhaustion after (3-blocker administration.
SUBJECTS AND METHODS
Eleven trained healthy males volunteered in this study. All subjects were
cyclists involved in a consistent cardiorespiratory training regime. They were
normotensive (blood pressure < 140/90 mmHg) and used no medication.
Each subject gave written informed consent. The protocol of the study was
approved by the Ethical Committee of the University of Limburg. The physi-
cal characteristics are described in table 1. Each subject completed an initial
progressive maximal cycle ergometer (Lode, Groningen, The Netherlands)
test without medication to determine maximal aerobic power ( W ^ ^ This
test started with a work rate of 100 W for 5 minutes, which was increased by
50 W every 3 minutes until a heart rate of 160 beats/min, whereafter the
increment was 25 W every 3 minutes until exhaustion. Two days later, the
subjects returned to the laboratory to perform their first endurance test,
followed by a second endurance test one week later. A light standardized
breakfast was taken two hours before arrival in the lab. In combination with
the meal, one tablet of propranolol 80 mg was taken before the first test and
one placebo tablet before the second test (single blind). Systolic and diastolic
blood pressure (Hawksley random-zero, Korotkoff V) and heart rate were
measured after 5 minutes of quiet sitting. The first endurance test started with
a 5 minutes warming-up at 100 W; thereafter, subjects cycled at 70% W^ax
until exhaustion, which was defined as the moment the subjects were no
longer able to maintain a pedalling frequency above 50 revolutions per
minute. The exercise time to exhaustion was recorded. The second endurance
test was performed at the same intensity until the exercise time to exhaustion
of the first test, so that the same amount of work was delivered. The subjects
Table 1. Characteristics of the subjects (mean ± SEM)
Age (y)
Height (cm)
Weight (kg)
VCbmax (ml.mirr ')
VChmax.kg-' (ml.min-'.kg-'
Wmax (watt)
Rmax
HRmax (beats.min"')
23 ± 1
182 ±3
74±4
4701±171
) 64±2
340±12
1.15 ±0.02
192 ±2
n = 2I; VO2max= maxima/ oxygen upfate; Wmax = max/ma/ aerobic power; Rmax
respiratory exc/iange rafr'o; HRmax = maxima/ Ziearf rate
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were unaware of the purpose of this procedure and were told they had to
cycle to exhaustion in the second test as well. After exhaustion, the subjects
cycled for 10 minutes at 75 W (recovery). Blood samples were obtained from
a cubital vein for determination of plasma glycerol, non-esterified fatty acids
(NEFA), lactate, glucose, and potassium concentrations. To detect changes in
plasma volume, hemoglobin and hematocrit were measured (6). Heart rate,
systolic and diastolic blood pressures (sphygmomanometry, Korotkoff IV
during exercise) were measured. All these measurements were performed at
rest, every 10 minutes during exercise, just before exhaustion and 3, 6 and 10
minutes in the recovery phase, in a sitting position. At rest and during exercise
oxygen consumption and respiratory exchange ratio (R) were also measured
(SensorMedics Horizon metabolic measurement cart). Subjective feelings of
exertion were rated with the Borg scale every 10 minutes during exercise and
at exhaustion (3). Plasma lactate and glucose levels and plasma glycerol and
NEFA concentrations were measured by enzymatic autoanalyzer methods,
and potassium levels by flame photometry (Instrumentation Laboratory 243).
Results are presented as mean values ± SEM. Statistical analysis was per-
formed by Zerbe's test for response curves (23). The Wilcoxon-test was used
for two-point pairwise comparison. Statistical significance was established at
p < 0.05.
RESULTS
At rest, sitting systolic blood pressure was reduced from 128 ± 5 mmHg after
placebo to 115 ± 4 mmHg during beta-blockade (p < 0.01), while sitting dias-
tolic pressure was unaffected (73 ± 3 mmHg and 77 ± 3 mmHg respectively).
Heart rate was significantly reduced from 67 ± 3 beats.min'l on placebo to 51
±2 beats.min-1 during beta-blockade (p <0.01). Exercise time was 24 ±2
minutes in the first endurance test (propranolol) and as a consequence of the
design of the study the same in the second (placebo) test. Rating of perceived
exertion at the end of exercise was significantly higher during propranolol
(18.2 ±0.3 vs. 12.5 ±0.7; p < 0.05). Exercise systolic blood pressure was sig-
nificantly lower during propranolol than during placebo treatment (figure 1).
After 20 minutes of exercise blood pressure during placebo was 189 ± 4/71 ±
6 mmHg and 166 ± 3/65 ± 5 mmHg during propranolol (p < 0.01 for systolic
blood pressure). Diastolic exercise blood pressure was not different. During
exercise, heart rate (figure 2) was significantly reduced after propranolol (167
±3 vs. 124 ±2 beats.min'l; p <0.01). There was no statistically significant
difference in plasma NEFA concentration during exercise between placebo
and propranolol (figure 3). However, during recovery a clear and strong
increase in plasma NEFA concentration was seen after placebo, which dif-
fered significantly from an only modest increase after propranolol (p < 0.05).
At 10 minutes recovery, the mean plasma NEFA concentration was 0.91 ± 0.14
mmol/1 after placebo and 0.45 ±0.08 mmol/1 during propranolol treatment
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Fig. 2 Heart rafe dun'ng p/acebo and proprano/o/. Means and SEM
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af exhausfion, wh/crt /s s/iown af fhe appropriate average exercise
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(p < 0.05). Although lower after p-blockade during exercise, plasma glycerol
concentrations did not differ significantly between placebo and propranolol
(figure 4). During recovery the plasma glycerol concentrations were sig-
nificantly higher after placebo (p < 0.05). In contrast to NEFA, no clear post-
exercise peak was seen and glycerol concentrations gradually declined. The
plasma glucose concentration decreased during the first 20 minutes after
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propranolol but not on placebo (significant difference between placebo and
propranolol; p < 0.01; figure 5). At exhaustion the plasma glucose concentra-
tion after propranolol was 3.87 ± 0.14 mmol/1 compared to 4.40 ± 0.20 mmol/1
at rest (p < 0.05). During exercise there was a higher plasma glucose con-
centration after placebo (p < 0.05). Because the average resting value for
plasma glucose also differed between propranolol and placebo (4.40 ± 0.20 vs.
4.86 ±0.15 mmol/1, p < 0.05) we compared the change in plasma glucose
during and after excercise from resting values in the two conditions. No
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significant differences were found. After exhaustion, the plasma glucose
levels quickly rose above pre-exercise levels. Compared to placebo, differen-
ces from the resting values were higher during recovery after propranolol (p
< 0.05). During and after exercise plasma lactate was higher after propranolol
(p < 0.05; figure 6). After 20 minutes of exercise, plasma lactate was 5.25 ± 0.80
mmol/1 after propranolol and 3.65 ±0.43 mmol/1 after placebo (p < 0.05).
Significant differences in plasma potassium were seen during and after exer-
cise (p < 0.01; figure 7). At exhaustion, the mean plasma potassium concentra-
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tion was 5.73 ±0.14 mmol/1 after propranolol and 5.01 ±0.10 mmol/1 after
placebo (p < 0.01). VO2 and R rose during exercise in both conditions. R was
significantly higher during exercise on propranolol. After 10 minutes exercise,
R was 1.09 ±0.03 after propranolol vs 1.04 ±0.03 after placebo. R declined
towards exhaustion in both conditions. VO2 during exercise was not different
between propranolol and placebo.
DISCUSSION
The mobilization of lipids from adipose tissue plays a key role in the regula-
tion of the energy balance at rest and during exercise. Fat is an important
oxidative fuel during sustained exercise. The rate of fatty acid oxidation may
be limited by the rate of release from adipose tissue, by the transport capacity
of the plasma, by transport across the cells in which fatty acid oxidation takes
place, or by the oxidative capacity of the muscle. In vivo, lipolysis in adipose
tissue is regulated by adrenergic mechanisms at rest and during exercise.
Alpha-adrenergic inhibitory effects modulate lipolysis at rest, whereas (3-
adrenergic stimulatory effects modulate lipolysis during exercise (1). Further-
more, human lipolysis seems to be continuously inhibited by the action of
hormones and parahormones (insulin, growth hormone, prostaglandins,
adenosine, nicotinic acid) (12).
Submaximal endurance performance is seriously impaired by fi-blockade
(21) and one of the mechanisms might be a reduction in fat supply to working
muscles which causes an increased carbohydrate utilization. (11). A reduced
fat supply may be caused by an inhibited lipolysis. Several studies have tried
to monitor lipolysis during exercise by plasma NEFA and glycerol concentra-
tions. It is assumed that during exercise changes in glycerol levels are a better
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indicator for lipolysis than changes in NEFA, which also reflect their con-
sumption. These studies differ with regard to the influence of a non-selective
beta-blockade on the NEFA and glycerol concentrations during exercise,
ranging from no statistically significant difference in this study and others (10,
13,15) to highly significant differences (11,14).
Variation in study protocols could give rise to different stimuli to increase
lipolysis. Release of fatty acids during prolonged submaximal exercise is
dependent on several factors of which intensity of exercise, duration of exer-
cise and physical conditioning are the most important. Adipocytes in trained
men are more sensitive to sympathetic stimulation (16) and conditioned
subjects rely more on fat combustion during prolonged exercise (9). In our
study trained cyclists performed submaximal exercise at 70% W^x- which is
in our experience close to their normal daily routine training intensity and is
sustained for at least 45-60 minutes under normal (placebo) circumstances. On
the other hand, the methodology of studying lipolysis by measurement of
plasma NEFA and glycerol concentration during exercise can be erroneous
and may also (in part) explain the variation of results in different studies.
Plasma NEFA concentration reflects the balance between a continuing
release of NEFA from adipose tissue and uptake of NEFA by the working
muscle. When endurance exercise is performed to exhaustion P-blockade
blunts the post-exercise peak of NEFA (15, 21). This could indicate an in-
hibited lipolysis, but in these studies a decrease in NEFA concentration with
P-blockade goes with a concomitant shorter time to exhaustion. It therefore
can be argued that this decrease reflects an early interruption of the produc-
tion of free fatty acids in the adipose tissue.
This study was designed to see whether differences due to P-blockade still
exist if the amount of work was fixed. During acute P-blockade with
propranolol moderate exercise was performed to exhaustion and the same
amount of work was performed one week later on placebo. Consequently the
design was not double-blind, but the subjects were unaware of the purpose of
the study, blinded for their medication and they were told to perform to
exhaustion in both conditions. A 75% decrease in post-exercise NEFA and
50% decrease in post-exercise glycerol was found on propranolol, while
during exercise differences never reached statistical significance. So it seems
that adipose tissue lipolysis is inhibited during exercise by P-blockade, which
becomes more apparent during recovery from exercise.
The reason for a rapid increase in plasma concentration of NEFA after
exercise is not clear, but it is a common finding in studies on fat metabolism
(2, 7, 22). After exercise there may be a continuing high rate of production of
NEFA when utilization is suddenly decreased. In this way a decreased rate of
production of NEFA during P-blockade can be unmasked during early
recovery. An alternative hypothesis is suggested by Hodgetts et al (8). They
studied fat mobilization during exercise by sampling venous blood that
drains from subcutaneous tissue of the anterior abdominal wall. From that
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study there is strong evidence that free fatty acids accumulate within the
adipose tissue during exercise because of a limitation of transport into the
systemic plasma, whereas glycerol because of its smaller size and water
solubility is able to escape into the general circulation. The last could also
explain the fact that in studies on fat metabolism no pronounced post-exercise
peak for plasma glycerol is found.
When lipolysis is attenuated, a lower availability of NEFA for energy
production in the active skeletal muscles would cause a shift from fat to
carbohydrate combustion. An increased use of carbohydrates may lead to a
more rapid depletion of the limited carbohydrate stores in the body and thus
to early fatigue. A shift from fat to carbohydrate combustion is in line with a
higher lactate production, leading to the higher plasma lactate concentration
that was found during propranolol treatment. Since during endurance exer-
cise the rate of muscle glycogen utilization has been found to be unaffected by
non-selective as well as Pj-selective blockade (5), mainly plasma glucose will
be used as source for carbohydrate conbustion. A small, but insignificant drop
in plasma glucose was seen after propranolol treatment in this study. It could
indicate that the liver is unable to produce sufficient amounts of glucose.
Theoretically, one could argue that the lower levels of NEFA after exercise are
due to the fact that the consumption of NEFA was higher during exercise after
P-blocker treatment. This is, however, not in keeping with the higher
respiratory exchange ratio found during exercise. Cleroux et al (5) by actually
measuring muscle triglyceride levels suggest that the decreased exercise
capacity found by non-selective beta-blockade may at least in part be due to
inhibition of triglyceride hydrolysis in slow-twitch fiber by blockade of P2-
adrenoceptors. In the same study non-selective beta-blockade, but not Pi-
selective blockade induced a significant decrease in muscle potassium with a
simultaneous rise in serum potassium during exhaustive exercise. In our
study a significant increase in serum potassium during submaximal exercise
on propranolol was found. The mentioned effects on potassium homeostasis
may induce significant changes in muscle membrane potential resulting in
impaired excitability and thus contractibility of the muscle fibers, thereby
contributing to the decreased exercise capacity observed with non-selective
P-blockade(19).
In conclusion, the results of the present study suggest that the reduction of
plasma non-esterified fatty acid concentration during recovery from exhaus-
tive endurance exercise during non-selective P-blockade reflects attenuation
of adipose tissue lipolysis during exercise.
The authors thank Monique Fuss, Annemie Gijssen and Jet Bost for excellent
technical assistance, and Els Geurts and Mia Hogenboom for secretarial assis-
tance.
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ABSTRACT
/n o randomized cross-ouer sfudy 0/ 26 paf/enfs wifn mi7d to moderate essenfia/
nyperfension, fne in/7uence 0/ flufiTiyperfens/'ye freafmenf wifn caryedi/o/, a non-
se/ecfi'ye befa-b/ocfcer wi'fn uasodi/flh'n^ e//ecf o« submaxima/ exercise performance
was sf udied. Resting b/ood pressure, and sysfo/ic Wood pressure and nearf rafe during
exercise were signi/i'canf/y reduced during carc>edi7o/ freafmenf. Submaxi'mfl/ en-
durance exercise performance was reduced by 36% (p < 0.002). P/asma /actafe and
g/ucose /eue/s were not in/7uenced during exercise, buf p/asma non-esferified /afty
acid and g/ycero/ concenfradons were signi/icanf/y reduced by caruedi/o/ freatmenf.
Signi/icanf/y ni'gner p/asma pofflssium concenfrafi'ons were/bund during exercise on
caryedi/o/. Compared fo p/ocebo conditions, p/asma cafecno/amines and atn'a/
nafn'ureh'c pepfide concentrations were signi/icanHy ni'gwer during exercise, wnereas
p/asma renin was reduced f-20%) a/fnougn not sigm/icanf/y. Our resu/fs indicate
tnat caryedi/o/ 25 mg once dai/y is an e/fecfiue anfi'nypertensiue drug. Tne nemo-
dynamic, mefabo/ic, and numora/ ejects during exercise and fne e/fecfs on endurance
performance o/caruedi/o/ resemb/e fnose 0/ non-se/ecfiye befa-b/ocfcers.
INTRODUCTION
Maintenance of good quality of life is a key factor in a successful and optimal
treatment strategy for patients with hypertension. When treating physically
active patients with hypertension, physicians should choose an antihyperten-
sive drug that does not interfere with exercise performance. Especially, beta-
blocker therapy is often accompanied by a reduced exercise tolerance and a
feeling of increased exertion during exercise (1). The impairment becomes
even more marked during submaximal endurance performance, which more
closely mirrors leisure time sporting activity, and is more pronounced during
non-selective than during beta-1 selective blockade (2).
At present, the precise mechanism underlying this impairment is incom-
pletely understood. The hemodynamic effects of beta-blockers may play a
role, because a reduction of skeletal muscle blood flow during submaximal
exercise has been observed (3, 4). Alternatively, it has been suggested that
inhibition of adipose tissue lipolysis or changes in potassium homeostasis
may be involved (2). Currently, beta-blockers with vasodilating activity become
more widely available and may prove to be an attractive alternative to classical
beta-blockers in the treatment of the physically active patient by lowering blood
pressure in a more physiological way: by lowering the elevated peripheral
resistance usually seen in hypertension, in addition to a minor decrease in cardiac
output. Studies on the effect of these drugs on endurance performance and
metabolism during exercise are, however, limited.
Carvedilol is a new antihypertensive agent with both non-selective beta-
blocking and vasodilating properties. Vasodilation is mainly due to alpha-1
adrenoceptor blockade (8). Carvedilol has been shown to effectively reduce
blood pressure at rest and during exercise in hypertensive patients, by lower-
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ing both total peripheral resistance and cardiac output (9,10). Alpha-1 block-
ers have little potential for adverse effects on exercise performance and
metabolism (5,6), while they may increase exercise blood flow (7). Therefore,
reduction in exercise tolerance by non-selective beta-blockade might be at-
tenuated by alpha-1 blocker mediated increase in exercise blood flow.
The present study investigates the effects of carvedilol on exercise tolerance,
perceived exertion and metabolic parameters during submaximal exercise in
physically active patients with mild to moderate hypertension. Furthermore, the
effect of carvedilol on some blood pressure regulatory hormones
(catecholamines, atrial natriuretic peptides and renin) during exercise is studied.
PATIENTS AND METHODS
Initially, 31 patients were recruited for this study from the outpatients' clinic
of the department of Internal Medicine or by newspaper advertisement.
Fourteen patients did not enter the study: 10 because of normotension after
the placebo wash-out period, 3 had a systolic blood pressure > 170 mmHg at
rest, and one was suspected of coronary heart disease. Seventeen patients
entered the study. One patient dropped out because of poor compliance and
16 subjects, all men with a mean age of 42 ± 2 years, mean body mass 78 ± 3
kg, and mean height of 175 ±3 cm, completed the study. All had mild to
moderate hypertension (mean sitting diastolic blood pressure: 91-115
mmHg). They were physically active on a recreational level. The protocol of
the study was approved by the Ethics Committee of the University of Limburg
(Maastricht, The Netherlands). Each subject gave written informed consent.
Design o/ tfze sfwdy
All patients underwent an extensive, preliminary examination, consisting of
a complete medical history, physical examination, laboratory analyses, chest
X-ray, 12-lead resting ECG, and eye-mirroring. All hypertensive patients were
in WHO stage I and none had overt cardiovascular disease, or other obvious
disease. The study started with a 3-week placebo wash-out period. After 2
weeks in the wash-out period, blood pressure (BP) was measured 3 times with
a Hawksley random zero meter and maximal exercise capacity (W^x) was
determined on a cycle ergometer. Three days later, the subjects returned to the
laboratory and performed a submaximal endurance test at 70% of their max-
imal exercise capacity (W^x) for familiarization purposes.
Subjects were then treated orally in a single-blind, randomized cross-over
manner with carvedilol for 2 weeks or placebo (double-dummy method) for
3 weeks. 12.5 mg Carvedilol was given for 2 days, followed by 12 days of 25
mg carvedilol once daily.
At the end of each period, sitting (after 10 min of rest) and standing blood
pressure (after 2 min) (Hawksley random zero meter) and heart rate were
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measured 2 hr after the last intake of medication, followed by a submaximal
endurance test.
Profoco/ 0/ Me SMbmaxima/ e«d«ra«ce
The subjects were asked to avoid intensive physical exercise for 48 h preced-
ing the examination and not to consume alcohol, coffee or nicotine on the day
of the test. Exercise tests were performed at least 2 hr after the last light meal.
After insertion of a short catheter in the v. cubitalis, the subjects rested for
20 min. Subsequently, the exercise test was started. After a warming-up
period at 100 Watt on a cycle ergometer (Lode, Groningen, The Netherlands),
subjects exercised at the predetermined workload of 70% W^ax until exhaus-
tion. The test was terminated when the subject was unable to maintain a
pedalling rate > 50 revolutions per min.
Just prior to the start of the test, every 10 min during exercise, at exhaustion,
and after 3, 6, and 10 min of recovery, heart rate (from the electrocardiogram)
and systolic and diastolic blood pressure (mercury sphygmomanometry,
Korotkoff I and IV during exercise) and blood samples were obtained. The
latter for determination of hemoglobin, oxygen saturation, hematocrit, plas-
ma glycerol, non-esterified fatty acid (NEFA), lactate, glucose, and potassium
concentrations. At 30 min of exercise, blood samples were obtained for deter-
mination of plasma ANP, renin (REN), prorenin (PRO), norepinephrine (NE)
and epinephrine (E). Every 10 min during exercise and at exhaustion, ratings
of perceived exertion were recorded using the Borg scale (11).
Mef/iods
Plasma glycerol, NEFA, glucose, and lactate were measured by enzymatic
methods and plasma potassium levels by flame photometry (Instrumentation
Laboratory 243). Venous blood hematocrit (microcentrifugation) and
hemoglobin and oxygen saturation (Hemoximeter OSM2, Radiometer,
Copenhagen, Denmark) were determined immediately.
Blood samples were collected in 5 ml polystyrene tubes for ANP and PRA
and in 10 ml polystyrene chilled tubes for NE and E, kept on ice-water. Tubes
for ANP and PRA contained EDTA (1 mg). Those for NE and E were
heparinized and contained 12 mg of glutathione. For ANP, the peptidase
inhibitor aprotinin (10,000 U/1) was added. After collection, the samples were
centrifuged immediately at 4°C for 30 min at 1,500 g for NE/E and for 15 min
at 1, 500 g for the other hormones. Plasma was stored at -70°C until assayed.
ANP was determined with an indirect RIA (INC-star; Stillwater, USA) after
extraction on SepPak C18 cartridges (Waters Associates, Milford, Mas-
sachusetts, USA). The intra-assay coefficient of variation was 8.6% and the
inter-assay coefficient of variation 11.6% (12).
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REN and PRO were quantitated with an indirect RIA as described by Derkx
et al (13). REN and PRO concentrations as measured by this method have
shown to be a valid estimate of the real renin and prorenin content in human
plasma. NE and E levels were measured by means of HPLC with fluorescence
detection, according to Van der Hoorn et al (14). The intra-assay coefficient of
variation was 4% for NE and 12.3% for E, and the inter-assay coefficient of
variation 6.9% for NE and 16% for E. The detection limit was 20 pg/ml for NE
and 3 pg/ml for E.
Date ana/ysis
Results are presented as mean ± S.E.M. Changes in plasma volume were
calculated from hemoglobin and hematocrit (15). T-test or Mann-Whitney test
(for humoral data) were performed to test for period effects or treatment-
period interaction. Paired-t-test or Wilcoxon matched pairs test (for humoral
data) were used to test for treatment effects. Zerbe's randomization test (16)
was used to compare response curves. Post-hoc pairwise comparisons be-
tween groups were performed with Scheffe's F-test; P < 0.05 was regarded as
statistically significant.
RESULTS
B/ood pressure and heart rafe
During carvedilol treatment, measurement of standing blood pressure imme-
diately after a 10-minute sitting period did not show a drop of systolic blood
pressure > 30 mmHg in any of the patients; in 5 patients a drop of diastolic
blood pressure between 20 and 30 mmHg was measured.
No period effects or interactions occurred between the two cross-over
periods. Sitting blood pressure was reduced from 136 ±3/95 ±3 mmHg
during placebo to 125 ±4/86 ±3 mmHg during carvedilol treatment (p <
0.0001). Sitting heart rate did not differ significantly between placebo (66 ± 2
beats.min'l) and carvedilol treatment (63 ± 3 beats.min-1). Standing blood
pressure decreased from 139 ±3/101 ±2 mmHg to 123 ±4/91 ±3 mmHg
during carvedilol (p < 0.0001). Standing heart rate decreased from 72 ± 3 to 67
± 3 beats.min-1 (p < 0.05).
During exercise, systolic blood pressure was significantly lower during
carvedilol treatment than during placebo treatment (Fig. 1). After 30 min of
exercise, the average blood pressure during placebo was 207 ± 5/96 ± 3
mmHg and was 191 ± 7/99 ± 4 mmHg during carvedilol (p < 0.01 for systolic
blood pressure). Exercise diastolic blood pressure was unaffected by car-
vedilol. Exercise heart rate was significantly lowered by carvedilol (Fig. 2).
After 30 min of exercise, average heart rate was 160 ±4 beats.min'l during
placebo and 127 ± 4 beats.min-1 during carvedilol (p < 0.01).
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Fig. 2 Heart rafe during p/«cek> and carpedi7o/ freafmenf. Means and SEM are s/iown.
O P/acebo; • Carwdi/o/
Efidw ranee fime
Endurance time was 64 ± 4 min in the placebo exercise test and decreased
during carvedilol treatment to 41 ± 4 min. This decrease of 36% was statisti-
cally significant (p < 0.001).
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Fig. 3 P/asma g/ycero/ concentration during p/acebo nnrf rarwo'i/o/ freafmenf. Means and
SEM are S/JOWn. o P/acebo;
Mefabo/ic parameters
During the placebo treatment oxygen saturation of the forearm venous blood
increased from 39 ± 5% at rest to 89 ± 2% at 30 min of exercise, and did not
differ significantly from the carvedilol treatment. The changes in plasma
volume were small (< 7%) and did also not differ between the treatments.
The plasma glycerol concentration was not significantly different between
the two treatment conditions at rest, but in contrast to placebo carvedilol
lowered plasma glycerol both during and after exercise (p < 0.001; Fig. 3). At
30 min of exercise, the mean plasma glycerol concentration was 0.21 ± 0.02
mmol/1 during placebo and 0.13 ±0.02 mmol/1 during carvedilol treatment
(p < 0.001). The plasma NEFA concentrations were not statistically different
at rest. During exercise, the plasma NEFA concentrations were reduced on
carvedilol compared to placebo and this reduction was even more marked
after exercise (p < 0.001; Fig. 4). At 30 min of exercise, the average plasma
NEFA concentration was 0.50 ± 0.05 mmol/1 during placebo and 0.29 ± 0.05
mmol/1 during carvedilol (p < 0.02). At 10 min into recovery, the mean plas-
ma NEFA concentration was 1.75 ±0.16 mmol/1 during placebo and 0.77 ±
0.13 mmol/1 during carvedilol (p < 0.001).
Plasma glucose concentrations were not different at rest, during or after
exercise between both conditions (Fig. 5).
Plasma lactate levels tended to be lower after carvedilol treatment at rest
and during exercise, but the differences became only significant during
recovery (p < 0.01; Fig. 6).
No statistically significant difference in plasma potassium concentration at
rest was found between the treatment periods. During and after exercise,
plasma potassium was increased during carvedilol treatment (p < 0.001; Fig.
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7). At 30 min of exercise, average plasma potassium concentration was 4.98 ±
0.09 mmol/1 during placebo and 5.43 ± 0.09 mmol/1 during carvedilol treat-
ment (p < 0.001).
Hormones
Average ANP levels at 30 min of exercise were significantly increased from
212 ± 14 pg/ml during placebo to 391 ± 31 pg/ml during carvedilol treatment
(p < 0.001). Both NE and E mean concentrations were significantly higher (p
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< 0.001) at 30 min of exercise during carvedilol treatment (NE: 3235 ±302
pg/ml; E: 631 ± 128 pg/ml) compared to placebo (NE: 1811 ± 169 pg/ml; E:
156±15pg/ml).
No statistically significant differences in plasma REN and PRO concentra-
tions were found between the two treatments, although REN averaged 20%
lower during carvedilol. At 30 min of exercise, average REN concentration
was 35 ± 7 |j.U/ml during placebo and 28 ± 6 |iU/ml during carvedilol treat-
ment (n.s.). Average PRO concentrations were at 30 min of exercise 144 ± 12
(lU/ml during placebo treatment and 165 ± 17 |j.U/ml during carvedilol (n.s.).
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Ratings of perceived exertion during exercise were significantly higher (p <
0.05) during carvedilol treatment. At 30 min of exercise, the average Borg
score was 13.1 ± 0.4 during placebo treatment and 14.0 ± 0.7 during carvedilol
treatment (p < 0.05).
DISCUSSION
This study shows that 25 mg carvedilol given in a once daily dosing regime is
effective in reducing blood pressure in patients with mild to moderate hyper-
tension. The reduction of sitting and standing systolic and diastolic blood
pressure (8-11%) during carvedilol treatment was comparable to other studies
measuring supine blood pressure with the same dose of carvedilol (17,18). A
slight though significant reduction in standing, but not in sitting heart rate,
was found which is in agreement with the afore-mentioned studies (17, 18).
During exercise, the systolic blood pressure was significantly reduced during
carvedilol treatment, which is also found in acute and chronic effect studies
of carvedilol treatment using intra-arterial recordings of blood pressure (9,
10). In those studies, 25 mg of carvedilol reduced exercise diastolic blood
pressure which contrasts with the present study in which no statistically
significant change was found. This could be partly due to lack of accuracy of
indirect auscultatory blood pressure measurement during exercise (19). On
average exercise-induced tachycardia was decreased with 19% during car-
vedilol, which is comparable to that usually seen with a non-selective beta-
blocker (20-25%)(2).
Carvedilol was found to reduce submaximal endurance exercise by an
average of 36% in patients with essential hypertension, with an associated
increased feeling of perceived exertion. This reduction is in line with the
effects seen during antihypertensive treatment with non-selective beta-
adrenergic blocking agents (approximately 40%) and larger when compared
to beta-1 selective blockers (approximately 25%) (20). The metabolic effects of
carvedilol during submaximal steady-state exercise found in this study were
[1] a significant reduction of plasma glycerol and NEFA concentrations by
25-40%; [2] unchanged levels of plasma glucose and a tendency of lower
lactate levels; [3] increased potassium levels by 5-10%. Administration of
beta-1 selective or non-selective beta-blockers have found to reduce plasma
glycerol and NEFA concentrations during exercise by approximately 30%
(range 0-50%), slightly reduce plasma lactate and not to change plasma
glucose in normally fed subjects (2). Increased plasma potassium concentra-
tions (5-10%) during exercise after beta-blockade have usually been found (2).
So the metabolic effects of carvedilol closely resemble those seen with classical
beta-blocker therapy.
Both an inhibition of adipose tissue lipolysis or changes in potassium
homeostasis have been postulated as mechanisms by which beta-blockade
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impairs endurance performance (2). However, definite prove has yet not been
found and the question how beta-blockers reduce endurance performance is
still unanswered (20) (see for detailed discussion Chapter 1).
Several humoral parameters were measured at 30 min of exercise. It is a
common finding that exercise increases plasma NE and E (21), plasma ANP
(22) and PRA (21) in patients with essential hypertension. Compared to
placebo treatment, catecholamines were significantly higher during exercise
on carvedilol. This is in accordance with Omvik et al (23), who found higher
catecholamine concentrations at a work load of 100 watt during carvedilol
treatment and is similar to the changes normally seen with other beta-blockers
without alpha-1 blocking activity (24,25). Furthermore, these studies indicate
that carvedilol (23) and beta-blockers in general (24, 25) potentiate the exer-
cise-induced increase in plasma catecholamines. Possibly this is caused by a
reduction in plasma clearance of catecholamines (26) as a consequence of a
lower splanchnic-hepatic blood flow during exercise seen after beta-blocker
administration (27). A possible effect of the alpha-1 blocking activity of car-
vedilol on plasma catecholamines cannot be ruled out, although it is reported
by Omvik et al (23) that studies on isolated alpha-1 receptor blockade with
prazosin and doxazosin have failed to show significant changes in plasma
catecholamines.
Several studies have shown that beta-adrenoceptor blockade potentiates the
exercise-induced release of ANP in healthy men (28, 29), while alpha-1
adrenoceptor blockade attenuates this increase in normotensive subjects and
hypertensives (30, 31). It has been suggested that the exercise-induced in-
crease in plasma ANP by beta-blockers may be due to atrial stretching follow-
ing a decreased myocardial contractility and relaxation and not to alpha-1
adrenoceptor stimulation (30). Compared to placebo conditions, ANP levels
were significantly higher during exercise after carvedilol which is in line with
the afore-mentioned studies in healthy men. Omvik et al (23), however,
observed only an enhanced exercise response of ANP following acute ad-
ministration of a single dose of 25 mg carvedilol in a hypertensive population,
but not after chronic treatment for 9 months, suggesting an adaptation in time.
The exact physiological role of an induced release of ANP during exercise and
its potentiation during beta-blockade is not known.
REN levels at 30 min of exercise were not significantly altered by carvedilol
treatment compared to placebo. There was, however, a tendency for lower
levels (-20%). It has been shown that the release of renin is at least partially
mediated by beta-1 adrenergic receptors at rest and during exercise, whereas
the beta-2 adrenergic receptors play only a minor or no role in the control of
renin secretion, especially during exercise (32, 33). Although our data failed
to show significant differences, lower levels would be in agreement with most
studies finding a reduction in REN at rest and during exercise with beta-1
selective or non-selective beta-blockers (33-35). Whether the increase in REN
during exercise is suppressed by beta-blockade remains controversial (33-35).
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Lower levels of REN at rest and during exercise have also been observed with
labetalol (36, 37), a non-selective beta-blocker with alpha-1 antagonistic ac-
tivity, but not with the alpha-1 blocker prazosin (31). Chronic treatment with
carvedilol reduced REN at rest in hypertensive subjects (38). PRO, a precursor
of active renin, was not significantly different between the 2 treatments,
although on average slightly higher levels after carvedilol treatment were
seen (+15%). This could point to the possibility of reduction in negative
feedback regulation of REN by angiotensin II, which, in turn, augments PRO
from renal or extrarenal sources (39).
In conclusion, the study shows that carvedilol is an effective, antihyperten-
sive drug in patients with mild to moderate essential hypertension. During
exercise, metabolic and humoral effects of carvedilol resemble those seen with
non-selective beta-blockers. It reduces endurance exercise capacity com-
parable to non-selective beta-blockers, which suggests that in physically ac-
tive patients, it might not be a first line drug.
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CHAPTER 8
General discussion
INTRODUCTION
Regular physical exercise has become an integral part of lifestyle modification
programs for the general population because there is increasing agreement
that it benefits health and promotes quality of life.
Epidemiological studies have provided evidence that individuals with low
levels of physical activity and poor fitness are at greater risk to develop
hypertension and cardiovascular disease (1, 2). This greater risk depends
partly on a more unfavorable profile of established cardiovascular risk fac-
tors, such as blood pressure or serum cholesterol, found with a sedentary
lifestyle, but even exists after taking these factors into consideration. Possibly
the independence of physical inactivity as a risk factor is linked to direct
changes at the level of the heart and/or vasculature.
In patients with hypertension, diabetes, CHD or osteoporosis, regular
physical activity is more often considered as the first step in the prevention of
further deterioration of the disease, as non-pharmacological treatment or as
adjuvant to medication. When starting drug therapy, it is preferable to choose
a drug that does not interfere with exercise performance.
Exercise testing has become an important tool to promote adherence to
exercise programs, to screen participants to these programs and is widely
used as a prognosticum and diagnosticum in various diseases (CARA, CHD,
hypertension).
In the present thesis, seven studies related and relevant to the above-men-
tioned topics have been described.
ENDURANCE TRAINING AND BLOOD PRESSURE
There is strong evidence from training studies that regular isotonic exercise
can lower resting casual blood pressure in sedentary untreated hypertensive
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subjects. Studies meeting the highest scientific standards with regard to
design have found an average reduction of 7 mmHg for systolic blood pres-
sure and 5 mmHg for diastolic blood pressure (3). This modest reduction may
be sufficient to normalize blood pressure in a large group of patients with
borderline or mild hypertension and compares favorably with that of other
non-pharmacological interventions (4).
However, one should bear in mind that the majority of studies has
evaluated the effect of regular exercise on blood pressure only for weeks or
months. Whether regular exercise will result in sustained and equally effec-
tive lowering of blood pressure over years remains to be established. It has
been reported that some hypertensive patients were not able to maintain
normotension with training beyond one year, despite an initial fall in blood
pressure and good compliance to the exercise program (5). Adherence to
exercise may be critical because it is likely that blood pressure will gradually
return to pre-training levels on cessation of regular exercise. For most hyper-
tensive patients, it is easier to comply to a low-intensity exercise program than
to a more strenuous regimen. In this respect, there is growing support to
assume that low-intensity training (approximately 50% VC>2max) is almost
equally effective in lowering blood pressure as moderate-intensity training
(approximately 70% VO2max) (6).
Although blood pressure is lowered in many hypertensive patients by
exercise training, the magnitude of the decrease is often not sufficient to
normalize blood pressure whereas some patients do not respond at all (7).
Future research should determine subsets of patients with hypertension who
are not responsive to the blood pressure lowering effect of exercise training.
In normotensive sedentary subjects, a possible hypotensive action of regular
endurance training still remains a matter of debate although in recent reviews
(3,8) a small average decline of 2 to 4 mmHg for systolic as well as for diastolic
blood pressure at rest is assumed. Even such a small change in BP could
produce a substantial reduction in cardiovascular risk in the general popula-
tion. It has been estimated that a 2 mmHg downward shift in the entire
distribution of systolic blood pressure in the general population might reduce
the annual mortality from stroke by 6% and coronary heart disease by 4% (9).
A lowering of diastolic blood pressure by 1 to 3 mmHg in subjects with high
normal blood pressure may reduce the incidence of hypertension by as much
as 20-50% (9).
The reason why some controlled studies failed to show any blood pressure
lowering effect by endurance training is not clear. Some investigators sug-
gested that in the basal state the effect of endurance training on blood pressure
is very small if any, becoming more important, however, during conditions of
stress (10). Furthermore, a small anticipated fall in blood pressure of 2-4
mmHg by training, representing a change of 2-5% from sedentary levels,
could be difficult to detect, when viewed against the magnitude of a 40%
fluctuation in blood pressure that can occur at random during the day (11).
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Using ambulatory monitors, it is possible to achieve a 24-hour profile of blood
pressure during normal daily stress and to detect smaller differences more
easily by reducing within-subject variability due to a greater number of
measurements. In addition, although not conclusive, evidence is growing that
ambulatory blood pressure measurements are superior to traditional blood
pressure measurements in providing a proper estimate of the real pressure
load to the heart (12).
In chapter 2, the effect of a 6-week moderate-intensity endurance training
program on ambulatory blood pressure in 19 sedentary male subjects with
normal or slightly elevated resting casual blood pressure was described.
Based on baseline 24-hour blood pressure, all but one of the 7 subjects with
elevated casual blood pressure were judged to be normotensive. The latter
pointing to an additional advantage of ambulatory monitoring, namely to
better differentiate between true and pseudo-hypertensives. Endurance train-
ing resulted in a significant increase in VC>2max' clear cardiac adaptations and
a decrease in total systemic vascular resistance. Despite these hemodynamic
changes, blood pressure measured either at rest, during exercise or am-
bulatory during 24 hours was not affected by training.
To date, three other studies (13-15) have used the technique of ambulatory
monitoring to evaluate the effect of endurance training on blood pressure in
normotensive subjects. Like the present study none of these studies seem to
indicate that endurance training lowers blood pressure at night. With regard
to the effect of training on blood pressure during daily activities, studies are
inconclusive. No effect on day-time blood pressure was found (13) in keeping
with the present study, a significantly lowering of only diastolic day-time
blood pressure was observed (14) and a significant reduction of both systolic
and diastolic day-time blood pressure with endurance training has been
reported (15).
The reason of the discrepancy in results between the studies is not clear.
Blood pressure evaluation using the ambulatory technique could be biased by
deviation in extent and intensity of daily activities between measurement
days since the blood pressure profile during the day is mainly determined by
physical activity (16). Further studies should therefore better document levels
of physical activity during measurement days. The same holds for documen-
tation of baseline levels of sedentary activity before enrollment in a training
study. As suggested by Jennings et al (15), the antihypertensive effect of
regular exercise could be a low threshold phenomenon and the major effect
occurs when strictly sedentary subjects increase their activity level to only
very moderate levels. Although in some studies, including the present study,
subjects were judged to be sedentary because they had white-collar jobs and
did not engage in regular sporting activities, their baseline levels of normal
daily activities could have been already too high to show a blood pressure
lowering effect by endurance training.
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ENDURANCE TRAINING AND VESSEL WALL PROPERTIES OF
LARGE ARTERIES
Large arteries have a conduit and buffering function and they transform the
systolic flow jet from the heart into a more continuous flow for tissue per-
fusion. Vessel wall distensibility and arterial compliance are important vessel
wall properties. Distensibility reflects the elasticity of the artery and is a
determinant of the stress on the vessel wall. Compliance reflects the buffering
capacity of large arteries and is an important determinant of the afterload on
the heart. In aging subjects and in (borderline) hypertensive subjects, arteries
become less elastic leading to a decrease in distensibility and compliance (17,
18). A decrease in arterial distensibility and compliance increases pulse
pressure and left ventricular load and may play a role in the onset of
atherosclerotic disease and cardiac hypertrophy (19, 20).
As described in chapter 1, physically inactive and unfit persons have a
higher likelihood to develop future hypertension and are at higher risk of
death from coronary heart disease and other cardiovascular diseases. Since
these findings seem not to be due to confounding by conventional cardiovas-
cular risk factors, other possible mechanisms should be considered.The objec-
tive of the studies described in chapter 3 and 4 was to investigate possible
changes in vessel wall properties of large arteries at rest in relation to regular
physical exercise.
In chapter 3, a cross-sectional comparison of vessel wall properties (disten-
sibility and compliance) of the elastic common carotid artery and the mus-
cular femoral and brachial arteries was described between cyclists and
sedentary controls. The main findings of this study were a significantly higher
cross-sectional compliance of the brachial artery and a tendency for a better
compliance of the common femoral artery in cyclists compared to the seden-
tary controls, without significant differences in pulse pressure between the
two groups.
Because the diameter of the brachial artery was not different between the
sedentary and the trained group, whereas the distensibility coefficient was
23% higher in the trained the better compliance must be considered to be the
resultant of a better vessel wall distensibility of this artery. With regard to the
common femoral artery, the internal diameter was found to be 12% larger in
cyclists. Most likely, this represents a local adaptation to facilitate the large
blood flow to the quadriceps muscles during strenuous exercise and is struc-
tural in origin, comparable to the larger diameter of the radial artery observed
in hammer-throwers (21). Distensibility coefficient of the femoral artery was
not significantly different in cyclists, probably as a consequence of the struc-
turally larger diameter. Since the diameter of the femoral artery was sig-
nificantly larger in cyclists and vessel wall distensibility unchanged, an
increased cross-sectional compliance of this artery could be expected. An
obvious explanation for the absence of statistical significance in compliance
could be the wide dispersion of individual data.
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The observed findings, especially of the brachial artery, suggest that aerobic
training can induce a decrease in muscle tone of predominantly muscular
arteries. This is further supported by studies which found a higher regional
compliance of the aorta in athletes compared to age-matched controls (22) and
a strong positive relationship between aortic distensibility and physical work-
ing capacity in young men (23).
Therefore, we trained sedentary men for 6 weeks at a moderate intensity
level (chapter 4). It was hypothesized that endurance training would result in
an improvement of vessel wall properties of large arteries and that these
changes could be dependent on or independent of a blood pressure lowering
effect of training. Despite a clear training effect, judged by an increase in
VO2max arid a decrease in resting heart rate, vessel wall properties were
unchanged. Because blood pressure in the basal state (after 45 min of rest) was
not lowered by conditioning, it was concluded that no intrinsic modification
of vessel wall properties occurred, which is in line with findings of Gilders et
al (24), who did neither observe a reduction in blood pressure with training
nor a change in pulse wave velocity both in normotensive and hypertensive
subjects. Furthermore, in the present study basal levels of plasma
catecholamines, plasma ANP and plasma renin were not changed following
endurance training. On the other hand, in a recent study by Cameron et al (25)
a fall in systolic blood pressure with concomitantly increased arterial com-
pliance was found following training, which suggests a dependency of a
better compliance on a reduction in transmural pressure. The combined
results of chapter 3 and 4 could implicate that modification of vessel wall
properties of large arteries with regular exercise is a long-term adaptation
which takes months or even years to develop. Alternatively, it is possible that
the observed differences between cyclists and sedentary subjects merely
reflect genetic endowment. Further research should determine whether en-
durance training of longer duration (at least 6 months) can improve vessel
wall properties of large arteries and should include subjects with (borderline)
hypertension who are likely to have a decreased arterial compliance and
distensibility (20).
VARIATIONS IN EXERCISE SYSTOLIC BLOOD PRESSURE
Exercise stress testing usually includes measurements of blood pressure
before, during and for several minutes after exercise. In the last decades, it has
been indicated that the blood pressure response during exercise may be of
diagnostic and prognostic value in various populations (see chapter 1). A
common finding in most of these studies is a considerable amount of intersub-
ject variation in the response of blood pressure to exercise. Factors inde-
pendently contributing to this variation are insufficiently evaluated and
reference values for exercise blood pressure are rather scarce, especially in
older and female populations. In chapter 5.1 (males) and chapter 5.2 (females),
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the response of systolic blood pressure (eSBP) to a progressive maximal
bicycle ergometer test was investigated in three large population samples of
subjects 40 years or older with either normal, borderline elevated or elevated
resting blood pressure. The influence of several variables on the blood pres-
sure response was studied, including age, weight, blood pressure at rest, heart
rate at rest and during exercise, smoking, alcohol consumption, and maximal
work capacity. Reference values at different work loads were established for
eSBP. In males, 53% of the variation in eSBP during cycle ergometry could be
explained by work load, SBP at the start of the exercise test and maximal
working capacity. In females, 63% of the variation in eSBP was explained by
work load, SBP at the start of the exercise test, age, and exercise heart rate. In
both males and females, no differences in the slope of eSBP between groups
of subjects with normal, borderline elevated and elevated supine blood pres-
sure were seen, although absolute values were clearly different, which con-
firms studies by other authors. It has been suggested that an excessive rise in
SBP during exercise is mainly seen in hypertensives with advanced stages of
disease (26); they were excluded in our studies. Subjects in the elevated blood
pressure groups had a significantly lower maximal working capacity com-
pared to the two other groups, although maximal heart rates were similar,
suggesting differences in stroke volume between the groups (27).
The main finding in the male study was the negative association between
eSBP and W ^ ^ Classification of physical fitness based on a questionnaire has
failed to show a relationship with eSBP (28), possibly because no reliable
estimate of physical fitness was obtained. In the female study, W^ax was not
associated with eSBP, possibly because of the relative small range in W^ax-
On the other hand, eSBP was positively associated with exercise heart rate
which could be an indicator of physical fitness (29).
A fairly large proportion of the variation in eSBP could not be explained,
neither in males nor in females. We believe that at least part of the remaining
variation could be accounted for by the variability of the indirect method of
blood pressure measurement itself.
ENDURANCE EXERCISE AND BETA-BLOCKADE
Beta-adrenoceptor antagonists are commonly used in the treatment of various
cardiovascular disorders, such as hypertension, coronary artery disease, and
cardiac arrhythmias. For many patients with these disorders, dynamic physi-
cal exercise is thought to be beneficial. Since a large number of the physically
active patients are treated with beta-blocking drugs, the side-effects of block-
ade of beta-1 and beta-2 adrenoceptors during exercise has become the scope
of numerous studies. It has been shown that beta-blockade interferes with
hemodynamics, energy metabolism, thermoregulation and potassium
homeostasis during exercise. Maximal aerobic exercise capacity is significant-
ly reduced in most studies in normotensive and hypertensive subjects (30).
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More important from a therapeutic point of view, however, is the effect of
beta-blockade during endurance exercise, i.e., the performance of work at a
constant submaximal intensity. Both in normotensive and hypertensive sub-
jects reductions in exercise time ranging from 11-55% were found compared
to placebo (30).
The exact mechanism behind this reduced endurance performance is not yet
clear. Both reduced exercise cardiac output and reduced rate of lipolysis or
changes in potassium homeostasis have been held responsible. With regard to
an inhibition of adipose tissue lipolysis, plasma glycerol and NEFA reduc-
tions ranging from 0 to 50% were found during exercise (31). During recovery
from exhaustive endurance exercise however, consistently lower levels were
found. These lower NEFA and glycerol levels could be the consequence rather
than the cause of a shorter exercise time. Therefore, a study was designed
(chapter 6) in which the amount of work performed was the same after acute
administration of propranolol and placebo. While during exercise no sig-
nificant differences were found in serum NEFA and glycerol concentrations
between propranolol and placebo, a decrease of 75% in post-exercise NEFA
and 50% in post-exercise glycerol on propranolol was found, compared to
placebo. Although this study is supportive for the hypothesis that reduced
availability of NEFA during exercise may be involved in the impairment of
endurance exercise performance after beta-blocker administration, this was
questioned by a recent study of our group (32). In this study, we increased the
availability of NEFA during exercise by Intralipid (triglyceride) infusions,
when healthy volunteers were treated with placebo, atenolol and propranolol.
Endurance time was significantly reduced by 40% by propranolol compared
to placebo and by 49% by propranolol plus Intralipid compared to placebo
plus Intralipid. The results of this study do not support the lack of NEFA for
energy consumption during exercise with beta-blockade. However, an effect
of beta-blockade on NEFA membrane transport can not be ruled out.
In chapter 7 the effect of antihypertensive treatment with carvedilol on
endurance performance was studied in patients with essential hypertension.
Carvedilol is a non-selective beta-blocker with vasodilating activity. It was
speculated that carvedilol would impair endurance performance to a lesser
extent than classical beta-blockers because of its vasodilating properties. Fur-
thermore, to date only limited data are available on the metabolic effects of
vasodilating beta-blockers during exercise (20). Compared to placebo treat-
ment, endurance time was reduced by 36% by carvedilol, a reduction com-
parable to that seen with non-selective beta-blockade (30). The hemodynamic
and metabolic effects during exercise resembled those seen during non-selec-
tive beta-blockade (31). In line with other studies (31), both propranolol
(chapter 5) and carvedilol (chapter 7) increased potassium levels significantly
during exercise. Increased plasma potassium levels could induce significant
changes in muscle membrane potential, resulting in impaired excitability and
thus contractibility of muscle fibers (33), which could explain (in part) the
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impairment of endurance performance by beta-blockade. The role of changes
in potassium homeostasis in the impaired endurance performance by beta-
blockade needs further research.
As described in chapter 1, thus far all antihypertensive agents studied have
been found to reduce endurance performance, although the largest impair-
ment in endurance performance is clearly found with beta-blockers and
diuretic agents. From the viewpoint of the patient with uncomplicated hyper-
tension who wants to engage in sporting activities, treatment with ACE-in-
hibitors or calcium antagonists is preferable. Based on current knowledge,
these agents will only lead to a minor impairment in endurance performance
and complaints about fatigue in relation to physical exercise have usually not
been reported (34, 35). The therapeutic dilemma facing the physician how-
ever, is the absence at present of studies showing ACE-inhibitors and calcium-
antagonists to reduce cardiovascular morbidity and mortality in contrast to
beta-blockers and diuretics (36).
REFERENCES
1. Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of
hypertension in healthy normotensive men and women. JAMA 252: 487-490,1984.
2. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence
of coronary heart disease. Ann Rev Publ Health 8: 253-287,1987.
3. Fagard RH. Physical fitnes and blood pressure. J Hypertens 11 (suppl 5): 47-52,1993.
4. Gordon NF, Scott CB, Wilkinson WJ et al. Exercise and mild essential hypertension.
Sports Med 10: 390-404,1990.
5. Jennings G, Nelson L, Dewar E et al. Antihypertensive and hemodynamic effects of one
year's regular exercise. J Hypertens 4 (suppl 6): 659-661,1986.
6. Tashiro E, Miura S, Koga M et al. Cross-over comparison between the depressor effects
of low and high work-rate exercise in mild hypertension. Clin Exp Pharmacol Physiol
20: 689-696,1993.
7. Tipton CM. Exercise, training and hypertension: an update. Exerc Sports Sci Revs 19:
447-505,1991.
8. Fagard R. Physical exercise in the management of hypertension: a consensus statement
by the World Hypertension League. J Hypertens 9:283-287,1991.
9. National High Blood Pressure Education Program Working Group Report on Primary
Prevention of Hypertension. Arch Intern Med 153:186-208,1993.
10. Vanhees L, Hespel P, Van Hoof R et al. Effect of physical training on systemic and brachial
artery hemodynamics in normal men. Int J Sports Med 13:145-151,1992.
11 Mancia G, Parati G, Pomiodossi G et al. Arterial baroreflexes and blood pressure and
heart rate variabilities in humans. Hypertension 8:147-153,1985.
12. Mancia G, Zanchetti A. Value of echocardiographic and ambulatory blood pressure
monitoring in hypertension. Clin Exp Hypertens All: 869-886,1989.
13. Gilders RM, Voner C, Dudley GA. Endurance training and blood pressure in normoten-
sive and hypertensive adults. Med Sci Sports Exer 21: 629-636,1989.
14. Van Hoof R, Hespel P, Fagard R et al. Effect of endurance training on blood pressure at
rest, during exercise and during 24 hours in sedentary men. Am J Cardiol 63: 945-949,
1989.
15. Jennings GL, Deaking G, Dewar E et al. Exercise, cardiovascular disease and blood
pressure. Clin Exp Hypertens All: 1035-1052,1989.
16. Baumgart P, Walger P, Fuchs G et al. Twenty-four hour blood pressure is not dependent
of endogenous circadian rhythm. J Hypertens 7: 331-334,1989.
17. Reneman RS, Van Merode T, Hick P, Hoeks APG. Flow velocity patterns in and disten-
sibility of the carotid artery bulb in subjects of various ages. Circulation 71:500-509,1985.
18. Van Merode T, Hick PJJ, Hoeks APG et al. Carotid artery wall properties in normotensive
and borderline hypertensive subjects of various ages. Ultrasound Med Biol 14: 563-569,
1988.
19. O'Rourke M. Arterial stiffness, systolic blood pressure, and a logical treatment of arterial
hypertension. Hypertension 15: 339-347,1990.
20. Van Bortel LM. Beyond the tension of hypertension. Ph.D. Thesis, Rijksuniversiteit
Limburg, Maastricht, 1993.
21. Giannattasio C, Cattaneo BM, Mangoni A A et al. Changes in arterial compliance induced
by physical training in hammer-thowers. J Hypertens 10 (suppl 6): 53-55,1992.
22. Mohiaddin R, Underwood SR, Bogren HG et al. Regional aortic compliance studied by
magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br
Heart J 62: 90-96,1989.
23. Eugene M., Vandewalle H., Bertholen JF, Teillac A. Arterial elasticity and physical
working capacity in young men. J Appl Physiol 61:1720-1723,1986.
24. Gilders RM, Dudley GA. Endurance training and treatment of hypertension: the con-
troversy. Sports Med 13: 71-77,1992.
25. Cameron JD, Dart AM, Topham S. Effects of 4 weeks of exercise training on arterial
compliance in men. Circulation 86 (suppl 1): 276,1992.
26. Sannerstedt R. Hemodynamic response to exercise in patients with arterial hypertension.
Acta Med Scand suppl 458: 7-83,1966.
27. Fagard R, Staessen J, Amery A. Maximal aerobic power in essential hypertension. J
Hypertens 6: 859-865,1988.
28. Criqui MH, Haskell WL, Heiss G et al. Predictors of systolic blood pressure response to
exercise: the lipid research clinic program prevalence study. Circulation 68:225-233,1983.
29. Astrand P-O, Rodahl K. Textbook of work physiology. McGraw Hill, New York, 1986.
30. Van Baak MA. Hypertension, beta-adrenoceptor blocking agents and exercise. Int J
Sports Med 15:112-115,1994.
31. Van Baak MA. Beta-adrenoceptor blockade and exercise: an update. Sports Med 5:
209-225,1988.
32. Van Baak MA, Mooij JM, Wijnen JA. Effect of increased plasma non-esterified fatty acid
concentrations on endurance performance during beta-adrenoceptor blockade. Int J
Sports Med 14: 2-8,1993.
33. Sjogaard G. Adams RP, Saltin B. Water and ion shifts in skeletal muscle of humans with
intense dynamic knee extension. Am J Physiol 248: R190-R192,1985.
34. Van Baak MA, Mooij JM, Wijnen JA, Tan FS. Submaximal endurance exercise perfor-
mance during enalapril treatment in patients with essential hypertension. Clin Phar-
macol Ther 50: 221-227,1991.
35. Mooij J, Van Baak MA, Bohm R et al. The effects of verapamil and propranolol on exercise
tolerance in hypertensive patients. Clin Pharmacol Ther 41:490-495,1987.
36. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment
of High Blood Pressure (JNC V). Arch Intern Med 153:154-183,1993.
145
146
Samenvatting
Uit epidemiologisch onderzoek blijkt dat lichamelijke inaktiviteit en een
gering lichamelijk prestatievermogen belangrijke en onafhankelijke risikofak-
toren zijn voor hart- en vaatziekten net zoals onder meer roken en een
verhoogde bloeddruk. Tevens blijkt dat bij fysieke inaktiviteit het risiko op
een hoge bloeddruk duidelijk toeneemt.
Verschillende studies hebben aangetoond dat een aantal risikofaktoren
voor hart- en vaatziekten, bijvoorbeeld het cholesterolgehalte of de bloeddruk
gunstig kan worden beinvloed door regelmatige lichamelijke aktiviteit.
Meestal worden in deze studies vrijwilligers die een zittend bestaan leiden,
getraind; dat wil zeggen, de konditie wordt verbeterd, maar of konditieverbe-
tering per se een voorwaarde is voor een verbetering van risikofaktoren staat
momenteel ter diskussie.
Van met name duurinspanning (fietsen, joggen) is overtuigend aangetoond
dat het de bloeddruk in rust kan verlagen bij mensen met hypertensie, gemid-
deld met ongeveer 7 mmHg voor de bovendruk (systolische bloeddruk) en
met gemiddeld 5 mmHg voor de onderdruk (diastolische bloeddruk). Een
voorwaarde is wel dat de inspanning van voldoende duur is (minstens 30
minuten) en voldoende zwaar (circa 50-70% van iemands maximaal prestatie-
vermogen). De effekten van regelmatige duurinspanning op de bloeddruk bij
gezonde mensen met een normale rust-bloeddruk zijn geringer, ongeveer 2-4
mmHg voor zowel de systolische als de diastolische bloeddruk. Door sommi-
ge onderzoekers wordt overigens betwijfeld of regelmatige inspanning de
bloeddruk in rust kan verlagen, omdat zij dit in hun training-studies niet
konden bevestigen. Een mogelijke verklaring hiervoor zou kunnen zijn dat
het moeilijk is een klein verschil van 2-4 mmHg in bloeddruk aan te tonen bij
de grote schommelingen in rust bloeddruk (tot ± 40%), gedurende de dag. j
Een andere verklaring veronderstelt dat een bloeddruk verlagend effekt voor- '
al wordt gezien onder meer stressvolle omstandigheden, zoals die gedurende
het dagelijks leven of tijdens inspanning. In hoofdstuk 2 worden de resultaten
beschreven van een studie waarbij ongetrainde vrijwilligers met een normale
of licht verhoogde bloeddruk gedurende 6 weken werden getraind. De bloed-
druk werd gemeten in rust (basaal nivo), tijdens inspanning en gedurende 24
uur tijdens het normale dagelijkse leven met behulp van een ambulante
monitor. Ondanks een duidelijke verbetering in konditie en een daling van de
hartfrekwentie in rust en tijdens inspanning, was er geen effekt van de
training op de bloeddruk.
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De efficientie van het hart- en vaatstelsel wordt verbeterd door regelmatige
duurinspanning. Mortaliteit en morbiditeit ten gevolge van hypertensie toont
een beter verband met de systolische bloeddruk dan met de diastolische
bloeddruk, wat een pulsatiel stress-effekt suggereert. Vaatwandeigenschap-
pen (kompliantie en distensibiliteit) van grote arterien bepalen voor een
belangrijk deel dit pulsatiel stress-effekt. Of deze vaatwandeigenschappen
verbeteren door training is onbekend.
In hoofdsruk 3 vergeleken wij de vaatwandeigenschappen van drie grote
arterien (de a. carotis, de a. femoralis en de a. brachialis) van zeer goed
getrainde wielrenners met die van ongetrainden van gelijke leeftijd, gewicht
en lengte. Er bleek geen verschil in vaatwandeigenschappen van de a. carotis
tussen de getrainden en ongetrainden. De diameter van de a. femoralis van de
wielrenners was signifikant groter en de kompliantie beter, hoewel statistisch
juist niet signifikant. De kompliantie van de a. brachialis van de wielrenners
was signifikant beter door een grotere distensibiliteit (rekbaarheid) van de
vaatwand. Deze bevindingen suggereren een mogelijke daling van spiertonus
van de muskulaire arterien door duurtraining.
In hoofdstuk 4 toetsten wij deze hypothese door ongetrainde vrijwilligers 6
weken te trainen. Wij veronderstelden hierbij dat de vaatwandeigenschappen
een verbetering konden laten zien ten gevolge van een eventuele bloeddruk-
daling of onafhankelijk hiervan door intrinsieke veranderingen. Ondanks een
duidelijke verbetering van de VC>2max (konditieverbetering) na 6 weken trai-
ning werden er geen verschillen gezien in de vaatwandeigenschappen. Een
mogelijke verklaring hiervoor zou kunnen zijn dat het langer duurt, voordat
door training vaatwandeigenschappen worden veranderd of dat de verschil-
len die wij zagen tussen wielrenners en ongetrainden, eerder een uitdrukking
zijn van verschillen in genetische aanleg.
De laatste jaren staat de bloeddrukreaktie tijdens gestandaardiseerd inspan-
ningsonderzoek in de belangstelling. Een abnormaal sterke bloeddrukstijging
bij mensen met een normale rust-bloeddruk zou een belangrijke voorspeller
zijn voor het ontwikkelen van een latere hypertensie. Verder zou de bloed-
drukstijging tijdens inspanningsonderzoek een betere differentiatie mogelijk
maken tussen individuen met een echte hypertensie in rust en een verhoogde
bloeddruk in rust ten gevolge van bijvoorbeeld spanning. Tegelijkertijd wordt
echter gekonstateerd dat referentiewaarden voor bloeddruk tijdens belasting
grotendeels ontbreken, vooral voor ouderen en vrouwen. Tevens blijkt er een
aanzienlijke variatie tussen personen te bestaan in inspanningsbloeddruk.
Het doel van de studies in hoofdsruk 5.1 (mannen) en hoofdstuk 5.2 (vrou-
wen) was een evaluatie van die faktoren die een onafhankelijke bijdrage
leveren aan de interindividuele variatie in systolische bloeddruk tijdens in-
spanning. Dit werd gedaan door 747 mannen en 871 vrouwen die 40 jaar of
ouder waren, op een gestandaardiseerde manier op een fietsergometer te
belasten en een groot aantal mogelijk prognostische faktoren te onderzoeken
(zoals: bloeddruk in rust, gewicht, vetpercentage, leeftijd, alkoholkonsump-
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tie, rookgewoonten, prestatievermogen). Bij de mannen blijkt 53% van de
interindividuele variatie in systolische bloeddruk te verklaren uit fysiek be-
lastingsnivo, de systolische bloeddruk vlak voor de start van de inspanning-
stest en het maximaal prestatievermogen. Bij vrouwen is 63% van de
interindividuele variatie te verklaren uit fysiek belastingsnivo, systolische
bloeddruk vlak voor de start van de inspanningstest, leeftijd en de hartfre-
kwentie tijdens inspanning. Voor zowel mannen als vrouwen werden er geen
verschillen gevonden in bloeddrukreaktie tijdens inspanning tussen groepen
met in rust een normale, borderline verhoogde of verhoogde bloeddruk.
Mannen en vrouwen met een hoge bloeddruk hebben gemiddeld een lager
prestatievermogen en hogere hartfrekwentie in rust. Referentiewaarden voor
systolische bloeddruk tijdens inspanning werden voor mannen en vrouwen
voorgesteld.
Bij de behandeling van patienten met een lichte tot matige hypertensie
wordt allereerst getracht de bloeddruk te normaliseren met behulp van een
aantal niet-medicamenteuze maatregelen: gewichtsreduktie, beperking van
zoutkonsumptie en regelmatige lichamelijke inspanning. Bij een groot aantal
van deze patienten wordt echter geen adekwate bloeddrukregulatie bereikt,
zodat medicamenteuze behandeling noodzakelijk wordt. Beta-blokkers zijn
hierbij medicijnen van eerste keuze, omdat hiervan overtuigend is aange-
toond dat zij de lange-termijn komplikaties van een te hoge bloeddruk beper-
ken. Beta-blokkade vermindert echter het maximaal lichamelijk prestatiever-
mogen aanzienlijk. Van grotere praktische betekenis is het feit dat het duur-
prestatievermogen belangrijk wordt beperkt. Het duurprestatievermogen
wordt hierbij gedefinieerd als de volhoudtijd van een submaximale belasting,
meestal ongeveer 70% van het maximaal prestatievermogen. Beta-blokkade
vermindert deze volhoudtijd met gemiddeld 11-55% zowel bij normotensieve
proefpersonen als bij patienten met hypertensie. Het mechanisme waardoor
het duurprestatievermogen wordt beperkt, is niet bekend. Een aantal moge-
lijke verklaringen is gesuggereerd: [1] een verminderd hartminuutvolume
tijdens inspanning vermindert de bloedstroom naar de spieren, [2] de lipoly-
sis in het vetweefsel wordt geremd, waardoor vrije vetzuren als energiebron
minder beschikbaar zijn, of [3] de kaliumhomeostasis verandert, waardoor de
prikkelbaarheid en dus het kontraktievermogen van de spiervezels afneemt.
Met betrekking tot de geremde lipolysis van het vetweefsel werden er tijdens
duurtesten met beta-blokkers zowel lagere, onveranderde en zelfs hogere
plasma glycerol- en vrije vetzuurspiegels gevonden. Een konsistente bevin-
ding was echter dat in de herstelfase na een uitputtende duurinspanning
lagere plasma glycerol- en vrije vetzuurspiegels werden gezien. Deze laatste
bevinding kan echter het gevolg in plaats van de oorzaak zijn van een beperk-
te duurprestatie. In hoofdstuk 6 werd getracht oorzaak en gevolg te scheiden
door gezonde vrijwilligers zowel tijdens beta-blokkade als tijdens placebo-
kondities een gelijke duurprestatie te laten verrichten. Tijdens duurinspan-
ning waren er geen signifikante verschillen in plasma glycerol- en vrije
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vetzuurkoncentraties tussen beide kondities. In de herstelfase echter waren
de vrije vetzuurkoncentraties 75% en de glycerolkoncentraties 50% lager
tijdens beta-blokkade. Deze studie bevestigt de hypothese dat beta-blokkade
de lipolysis in het vetweefsel tijdens inspanning remt.
In hoofdstuk 7 werd het effekt van een nieuwe niet-selektieve beta-blokker
met vaatverwijdende eigenschappen (carvedilol) op het duurprestatievermo-
gen en metabolisme tijdens inspanning onderzocht in patienten met essentiele
hypertensie. Wij veronderstelden dat carvedilol, omdat het de bloeddruk op
een meer fysiologische manier verlaagt (door een verlaging van de perifere
weerstand), het prestatievermogen minder zou beperken. Uit de resultaten
van deze studie blijkt echter dat carvedilol tijdens inspanning dezelfde meta-
bole effekten laat zien als een niet-selektieve beta-blokker en dat het duur-
prestatievermogen met 39% wordt beperkt, vergelijkbaar met niet-selektieve
beta-blokkers zonder vaatverwijdende eigenschappen.
Zoals beschreven in hoofdstuk 1, verminderen alle bloeddrukverlagende
medicijnen, die tot nu toe zijn onderzocht, in meer of mindere mate het
duurprestatievermogen. De grootste vermindering in duurprestatievermo-
gen wordt echter gezien bij behandeling met beta-blokkers en diuretica.
Vanuit het perspektief van de hypertensiepatient die lichamelijk aktief wil
zijn, is behandeling met ACE-remmers of calciumantagonisten te prefereren.
Deze middelen verminderen het duurprestatievermogen in geringe mate en
geven meestal geen vermoeidheidsklachten tijdens lichamelijke inspanning.
Het therapeutische dilemma voor de behandeld arts is echter, dat van deze
antihypertensiva nog niet is aangetoond dat zij een gunstig effekt hebben op
kardiovaskulaire morbiditeit en mortaliteit.
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List of abbreviations
ANP atrial natriuretic peptide
BA brachial artery
BP blood pressure
bpm beats per minute
BORD borderline elevated blood pressure group
CC cross-sectional compliance
CCA common carotid artery
CO cardiac output
CHD coronary heart disease
CVD cardiovascular disease
D diameter
AD change in diameter
DBP diastolic blood pressure
DC distensibility coefficient
E epinephrine
ECG electrocardiogram
eHR exercise heart rate
ELEV elevated blood pressure group
eSBP exercise systolic blood pressure
FA femoral artery
FFA free fatty acids
HDL high-density lipoprotein
HR heart rate
LDL low-density lipoprotein
LV left ventricle
LVH left ventricular hypertrophy
LVM left ventricular mass
LVMI left ventricular mass index
NE norepinephrine
NEFA non-esterified fatty acids
AP pulse pressure
PRA plasma renin activity
PRO prorenin
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R respiratory exchange ratio
R2 coefficient of determination
RAAS renin-angiotensin-aldosterone system
REN renin
SBP systolic blood pressure
SEM standard error of the mean
SD standard deviation
SNS sympathetic nervous system
SV stroke volume
SVR systemic vascular resistance
TPR total peripheral resistance
W watt
WL work load
maximal work capacity
maximal oxygen uptake
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